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1. Introduction 
 1.1. Intermediate filaments 
The cytoskeleton is the major factor of structural organization of a cell. The eukaryotic 
cytoskeleton consists of three main constituents that are distinguished by their size and 
composition. The microtubules are the largest type of cytoskeletal filaments with a 
diameter of approximately 25 nanometers (nm) and are composed of a protein called 
tubulin. The actin filaments are the smallest elements of the cytoskeleton, having a 
diameter of about 6 nm and are made up of the actin protein. However, the intermediate 
filaments (IF) have a diameter of 10 nm, which is in between that of the microtubules and 
actin. Mammalian IF polypeptides can be classified into several types based on the 
similarities between their amino acid sequences and show a varied distribution depending 
on the cell type (Hesse et al., 2001; Snider and Omary, 2014).  
Table 1: Nomenclature of intermediate filaments based on (Snider and Omary, 2014) 
IF type IF Cell type 
I Type I keratin  
( K9-K28, K31-K40) 
Epithelial cells 
II Type II keratin  
( K1-K8, K71-K86) 
III Vimentin Mesenchymal cells 
Desmin Myocytes 
Glial fibrillary acidic protein Glial cells 
Peripherin Peripheral neurons 
IV Neurofilaments CNS neurons 
ɑ-Internexin 
Nestin Developing and regenerating 
cells 
Syncoilin Myocytes 
Synemin 
V Lamins (lamin A, lamin B and lamin 
C) 
All nucleated cells 
VI Filensin Lens 
Phakinin 
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1.2. Keratin - the epithelial intermediate filaments 
Keratins are the intermediate filaments of epithelial tissue which line the internal surfaces 
such as the inner lining of the intestine (example of a simple epithelia) as well as external 
surfaces such as the outer layer of the skin (example of a stratified epithelia) (Moll et al., 
1982; Pekny and Lane, 2007). Further, keratins are expressed in ‘hard’ epithelia such as 
hair, nails and feathers and in ‘soft’ epithelia such as liver, skin and urinary bladder 
(Coulombe and Omary, 2002). The keratin intermediate filaments have mechanical as well 
as non-mechanical functions. Thus, keratins provide mechanical integrity to the epithelial 
tissue as well as contribute as regulatory factors in cellular signaling eg. stress-response, 
apoptosis, wound healing (Moll et al., 2008). 
Keratins are classified into type I (acidic) and type II (basic) depending on their isoelectric 
pH (Bowden et al., 1984). Keratins are obligatory heteropolymers, which are held together 
by hydrophobic coiled-coil interactions (Herrmann et al., 2003; Herrmann et al., 2009). 
The equimolar amounts of a specific type I and type II keratin pair contribute in 
maintaining the differentiation and the functional status of the epithelia (Bragulla and 
Homberger, 2009; Moll et al., 2008). 
1.3. Phosphorylation - a major post-translational modification of keratins 
Keratins share structural properties with other intermediate filaments. A keratin molecule 
is comprised of a conserved α -helical rod domain of 310 amino acids flanked by highly 
variable end domains (Steinert et al., 1983) (Fig. 1). The end domains consist of a head 
region at the amino-terminus and a tail region at the carboxyl-terminus. Several 
phosphorylation sites have been identified in the keratin end domains (Steinert et al., 1982; 
Steinert, 1978; Steinert, 1988) (Fig. 1). Each of the phosphorylation sites is a target of 
multiple kinases and phosphatases (Fig. 1). Keratin phosphorylation is a highly dynamic 
process, which is clearly evident from the rapid keratin filament network disassembly upon 
tyrosine phosphatase inhibition (Strnad et al., 2002; Strnad et al., 2003; Woll et al., 2007).  
1.3.1. Effect of phosphorylation on keratin filament organization 
Convincing evidences have provided links towards keratin phosphorylation and its possible 
influence on keratin network organization. The impact of phosphorylation-induced keratin 
structure modifications has been suggested at different levels of keratin filament network 
arrangement (Moch et al., 2013; Sanhai et al., 1999; Strnad et al., 2002; Yeagle et al., 
1990). 
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Fig. 1: Scheme depicting the structure and phosphorylation sites identified in type II keratin K8. 
Keratin filament assembly: Similar to other intermediate filaments, keratins follow a 
hierarchical mode of assembly which distinguishes them from microtubules and actin 
filaments. However, keratin filament assembly differs from the assembly of other 
intermediate filaments due to the requirement of equimolar amounts of both type I and type 
II keratins (Franke et al., 1983; Hatzfeld and Franke, 1985) (Fig. 2). Keratin filament 
assembly initiates by the formation of a parallel coiled-coil heterodimer of a type I and 
type II keratin, which further form an anti-parallel tetramer (Fig. 2). Tetramers associate 
laterally to form a unit length filament (ULF) (Fig.2). Several ULF molecules undergo 
longitudinal annealing to form the mature 10 nm filament (Fig. 2). (Coulombe and Fuchs, 
1990; Hatzfeld and Weber, 1990; Steinert, 1990).  
Post-translational modifications, which are one of the major factors changing the 
isoelectric point of the keratins can also influence keratin filament organization (Bowden et 
al., 1984). Specifically, conformational modifications in the keratin molecule upon 
treatment with either kinase- or ethanol- induced phosphorylation have been observed 
(Sanhai et al., 1999; Yeagle et al., 1990). Further, the keratin head domain, specifically the 
H1 (homology 1) subdomain of the type II keratin played a direct role in keratin assembly 
(Hatzfeld and Burba, 1994; Steinert et al., 1985; Wilson et al., 1992). The presence of 
abundant phosphorylation sites in the head domain including the highly conserved 
LLS/TPL motif in the H1 subdomain highlighted the importance of phosphorylation in 
keratin filament assembly (Toivola et al., 2002). Recently, phosphomimetic mutants of the 
The structural arrangement of the head, rod and tail domains of keratin 8 (K8) are described. Kinases 
phosphorylating each of the residues are mentioned alongside. Note that the majority of the phosphorylation 
sites are located in the keratin end domains. Figure reference- (Sawant and Leube, 2016). 
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keratin 8 (K8) head domain, S73E K8 and S52E K18, showed reduced filament length and 
network connectivity in vitro. The assembly kinetics were altered during longitudinal 
elongation of the bundles thus resulting in abnormally arrested keratin assembly 
intermediates during the mutant network assembly in vitro (Deek et al., 2016). 
             
Fig. 2: Scheme depicting the different stages of intermediate filament assembly.  
Keratin cycle: Besides, providing mechanical stability, the keratin cytoskeleton also 
confers the property of plasticity to the cell. This is possible due to the dynamic nature of 
the keratin filament network which is based on a constant cycle of assembly and 
disassembly of the keratin filaments referred to as the keratin cycle (Kolsch et al., 2010; 
Windoffer et al., 2011).The keratin cycle involves the nucleation of non-filamentous 
keratin particles called the keratin filament precursors (KFPs) at the cell periphery into 
keratin filaments. The keratin filaments continuously move towards the nucleus with a 
progressive integration into the keratin filament network (Windoffer et al., 2006; 
Keratins follow a hierarchical mode of filament assembly similar to all the intermediate filaments. However, 
in case of the keratins, a type I and a type II keratin partner is essential to form a coiled-coil dimer. Two such 
heterotypic dimers laterally associate in an anti-parallel, staggered fashion to form a tetramer. Further, eight 
tetrameric units form a ~ 60 nm long unit length filament (ULF), which undergoes longitudinal elongation to 
form the ~10 nm keratin intermediate filament. The figure was adapted from (Moch, 2015).  
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Windoffer and Leube, 2001). The centripetal movement of the keratin filaments either ends 
with the disassembly of the keratin filaments back into KFPs, which are re-utilized for 
another round of keratin filament assembly or with maturation to form a durable 
perinuclear keratin cage. Drug-induced kinase activation or phosphatase inhibition studies 
have shown that phosphorylation accelerated the keratin cycle (Moch et al., 2013; 
Windoffer and Leube, 1999; Windoffer et al., 2004). This revealed the potential of 
phosphorylation in modulating keratin dynamics. 
Keratin network remodeling: A certain rate of keratin subunit exchange between the 
filamentous and the non-filamentous form is essential to maintain the keratin cycle at an 
optimal pace. This can be explained by various observations from different approaches 
used to study drug-induced keratin phosphorylation.  
Keratin filament reorganization into granules was a common observation upon kinase 
activation or phosphatase inhibition suggesting the contribution of keratin phosphorylation 
in keratin network remodeling (Strnad et al., 2002; Strnad et al., 2003). Additionally, 
association of the keratin granules with phospho-epitopes in events such as drug-induced 
keratin phosphorylation, mitosis, stress or apoptosis indicated the link between keratin 
phosphorylation and keratin reorganization (Chou and Omary, 1993; Liao et al., 1997; 
Toivola et al., 2002; Woll et al., 2007). 
Besides the keratin cycle, the dynamic nature of keratin is reflected from the equilibrium 
between the detergent soluble (non-filamentous) and insoluble (filamentous) fraction. 
Anomalies in keratin dynamics have been linked to an imbalance in biochemical 
equilibrium of keratins. Furthermore, phosphorylation was an important factor influencing 
the balance between the filamentous and non-filamentous keratin. It was shown that drug-
induced phosphorylation enhanced the detergent solubility of the keratins (Feng et al., 
1999; Strnad et al., 2002; Woll et al., 2007; Zhou et al., 1999). 
On a larger perspective, it can be understood that drug-induced phosphorylation caused the 
speeding of the keratin cycle, keratin filament reorganization and enhanced keratin 
solubility. This served as an important hint towards the bias of the keratin cycle from 
assembly towards disassembly induced by phosphorylation. 
1.3.2. Role of keratin phosphorylation in cell physiology  
Phosphorylation-mediated keratin reorganization was a common observation in three 
important cellular phenomena, namely mitosis, stress and apoptosis. Keratin 
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phosphorylation contributed to each of these events in diverse ways as will be discussed 
further. Keratin phosphorylation also influenced other physiological processes by 
influencing protein-function, which was controlled by keratin binding. 
Mitosis: The process of mitosis includes considerable cell-shape changes. In line with this 
idea, mitosis involved substantial restructuring of the keratin network into diffused or 
granular pattern (Aubin et al., 1980; Baribault et al., 1989; Celis et al., 1983; Chou and 
Omary, 1993; Fey et al., 1983; Horwitz et al., 1981; Lane et al., 1982; Schwarz et al., 
2015). Further, the keratin reorganization during mitosis was linked to phosphorylation 
(Liao et al., 1997; Toivola et al., 2002; Woll et al., 2007). The highly conserved H1 
subdomain in the head of type II keratins contains the LLS/TPL motif. The LLS/TPL motif 
is phosphorylated during mitosis as reported for T133 K4, T150 K5, T145 K6 and S73 K8 
residues (Toivola et al., 2002). Besides, S431 K8 and type I keratin residues such as S33 
K18 and S52 K18 were also phosphorylated during mitosis (Ku et al., 1998a; Ku et al., 
2002; Ku and Omary, 1997; Liao et al., 1997; Liao et al., 1995a).           
Stress: Stressful situations in the cellular environment are accompanied with activated 
kinase signaling, which initiate the stress-response mechanism. However, the excess kinase 
activity can also have non-specific, harmful effects. Keratins being abundant 
phosphoproteins, buffer away the increased kinase activity and thus are called the 
‘phosphate sponge’ (Ku and Omary, 2006). Association of keratin phosphorylation was 
observed with various types of stresses. Alcohol, heavy metals and hepatotoxins led to 
aggregation of hyperphosphorylated keratins (S73 K8 and S431 K8) in the liver in the form 
of Mallory-Denk bodies (Denk et al., 2000; Nan et al., 2006; Stumptner et al., 2000; 
Zatloukal et al., 2004). The presence of Mallory-Denk bodies improved tolerance to 
hepatotoxic stress (Zatloukal et al., 2000). Phosphorylation-mediated keratin 
reorganization was also observed upon mechanical stress, heat stress, osmotic stress and 
microbial infection (Chamcheu et al., 2011; Liao et al., 1995b; McIntosh et al., 2010; 
Ridge et al., 2005; Sivaramakrishnan et al., 2009; Tao et al., 2006; Toivola et al., 2009). 
Apoptosis: Apoptosis leads to severe changes in cell morphology. Keratin phosphorylation 
was an early event in apoptosis as observed from phosphorylation of S73 K8, S431 K8, 
S52 K18, T150 K5 and S13 K20 residues (Ku and Omary, 1997; Ku et al., 2003; Zhou et 
al., 2006). Keratin filament network collapse upon caspase activation was accompanied by 
S52 K18 phosphorylation as detected in the apoptotic cellular aggregates (MacFarlane et 
al., 2000). However, apoptosis-inducing, cyclin-dependent kinase inhibitor roscovitine and 
A B 
C D 
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broad-reactive protein kinase inhibitor staurosporine-mediated prevention of S73 K8 
phosphorylation did not inhibit the appearance of keratin fragments in apoptotic inclusions 
(Schutte et al., 2004). Thus, keratin phosphorylation was not a pre-requisite for caspase-
mediated keratin filament cleavage but may have played a role in increasing keratin 
disintegration during this process. On the other hand, a negative correlation between 
keratin phosphorylation and keratin ubiquitination was observed suggesting the role of 
phosphorylation in maintaining optimal keratin levels in the cell (Jiang et al., 2014; Ku and 
Omary, 2000).  
Keratin interaction with other proteins: Another mode of influence of keratin 
phosphorylation on cell physiology is by regulating the binding of keratins with associated 
proteins. The most studied example of phosphorylation-dependent keratin-protein 
interaction was in context of the 14-3-3 proteins, which function in cell-cycle progression 
and signal transduction (Fu et al., 2000). 14-3-3-binding to K18, which required 
phosphorylation of S33 K18, was essential for normal mitotic progression (Liao and 
Omary, 1996). Similarly, binding of 14-3-3σ with the solubilized complex of K5/K17/actin 
was promoted by the kinase PKCζ and inhibited by phosphatase PP2A, both of which 
affect keratin phosphorylation (Boudreau et al., 2013). The soluble keratin-actin complex 
contributed in breast cancer invasion. Further, binding of 14-3-3σ to K17 required T9/S44 
K17 phosphorylation during the wounding of stratified epithelia. 14-3-3σ and K17 
interaction regulated tissue repair and homeostasis during skin development (Kim et al., 
2006). During oxidative or chemical stress, S33 K18 phosphorylation modulated Raf 
kinase activation and S52 K18 sequestered Raf kinase activity (Ku et al., 2004). Keratin 
phosphorylation also regulated the binding of keratins to cytolinker proteins plectin, 
periplakin and epiplakin, which led to keratin filament network remodeling, thus 
controlling cytoskeletal pliability (Long et al., 2006; Spazierer et al., 2008; Strnad et al., 
2002). 
1.4. Diseases linked to keratin phosphorylation 
The impact of keratin phosphorylation on cell physiology is also reflected in diseases of 
epithelia. Several disease models have served as important evidence in indicating the role 
of keratin phosphorylation in disease development, progression and its resistance. 
1.4.1. Diseases of simple epithelia  
Simple epithelia, by definition, consist of a single layer of cells that are attached to a 
basement membrane composed of connective tissue. The simple epithelia are present, e.g., 
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in liver, pancreas, intestine and kidney. They contain K8/K18 as the major keratins 
followed by K19 and K20. 
Liver: Phosphorylation of S73 K8 and S431 K8 was observed in mouse hepatocytes 
during liver injuries induced by toxins such as microcystin, thioacetamide and 
acetoaminophen (Guldiken et al., 2015; Ku et al., 1995; Strnad et al., 2008). 
Phosphorylation-mediated keratin network reorganization was often detected in the form of 
Mallory-Denk bodies in the liver during toxicity which contributed to improve stress-
resilience (Zatloukal et al., 2000). Mice overexpressing R89C K18 mutant showed S73 K8 
and S431 K8 phosphorylation accompanied with inflammation, necrosis and elevated Fas-
mediated apoptosis in hepatocytes (Ku et al., 2003). Further, S33 K18 and S52 K18 
phosphorylation was linked with cirrhotic and non-cirrhotic hepatitis and correlated with 
increasing liver lesions (Shi et al., 2010). 
Pancreas: K8/K18-overexpressing mice showed elevated S33 K18 phosphorylation in the 
pancreas which was linked to pancreatic secretory defects (Ku et al., 2002). In addition to 
S33 K18 phosphorylation, S73 K8 phosphorylation was also observed and was interpreted 
as an outcome of stress (Liao and Omary, 1996). 
Intestine: K8, K18 and K19 phosphorylation-mediated keratin redistribution was observed 
along with morphological abnormalities in the human colon carcinoma-derived CaCo2 
cells, induced by a cyclic adenosine monophosphate (AMP) activator, forskolin. The 
defects included decreased intercellular spaces, shortening of the microvilli and decreased 
expression of hydrolases in the apical brush border of the CaCo2 monolayer (Baricault et 
al., 1994). Further, S13 K20 phosphorylation was observed during dextran sulphate 
sodium-induced mouse colitis (Zhou et al., 2006). 
Cancer: Anomalous phosphorylation of the simple epithelial keratins has also been widely 
studied in cancer disease progression. S431 K8 hyperphosphorylation-mediated keratin 
reorganization led to increased cell migration and invasiveness in pancreatic cancer- 
derived Panc-1 cells (Beil et al., 2003). On the other hand, dephosphorylation of S73 K8 
and S431 K8 resulted in increased cell migration and tumorigenesis in colorectal cancer- 
derived DLD1 and HCT116 cells (Khapare et al., 2012; Mizuuchi et al., 2009). Thus, 
phosphorylation-dependent keratin network plasticity regulates tumor cell migration. 
Sorafenib-mediated dephosphorylation of S73 K8, S33 K18 and S52 K18 in hepatocellular 
carcinoma-derived hepatoma and OUMS29 cells showed increased apoptosis and tumor 
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angiogenesis. Sorafenib is a serine/threonine and receptor tyrosine kinase inhibitor, which 
primarily led to anti-proliferative effects in hepatocytes (Honma and Harada, 2013; Liu et 
al., 2006; Wilhelm et al., 2004). Contrariwise, AE-BS (acetone extract of Bupleurum 
scorzonerifolium) - mediated S73 K8 hyperphosphorylation caused increased apoptosis in 
lung cancer derived A549 cells. AE-BS manifests its anti-cancer properties by ERK 1/2 
activation (Chen et al., 2005). Also, K8/K18 hyperphosphorylation in cervical cancer- 
derived HeLa cells was linked to tumor suppression (Song et al., 2013). Hence, keratin 
phosphorylation affected cancer depending on the disease context. 
1.4.2. Diseases of stratified epithelia 
Stratified epithelia consist of a multiple layer of cells, in which the basal layer is attached 
to the basement membrane and the most superficial layer of the suprabasal layers form the 
surface of the epithelia (Fig. 3). The basal cell layer is mitotically active whereas the 
suprabasal cell layer undergoes differentiation (Fig 3). Unlike the keratins of simple 
epithelia, phosphorylation of the stratified epithelial keratins is not yet clearly studied in 
terms of disease mechanisms. However, there have been several hints towards alteration of 
keratin phosphorylation in skin diseases. 
Basal layer: Epidermolysis bullosa simplex (EBS), an autosomal dominant skin disorder, 
is caused by genetic missense or in-frame deletion mutations in either of the basal layer 
keratins, K5 or K14 (Albers and Fuchs, 1992). The disease manifests itself in the form of 
basal cell lysis and fluid-filled skin blisters in response to even mild physical trauma 
(Coulombe et al., 1991b). Formation of keratin aggregates, which further elevate upon 
mechanical stress, is a hallmark feature of this disease (Chan et al., 1993).  
There are various indirect evidences linking keratin phosphorylation to EBS. Epithelial cell 
lines expressing the EBS mutant R125C K14 showed that the mutant keratin aggregates 
had high mobility and enhanced detergent solubility, which were reported observations of 
increased keratin phosphorylation (Werner et al., 2004). However, this has to be 
investigated in detail. 
Further, a substitution mutation of I161 to S161 in the K5 H1 domain, which leads to 
Weber-Cockayne EBS (EBS-WC), a milder form of EBS, created a new potential PKC 
phosphorylation site (Chan et al., 1993). PKC phosphorylation mediated keratin filament 
remodeling upon mechanical stress. Additionally, the H1 subdomain was essential in the 
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lateral association of the keratin dimers during keratin filament assembly (Parry, 1992; 
Steinert, 1991a; Steinert, 1991b).  
                           
Fig. 3: Representation of the different layers of the mammalian skin and keratin expression in it.  
Next, immortalized cells derived from the patients of Dowling-Meara EBS (EBS-DM) 
(E475G K5 and R125P K14), a severe form of EBS, showed increased keratin aggregation 
upon heat stress. The level of EBS-DM mutant keratin aggregation elevated with an 
increased interaction between the T150 K5 phospho-epitopes and heat shock protein 70 
(HSP70) (Chamcheu et al., 2011). Further, chemical chaperone trimethylamine-N-oxide 
(TMAO) as well as kinase inhibition reduced keratin granules in the cells derived from 
EBS-DM patients, suggesting role of keratin phosphorylation-induced protein misfolding 
in EBS disease (Chamcheu et al., 2011). Further, biopsies from human psoriatic skin and 
squamous cell carcinoma have shown hyperphosphorylation of T150 K5, indicating keratin 
phosphorylation as a marker of hyperproliferation in stratified epithelia (Toivola et al., 
2002). 
Suprabasal layer: Epidermolytic hyperkeratosis (EH) is a skin disease, which involves 
disruption of the suprabasal layers of the epidermis. EH patients showed a substitution 
mutation at L160P in the K1 H1 subdomain, which led to the generation of a new potential 
phosphorylation site at the adjacent serine residue. This indicated the likelihood of 
phosphorylation-mediated conformational change in the H1 subdomain with a 
consequence on keratin filament assembly. The effect of L160P K1 mutation on keratin 
K5/K14 is the major keratin pair of the basal layer of the skin which undergoes proliferation. K1/K10 is 
expressed in the suprabasal layers which are the differentiating layers of the skin. The figure was adapted 
from (Radtke and Raj, 2003) 
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filament assembly was confirmed by the inability of the mutant peptide in disrupting 
preformed K1/K10 filament networks unlike the WT K1 peptide (Chipev et al., 1992). 
1.5. Determining the role of phosphorylation in keratin function 
The following mechanisms were studied to understand the potential role of keratin 
phosphorylation within a cellular environment: 
Oxidative homeostasis: One of the major manifestations of the EBS skin blistering 
disease is the presence of keratin aggregates (Chamcheu et al., 2011; Sawant and Leube, 
2016). Protein aggregation poses as a potential threat to the homeostasis of the cell due to 
the consequent endoplasmic reticulum (ER) stress owing to the unfolded protein response 
(UPR). Moreover, these molecular mechanisms often involve the coupling of 
mitochondrial activity to combat the resulting increase of oxidative reactions (Malhotra 
and Kaufman, 2011; Senft and Ronai, 2015). Hence, considering the involvement of 
mutant, misfolded keratin in the basal layer of skin diseases, it would be an important 
question to address the viability of the K5 phospho-site mutant cells and their ability to 
combat oxidative stress. Such altered cellular conditions are often reflected in the form of 
activation of the mitogen activated protein kinase (MAPK) pathway which involves 
phosphorylation mediated induction of enzyme activities in response to stimulus resulting 
in several biological responses (Fig. 4) (Cargnello and Roux, 2011). 
                          
Fig. 4: Scheme representing the activation of the mitogen activated protein kinase (MAPK) pathway. 
 The components for the activation of each of the MAPK namely, Jun-amino terminal kinases (JNK), 
extracellular signal related kinase (ERK) and p38 MAPK at different levels is shown in response to stimulus, 
resulting into a biological response. The figure was adapted from (Wang and Xia, 2012) 
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Cell cycle: The restriction of K5/K14 expression in the basal layer of the skin (Fig. 3) has 
been linked to cell proliferation and thus has a functional importance of replenishing the 
loss of cells in the suprabasal layers of the epidermis (Fig. 3). Hence, a normal structure 
and function of K5/K14 is essential to maintain the physical stability of the epidermis. This 
is evident from the extreme fragility of the skin of patients with the hereditary blistering 
skin disease epidermolysis bullosa simplex (EBS), which harbors mutations of either the 
K5 or K14 gene (Lane and McLean, 2004). 
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2. Objectives of the work 
The experiments discussed in this thesis were focused on the effect of phosphorylation on 
the type II keratin, keratin 5 (K5). This was because type II keratins were phosphorylated 
with a stoichiometric preference over the type I keratins (Liao et al., 1995a; Yano et al., 
1991) (Fig. 3). To overrule compensation by endogenous keratin, skin keratinocytes from 
mice lacking the type II keratin cluster, situated on chromosome 15, were used to 
investigate the properties of phospho-site mutants of the T150 K5 residue (Vijayaraj et al., 
2009). Since keratin assembly is obligatorily heteropolymeric (Fig. 2), the presence of only 
type I keratins in these cells was inadequate for the formation of a full-fledged keratin 
filament network. This provided an appropriate system to determine the properties of the 
expressed K5 mutant. Further, specific focus was on the highly conserved H1 subdomain 
of keratin 5 (Chipev et al., 1992; Steinert, 1988), which was crucial for a normal keratin 
filament assembly (Hatzfeld and Burba, 1994; Parry, 1992; Steinert, 1991a; Steinert, 
1991b; Wilson et al., 1992).  
The objectives of the work were to address the following questions: 
1. How does phosphorylation alter keratin filament network organization? 
In order to answer the above question, experiments using phospho-site keratin 
mutants regarding the following aspects were performed: 
 keratin filament network formation 
 keratin structure and filament assembly 
 keratin mobility 
2. Does keratin phosphorylation regulate cell physiology? 
Type II keratin knockout cell lines stably expressing phospho-site keratin mutants 
were analyzed for the following mechanisms: 
 Cell viability and oxidative stress response 
 Cell cycle progression 
3. Is keratin phosphorylation linked to skin disease? 
Immunostaining and immunoblot analysis of keratin phosphoepitopes in 
immortalized cell lines derived from patients suffering from epidermolysis bullosa 
simplex (EBS) skin disease was done. 
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Experiments based on the above objectives would further reveal the various mechanisms 
through which phosphorylation may result in reorganization of the keratin cytoskeleton. 
Studying the physiology of cells expressing keratin phospho-site mutants would indicate 
the potential of keratin phosphorylation in influencing the cellular mechanisms, thus 
providing an idea about the contribution of keratin phosphorylation to a disease phenotype. 
Finally, examining the status of keratin phosphorylation EBS disease keratin aggregates 
would enable the understanding of phosphorylation mediated keratin reorganization within 
the context of a disease. 
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3. Materials and Methods 
3.1. Materials 
3.1.1. Chemicals 
Table 2: List of chemicals 
Name Source of supply 
Acetic acid   Carl Roth, Karlsruhe, Germany 
Acetone Carl Roth, Karlsruhe, Germany 
Acrylamide/bisacrylamide 30%, mixing ratio 29:1 Carl Roth, Karlsruhe, Germany 
Agarose Sigma-Aldrich, St. Louis, MO, USA 
Ammonium persulfate (APS)   Sigma-Aldrich, St. Louis, MO, USA 
Beta-mercaptoethanol Carl Roth, Karlsruhe, Germany 
Boric acid Carl Roth, Karlsruhe, Germany 
Bovine serum albumin - Fraction V (BSA) Sigma-Aldrich, St. Louis, MO, USA 
Bromophenol blue SERVA Electrophoresis GmbH, Heidelberg, 
Germany 
Calcium chloride (CaCl2) Merck KGaA, Darmstadt, Germany 
2-(4-amidinophenyl)-1H-indole-6-carboxamidine 
(DAPI) 
ThermoFisher Scientific,Waltham, MA, USA 
Disuccinimidyl suberate (DSS) ThermoFisher Scientific,Waltham, MA, USA 
Dimethyl sulfoxide (DMSO) Merck KGaA, Darmstad, Germany 
Dithiothreitol (DTT) Merck KGaA, Darmstad, Germany 
Ethanol Carl Roth, Karlsruhe, Germany 
Ethylenediaminetetraacetic acid (EDTA)   Sigma-Aldrich, St. Louis, MO, USA 
Glycerol Carl Roth, Karlsruhe, Germany 
Glycine   Biomol GmbH, Hamburg, Germany 
Hydrochloric acid 1N   Carl Roth, Karlsruhe, Germany 
Hydrochloric acid 37%   Carl Roth, Karlsruhe, Germany 
Hydrogen peroxide 30% Merck KGaA, Darmstadt, Germany 
Isopropanol   Carl Roth, Karlsruhe, Germany 
jetPEI® + sodium chloride (NaCl) PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
Potassium chloride (KCl)   SERVA Electrophoresis GmbH, Heidelberg, 
Germany 
Manganese chloride (MnCl2) Sigma-Aldrich, St. Louis, MO, USA 
Methanol   Carl Roth, Karlsruhe, Germany 
Midori green advance Biozym Scientific, Germany 
3-(N-morpholino) propanesulfonic acid  (MOPS) SERVA Electrophoresis GmbH, Heidelberg, 
Germany 
Mowiol   Carl Roth, Karlsruhe, Germany 
MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) 
Carl Roth, Karlsruhe, Germany 
 
NaCl   Carl Roth, Karlsruhe, Germany 
NaOH   Carl Roth, Karlsruhe, Germany 
Nonidet P-40 (NP-40)     Sigma-Aldrich, St. Louis, MO, USA  
Phenylmethylsulfonyl fluoride (PMSF) Merck KGaA, Darmstadt, Germany 
Pierce TM Protein A/G magnetic beads ThermoFisher Scientific,Waltham, MA, USA 
Ponceau S   Sigma-Aldrich, St. Louis, MO, USA 
Materials and Methods 
16 
 
Propidium iodide Sigma-Aldrich, St. Louis, USA 
Potassium acetate (CH3CO2K) Sigma-Aldrich, St. Louis, USA 
Roti®-Block Blocking Reagent Carl Roth, Karlsruhe, Germany 
Rubidium chloride (RbCl2) Sigma-Aldrich, St. Louis, MO, USA 
Sodium dodecyl sulfate (SDS)   SERVA Electrophoresis GmbH, Heidelberg, 
Germany 
Sucrose Sigma-Aldrich, St. Louis, MO, USA 
Tetramethylethylenediamine (TEMED) Carl Roth, Karlsruhe, Germany 
Tris(hydroxymethyl)aminomethane (Tris base) Biomol GmbH, Hamburg, Germany 
Tris(hydroxymethyl)aminomethane hydrochloride 
(Tris HCl) 
Life Technologies, Carlsbad, CA, USA 
Triton-X 100 Sigma-Aldrich, St. Louis, MO, USA 
Trypan blue Sigma-Aldrich, St. Louis, MO, USA 
Tween-20 Merck KGaA, Darmstadt, Germany 
PBS, without Ca
2+
/Mg
2+
 Sigma-Aldrich, St. Louis, MO, USA 
Xfect polymer + Xfect reaction buffer Clontech laboratories, Mountain View, CA, USA 
3.1.2. Molecular ladders 
Table 3: List of molecular ladders 
Name Source of supply 
GeneRuler 1 kb DNA Ladder (SM0311)   Thermo Fisher Scientific, Waltham, MA, USA 
ProSieve QuadColor Protein Marker   Lonza, Basel, Switzerland 
3.1.3. Kits 
Table 4: List of kits 
Name  Source of supply 
AceGlow™ Chemiluminescence Substrate   PEQLAB, Erlangen, Germany 
Gel filtration markers kit Sigma-Aldrich, St. Louis, USA 
Quick Start Bradford Protein Assay   Bio-Rad, Hercules, CA, USA 
QIAfilter Plasmid Maxi Kit   Qiagen, Venlo, Netherlands 
QIAprep Spin Miniprep Kit   Qiagen, Venlo, Netherlands 
QIAquick PCR Purification Kit   Qiagen, Venlo, Netherlands 
Transcriptor First Strand cDNA synthesis kit Roche, Mannheim, Germany 
3.1.4. Enzymes 
Table 5: List of enzymes 
Name  Source of supply 
BamHI New England Biolabs, Ipswich, MA, USA 
DpnI New England Biolabs, Ipswich, MA, USA 
EcoRI New England Biolabs, Ipswich, MA, USA 
HindIII New England Biolabs, Ipswich, MA, USA 
Phusion® High-Fidelity DNA Polymerase Thermo Fisher Scientific, Waltham, MA, USA 
T4 DNA ligase Thermo Fisher Scientific, Waltham, MA, USA 
Trypsin, powder Biochrom, belongs to Merck KGaA, Darmstadt, 
Germany 
Accutase Sigma-Aldrich, St. Louis, MO, USA 
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3.1.5. Activators and inhibitors  
Table 6: List of activators and inhibitors 
Name  Source of supply 
Anisomycin Sigma-Aldrich, St. Louis, USA 
Nocodazole Sigma-Aldrich, St. Louis, USA 
cOmplete ULTRA tablets Mini EASYpack (Protease 
inhibitor) 
Roche, Mannheim, Germany 
PhosSTOP EASYpack (Phosphatase inhibitor) Roche, Mannheim, Germany 
Sodium butyrate Sigma-Aldrich, St. Louis, USA 
3.1.6. Cell culture media, media supplements, matrix proteins and antibiotics 
Table 7: List of cell culture media, media supplements, matrix proteins and antibiotics 
Name  Source of supply 
Adenine Sigma-Aldrich, St. Louis, USA 
Ampicillin sodium salt Carl Roth, Karlsruhe, Germany 
Aqua B. Braun (distilled H2O)   B. Braun Melsungen AG, Melsungen, Germany 
Collagen IV, mouse CORNING, Corning, NY, USA 
Chelex 100 Resin BIO-RAD, Hercules, CA, USA  
Choleratoxin Sigma C, St. Louis, USA 
Dulbecco's Modified Eagle Medium (DMEM),  
AQ media 
Sigma-Aldrich, St. Louis, USA 
DMEM/Ham’s F12 (3.5:1.1) medium with low 
calcium (50 μM) 
PAN Biotech, Aidenbach, Germany 
Epidermal growth factor (EGF) Invitrogen, Carlsbad, CA, USA 
EpiLife Gibco by life technologies, NY, USA 
FCS Gold  PAA, Cölbe, Germany 
Glutamax Invitrogen, Carlsbad, CA, USA 
Hydroxycortisone Sigma-Aldrich, St. Louis, MO, USA 
Human keratinocyte growth supplement Gibco by life technologies, NY, USA 
Insulin Sigma-Aldrich, St. Louis, USA 
Kanamycin sulphate Carl Roth, Karlsruhe, Germany 
Pyruvate (100X) PAA, Cölbe, Germany 
Penicillin/Streptomycin Invitrogen, Carlsbad, CA, USA 
Trypsin neutralizer solution Gibco by life technologies, NY, USA 
3.1.7. Antibodies 
Table 8: List of primary antibodies 
Antigen Clonality Species 
source 
Lot no. Lab 
antibody 
no. 
Immuno
blot 
dilution 
Source of supply 
Beta-Actin Polyclonal Rabbit 053M4786 Rb 123 1:2000 Sigma-Aldrich, St. 
Louis, MO, USA 
Cleaved 
caspase-3 
(Asp157) 
Polyclonal Rabbit - Rb 134 1:500 Cell signaling, 
Danvers, MA, USA  
ERK-1/2 Polyclonal Rabbit 8-2 
 
Rb 81 1:1000 Cell signaling, 
Danvers, MA, USA  
 
GFP  Monoclonal 
(clone 7.1 
&13.1) 
Mouse 12274200 
 
Mc 124 1:2000 Roche, Mannheim, 
Germany 
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HSP70 Monoclonal Mouse GR41755-
4 
Mc 186 1:5000 Abcam, Cambridge, 
UK 
HSP90 Monoclonal Mouse GR171855
-11 
 
Mc 183 1:1000 Abcam, Cambridge, 
UK 
HSP105 Monoclonal Rabbit GR163219
-3 
 
Rb 227 1:1000 Abcam, Cambridge, 
UK 
JNK/SAPK Polyclonal Rabbit 4-9 Rb 82 1:1000 Cell signaling, 
Danvers, MA, USA 
Keratin 5 Polyclonal Guinea pig 412151 
 
Gp 41 1:5000 PROGEN, Heidelberg, 
Germany 
Keratin 14 Polyclonal Rabbit - Rb 246 1:25000 Thomas Magin Lab, 
University of Leipzig 
p38 MAPK Polyclonal Rabbit 7 Rb 83 1:1000 Cell signaling, 
Danvers, MA, USA 
Pan-keratin Polyclonal Guinea pig 412111 
 
Gp 26 1:2000 PROGEN, 
Heidelberg, Germany 
Phospho-
ERK1/2 
(T202/Y204) 
Polyclonal Rabbit - Rb 85 1:1000 Cell signaling, 
Danvers, MA, USA 
Phospho-
histoneH3 
(S10) 
Polyclonal Rabbit 16 Rb 252 1:1000 Cell signaling, 
Danvers, MA, USA 
Phospho-
p38MAPK 
(T180/Y182) 
Polyclonal 
(Clone 
12F8) 
Rabbit 19 Rb 87 1:1000 Cell signaling, 
Danvers, MA, USA 
Phospho-
JNK/SAPK 
(T183/Y185) 
Polyclonal Rabbit 7 Rb 86 1:1000 Cell signaling, 
Danvers, MA, USA 
Phospho S73 
K8/ phospho 
T150 K5 
Monoclonal 
(LJ4) 
Mouse - Mc 97 IF 
dilution- 
1:100  
(Liao et al., 1997) 
 
Table 9: List of secondary antibodies 
Antigen Conjugate Species source WB dilution Source of supply 
Guinea pig IgG  
(H+L)       
Horseradish 
peroxidase (HRP) 
Goat 1:5000   Dianova, Hamburg, 
Germany 
Mouse IgG ( H+L) 
 
HRP Goat 1:2500   Dianova, Hamburg, 
Germany  
Rabbit IgG ( H+L) HRP Goat 1:2000   Dianova, Hamburg, 
Germany  
3.1.8. Labware 
Table 10: List of labware 
Name  Source of supply 
10 ml Serological pipette, sterile Corning Incorporated, Corning, NY, USA 
100 µl Bevelled, filter tip (Sterile) 
STARLAB INTERNATIONAL GmbH, Hamburg, 
Germany 
1000 µl, Filter tip (Sterile) 
STARLAB INTERNATIONAL GmbH, Hamburg, 
Germany 
2 ml Serological pipette, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
20 µl XL Graduated filter tip (Sterile) 
STARLAB INTERNATIONAL GmbH, Hamburg, 
Germany 
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200 µl Graduated, filter tip (Sterile) 
STARLAB INTERNATIONAL GmbH, Hamburg, 
Germany 
25 ml Serological pipette, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
5 ml Serological pipette, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
50 ml Centrifuge tubes with screw caps VWR International, Radnor, PA, USA 
96 well Tissue culture plates SPL Life Sciences Co., Ltd., Korea 
Amersham Hyperfilm ECL  GE Healthcare, Buckinghamshire, UK 
CELLSTAR culture dishes, 100x20 mm Greiner Bio-One GmbH, Frickenhausen, Germany 
CELLSTAR culture dishes, 60x15 mm Greiner Bio-One GmbH, Frickenhausen, Germany 
Cover slips, d=24 mm, #1.5 Gerhard Menzel GmbH, Braunschweig, Germany 
CRYO.S, PP, with screw cap, sterile Greiner Bio-One GmbH, Frickenhausen, Germany 
Cuvettes, 50-2000 µl Eppendorf AG, Hamburg, Germany 
Easy-Grip cell culture dish, 35x10 mm 
Becton Dickinson Labware, Franklin Lakes, NJ, 
USA 
epT.I.P.S. Standard/Bulk 100-5000 µl Eppendorf AG, Hamburg, Germany 
EU Classic thin-wall 8-tube Stripe 0.2 ml BIOplastics, Landgraaf, The Netherlands 
EU Optical semi-domed Cap BIOplastics, Landgraaf, The Netherlands 
Filter-Tips, 1000 µl (4x32) Qiagen, Venlo, Netherlands 
Glass Pasteur pipettes BRAND GmbH, Wertheim, Germany 
Glass bottom dishes, d=14 mm MatTek Corporation, Ashland, MA, USA 
Imaging plates 96 OG Zell-Kontakt GmbH, Nörten-Hardenberg, Germany 
Immobilon-P transfer membrane Merck Millipore, Darmstad, Germany 
Micro tube 1.5 ml SARSTEDT, Nümbrecht, Germany 
Micro tube 1.5 ml, green SARSTEDT, Nümbrecht, Germany 
Natural-rubber scraper Sigma-Aldrich, St. Louis, MO, USA 
Object slides, 76x26 mm R. Langenbrinck, Emmendingen, Germany 
Parafilm Pechiney Plastic Packaging, Menasha, WI, USA 
Pipette tip 200 µl, yellow SARSTEDT, Nümbrecht, Germany 
Pipettor tips Standard MIKRO, 0.1-10 µl PP Carl Roth, Karlsruhe, Germany 
SafeSeal micro tube 2 ml, PP SARSTEDT, Nümbrecht, Germany 
Tips Crystal-E-0.5-10 µl ratiolab GmbH, Dreieich, Germany 
Tissue culture flasks, 50 ml 
Becton Dickinson Labware, Franklin Lakes, NJ, 
USA 
Tube 15 ml, 120x17mm, PP, non-pyrogenic SARSTEDT, Nümbrecht, Germany 
Tube 50 ml, 114x28mm, PP, non-pyrogenic SARSTEDT, Nümbrecht, Germany 
Secureline Lab Markers Aspen Surgical, Southbelt Dr. SE, MI, USA 
Syringe filter, 0.45 µm, (surfactant-free) Sigma-Aldrich, St. Louis, MO, USA 
Syringe filter unit, 0.22 µm, Millex-GP Merck Millipore, Darmstad, Germany 
Whatman®, gel blotting papers VWR International, Radnor, PA, USA 
3.1.9. Laboratory equipment 
Table 11: List of cell culture equipment 
Name  Source of supply 
HERACell™ 150i CO2 Incubator Thermo Fisher Scientific, Waltham, MA, USA 
Heraeus™ BB15 CO2 Incubator Thermo Fisher Scientific, Waltham, MA, USA 
Integra VACUBOY® - Vacuum Hand Operator Integra LifeSciences, Plainsboro, NJ, USA 
MSC-Advantage Class II Biological Safety Cabinet Thermo Fisher Scientific, Waltham, MA, USA 
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Table 12: List of centrifuges and related equipment 
Name  Source of supply 
Centrifuge 5417C Eppendorf, Hamburg, Germany 
Centrifuge 5417R Eppendorf, Hamburg, Germany 
Centrifuge 5810 Eppendorf, Hamburg, Germany 
Heraeus™ Sepatech Megafuge™ 3.0R Thermo Fisher Scientific, Waltham, MA, USA 
Maxi-Dry Lyo centrifugal vacuum concentrator Heto, Alleröd, Denmark 
Rotanta 460R Hettich Zentrifugen, Tuttlingen, Germany 
Ultracentrifuge Beckman Coulter, Krefeld, Germany 
SW 41 swinging-bucket rotor Beckman Coulter, Krefeld, Germnay 
 
Table 13: List of electrophoresis equipment 
Name  Source of supply 
Mini-PROTEAN® 3 Cell System Bio-Rad, Hercules, CA, USA 
Mini-PROTEAN® TetraCellSystem  
(1 mm gel thickness) 
Bio-Rad, Hercules, CA, USA 
PerfectBlue™ Wide Gel System (40-2314) PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
 
Table 14: List of power supplies 
Name  Source of supply 
Biometra Power Pack P25 Biometra GmbH, Göttingen, Germany 
Consort E455 Consort, Turnhout, Belgium 
Electrophoresis power supply EPS 3500 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
Electrophoresis power supply EPS 3500XL 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
Electrophoresis power supply EPS 3501XL 
Pharmacia Biotech, belongs to General Electric, 
Fairfield, CT, USA 
PP3000 Programmable high voltage power supply Biometra, Göttingen, Germany 
 
Table 15: List of shakers and mixers 
Name  Source of supply 
Biometra OV-4 hybridisation oven Biometra, Göttingen, Germany 
ELMI Intelli-Mixer RM-2l (rotator mixer) ELMI ltd., Riga, Latvia 
GFL 3005 orbital shaker GFL, Burgwedel, Germany 
Heidolph 3002 magnetic stirring hotplate Heidolph Instruments, Schwabach, Germany 
Heidolph Reax 2000 shaker Heidolph Instruments, Schwabach, Germany 
HLC Heating-ThermoMixer MHR 23 DITABIS Digital Biomedical Imaging Systems AG, 
Pforzheim, Germany 
Incubator shaker series Innova® 42 New Brunswick Scientific, belongs to Eppendorf, 
Hamburg, Germany 
MR Hei-Mix L (magnetic stirring hotplate) Heidolph, Schwabach, Germany 
Reverstir RS-8 (magnetic stirring plate) Toyo Kagaku Sangyo Ltd., belongs to Advantec 
Toyo Kaisha Ltd., Tokyo, Japan 
RH basic 2 IKAMAG (magnetic stirring hotplate) IKA-Werke GmbH & Co. KG, Staufen, Germany 
Roller mixer RS-TR05 Phoenix Instruments GmbH, Garbsen, Germany 
SM25 mechanical shaker Edmund Bühler GmbH, Hechingen, Germany 
SW-20C (shaking water bath) JULABO GmbH, Seelbach, Germany 
Techne Dri-Block® Heater DB-1 Bibby Scientific Limited, Staffordshire, UK 
TS-100, Thermo-Shaker Biosan, Riga, Latvia 
Variomag Electronicrührer mono (magnetic stirrer) Thermo Fisher Scientific, Waltham, MA, USA 
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Table 16: Spectrometers 
Name  Source of supply 
BioPhotometer plus Eppendorf, Hamburg, Germany 
DU800 Spectrophotometer Beckman Coulter, Brea, CA, USA 
Nanodrop™ 1000 (microvolume spectrometer) Thermo Fisher Scientific, Waltham, MA, USA 
TECAN infinite 200 (microplate reader) Tecan Group Ltd., Männedorf, Switzerland 
Table 17: List of immunoblot and gel imaging equipment 
Name  Source of supply 
Fusion-Solo.WL.4M Vilber Lourmat, Marne-la-Vallée Cedex 1, France 
Quantum ST4 1100/26MX Vilber Lourmat, Marne-la-Vallée Cedex 1,France 
 
Table 18: List of miscellaneous equipment 
Name  Source of supply 
BioLogic LP Bio-RAD, Hercules, CA, USA 
BioLogic Fraction Collector Bio-RAD, Hercules, CA, USA 
Guava EasyCyte mini (flow cytometer) Guava technologies, Darmstadt, Germany 
peqSTAR 96 Universal (thermal cycler) 
PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
peqSTAR 96 Universal gradient (thermal cycler) 
PEQLAB Biotechnologie GmbH, Erlangen, 
Germany 
pH211 Microprocessor pH Meter Hanna Instruments, Woonsocket, USA 
QIAcube® (robotic station for DNA purification) Qiagen, Venlo, Netherlands 
Systec VX-150 autoclave Systec, Wettenberg, Germany 
TFX-20.M (super bright transilluminator) Vilber Lourmat, Marne-la-Vallée Cedex 1,France 
Ultra-TURRAX T8 (homogenizer) IKA labortechnik, Staufen, Germany 
3.1.10. Microscopes 
Table 19: List of the components Zeiss LSM 710 Duo 
Name  Source of supply 
Airyscan module Carl Zeiss, Jena, Germany 
Axio Observer.Z1   Carl Zeiss, Jena, Germany 
Objective Plan-Apochromat 63x / 1.40 Oil DIC  
M27 
Carl Zeiss, Jena, Germany 
Laser module LGK 7872 ML8 (Ar: 458, 488, 514  
nm)   
Carl Zeiss, Jena, Germany 
Laser module LGK 7786 P (HeNe: 543 nm)   Carl Zeiss, Jena, Germany 
Laser module LGK 7628-1F (HeNe: 633nm)   Carl Zeiss, Jena, Germany 
Laser cassette 405 cw (diode laser 405 nm) Carl Zeiss, Jena, Germany 
Definite Focus   Carl Zeiss, Jena, Germany 
HXP 120 Compact Light Source   Carl Zeiss, Jena, Germany 
Incubator XL LSM710 S1   Pecon GmbH, Erbach, Germany  
 
Heating Unit XL S   Pecon GmbH, Erbach, Germany  
 
CO2-Module S   Pecon GmbH, Erbach, Germany  
 
IsoStation Vibration Isolated Workstation   Newport Corporation, Irvine, CA, USA  
 
Zen system 2009 (Software)   Carl Zeiss, Jena, Germany 
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Table 20: List of the components Zeiss ApoTome 2 
Name  Source of supply 
Axio Imager.M2 Carl Zeiss, Jena, Germany 
AxioCam MRm (camera) Carl Zeiss, Jena, Germany  
ApoTome.2 Carl Zeiss, Jena, Germany  
HXP 120 C Carl Zeiss, Jena, Germany  
Objective: Plan-Apochromat 63X/1,4 Oil DIC Carl Zeiss, Jena, Germany  
Filters.: 38, 46, 47, 49, 50, 43 Carl Zeiss, Jena, Germany  
3.1.11. Bacterial strains 
Table 21: List of Bacterial strains 
Bacteria Genotype Source 
Escherichia coli XL1-
Blue 
F´::Tn10 proA
+
B
+
 lacI
q
 Δ(lacZ)M15/ recA1 endA1 
gyrA96 (Nal
R
) thi hsdR17 (rK
–
 mK
+
) glnV44 relA1 lac 
Stratagene, La Jolla, 
USA 
3.1.12. Primers 
Table 22: List of primers 
Primer no. Nucleotide sequence (5’3‘) 
11-37 CCCCCGGGCCTTCGACAGCCGCTCCTAC 
11-38 GTAGGAGCGGCTGTCGAAGGCCCGGGGG 
11-39 CCGGGCCTTCAGCGACCGCTCCTACACG 
11-40 CGTGTAGGAGCGGTCGCTGAAGGCCCGG 
11-41 CCTTCAGCAGCCGCGACTACACGAGTGGGC 
11-42 GCCCACTCGTGTAGTCGCGGCTGCTGAAGG 
11-43 CCGCTCCTACACGGATGGGCCCGGTTCC 
11-44 GGAACCGGGCCCATCCGTGTAGGAGCGG 
11-45 GGCCCCCGGGCCTTCGACGACCGCTCCTACACGAG 
11-46 CTCGTGTAGGAGCGGTCGTCGAAGGCCCGGGGGCC 
11-88 CTTCACCTCCGTGGACCGGTCCGGGGGT 
11-89 ACCCCCGGACCGGTCCACGGAGGTGAAG 
11-90 GGCTATGGCAGCCGGGACCTCTACAACCTGGG 
11-91 CCCAGGTTGTAGAGGTCCCGGCTGCCATAGCC 
11-92 CTCCAAGAGGATATCCATCGACACTAGTGGTGGCAGCTTC 
11-93 GAAGCTGCCACCACTAGTGTCGATGGATATCCTCTTGGAG 
11-94 TCAGCACTAGTGGTGGCGACTTCAGGAACCGGTTTG 
11-95 CAAACCGGTTCCTGAAGTCGCCACCACTAGTGCTGA 
11-96 GTCAACCAGAGTCTCCTGGATCCCCTCAACCTGCAAAT 
11-97 ATTTGCAGGTTGAGGGGATCCAGGAGACTCTGGTTGAC 
01-31 CGAGCAGATCAAGACCCT 
13-002 CTTGACCTCAGCGATGATG 
04-19 CAACGACCCCTTCATTGACC 
04-20 CAGTAGACTCCACGACATAC 
14-110 AGTCTCCTGGCTCCCCTCAA 
14-111 TGAGGGGAGCCAGGAGACTC 
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3.1.13. Plasmids 
Table 23: List of plasmids 
Plasmid no. Name Source 
358 
K8 S73D in pECFP-N1 using 
EcoRI and BamHI Dr. Stefan Wöll 
2091 
K5 in pEYFP-N1 using BamHI 
and Hind III Dr. Anne Kölsch 
3.1.14. Cell lines 
Table 24: List of cell lines 
Cell line Cell type Reference 
HaCaT Immortalized human epidermis-derived keratinocytes (Boukamp et al., 1988) 
Type II keratin 
knockout (KO) 
Immortalized epidermis-derived keratinocytes from type II 
keratin KO mice. (Vijayaraj et al., 2009) 
hKC Immortalized human epidermis-derived keratinocytes Dr. VerenaWally,  
Dr. Thomas Lettner and 
Prof. Julia Reichelt 
(EB House, Austria) 
EBDM-4 
Immortalized human epidermis-derived keratinocytes from 
patients with Dowling Meara epidermolysis bullosa simplex 
(EBS-DM) disease  
3.1.15. Software 
Table 25: List of softwares 
Name Version Manufacturer 
AxioVision 4.8.2.0 Carl Zeiss MicroImaging GmbH, 
Jena, Germany 
Clone Manager 9 Professional 9.0 and 9.2 Scientific & Educational 
Software, Cary, NC, USA 
FusionCapt Advance 16.06 Vilber Lourmat, France 
GraphPad Prism 5 5.01 GraphPad Software, Inc., La 
Jolla, CA, USA 
Illustrator CS3 16.0. (64 bit) Adobe Systems Incorporated, San 
Jose, CA, USA 
ImageJ (Fiji distribution) Fiji 1.4 National Institutes of Health, 
USA 
NanoDrop 1000 3.8.0 Thermo Fisher Scientific, 
Waltham, MA, USA 
Photoshop CS6 13.0. x64 Adobe Systems Incorporated, San 
Jose, CA, USA 
Quantum-Capt 15.12 Vilber Lourmat, France 
Zen 2011 (black) 7.0 Carl Zeiss MicroImaging GmbH, 
Jena, Germany 
Zen 2011 (blue) 1.0.0.0 Carl Zeiss MicroImaging GmbH, 
Jena, Germany 
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3.2. Methods 
3.2.1. DNA modifications 
Restriction enzymes facilitate a regulated cutting of the DNA strands due to the sequence 
specificity of the enzymes during the recognition and cleavage process of the DNA.  
Restriction digestion of 5 μg DNA was done using 10 U of restriction enzymes from either 
NEB or Fermentas in the presence of 1X concentration of the appropriate buffers in a total 
reaction volume of 50 μl. The restriction reaction was incubated overnight at 37 °C. The 
restricted DNA fragments were electrophoresed on agarose gels and purified with 
QIAquick PCR purification kit. 
Restriction digestion of DNA often leads to the formation of DNA strands with either a 5’ 
phosphate overhang or a 3’ hydroxyl overhang. Ligation of DNA involves the generation 
of covalent bonds to anneal the 5’ and 3’ DNA overhangs thus sealing the sugar phosphate 
DNA backbone.  
Ligation of DNA ends was done with 5 U of T4 DNA ligase in presence of 1X T4 DNA 
ligase buffer in total reaction volume of 20 μl, overnight at 16 °C. 25 ng of vector DNA 
was used and a molar ratio of 1:5 was maintained for the vector: insert. 
 3.2.2. DNA gel electrophoresis 
The separation of DNA fragments of different molecular sizes is possible by 
electrophoresing the negatively charged DNA on an agarose gel. 
The DNA sample was dissolved in the gel loading dye at a final concentration of 1X. The 
DNA samples were electrophoresed in the presence of Tris/Borate/EDTA (TBE) buffer 
(Table 26) on 1 % agarose gel dissolved in TBE buffer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
Table 26: Composition of Tris/Borate/EDTA (TBE) buffer (5X) 
Chemical Final concentration 
Tris base 0.45 M 
Boric acid 0.45 M 
EDTA 10 mM EDTA  
 Adjust to pH 8 
 
Midori green dye was added to the melted agarose at a concentration of 0.5 μl/15 ml to 
visualize and document the DNA bands under the UV light in Fusion-Solo.WL.4M. 
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3.2.3. Preparation of competent bacteria  
Bacterial cells are made capable of incorporating foreign DNA by modifying the cell 
walls, thus making them more ‘competent’. Bacterial cells were made competent by 
treating with positively charged CaCl2 which facilitates the passage of the negatively 
charged DNA into the bacteria. In this work XL-1 blue strain of bacteria was used. 
Competent cells were prepared by the protocol by (Hanahan et al., 1991). An isolated 
colony of XL-1 blue was inoculated in 20 ml of LB (Luria-Bertani) medium (Table 29) 
and grown overnight at 37 °C at 200 RPM. 0.5 ml of this overnight culture was inoculated 
in 7 ml LB medium and grown till the OD 600 (optical density at 600 nm) reached 0.3. 
This was called pre-culture. 5 ml of the pre-culture was inoculated in 100 ml prewarmed 
(37 °C) LB medium and grown till the OD reached 0.48. The bacteria were then chilled on 
ice and centrifuged for 15 minutes at 4000 x g [relative centrifugal force (RCF)] at 4 °C. 
The supernatant was discarded and the pellet was resuspended in 30 ml ice-cold TFB I 
(transformation buffer I) (Table 27). After incubating on ice for 1-2 h, the bacterial cell 
suspension was again centrifuged. The pellet was resuspended in 4 ml ice-cold TFB II 
(Table 28). The bacterial suspension was dispensed in 1.5 ml pre-cooled tubes in the form 
of 200 µl aliquots, snap frozen in liquid N2 and stored at -80 °C for a maximum period of 
one year. 
Table 27: Composition of transformation buffer I (TFB I) 
Chemical Final concentration   
RbCl2    100 mM 
MnCl2    50 mM   
Potassium-Acetate 30 mM   
CaCl2    10 mM   
Glycerol 15% (w/v) 
 Adjust pH to 5.8 with 0.2 M acetic acid. Sterilize by 
filtration. 
 
Table 28: Composition of transformation buffer II (TFB II) 
Chemical Final concentration   
CaCl2   75 mM 
RbCl2 10 mM 
MOPS 10 mM   
Glycerol   15% (w/v)   
 Adjust pH to 7.0. Sterilize by filtration. 
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Table 29: Composition of LB (Luria-Bertani) medium 
Name Quantity for 1000 ml 
Tryptone 10 g 
Yeast extract 5 g 
NaCl 5 g 
D/W Make up to 1000 ml 
 
 3.2.4. Transformation of bacteria 
The introduction of exogenous genetic material in to a bacterial cell is called as 
transformation.  
1 μl of plasmid DNA was added to 200 μl of thawed competent bacterial cells. The 
bacteria-DNA mix was chilled on ice for 30 minutes, followed by a heat-shock at 42 °C for 
90 seconds and incubation on ice for 10 minutes. The transformed bacteria were then 
grown with agitation at 37 °C for 30 minutes in 1 ml of LB medium (Table 29). The 
bacterial cells were separated from the LB medium and grown on LB agar plates with the 
appropriate antibiotic (ampicillin 150 μg/ ml; kanamycin 60 μg/ ml) at 37 °C overnight. 
 3.2.5. DNA purification 
Bacterial DNA purification was done by picking up isolated bacterial colonies from LB 
agar plates incubated overnight at 37 °C. Large-scale DNA isolation was done by growing 
up a bacterial colony in 200 ml of LB media at 37 °C, 200 RPM, overnight. DNA was 
purified with QIAfilter plasmid maxi kit. Small-scale DNA purification was done from 5 
ml bacterial cultures grown from isolated colonies by the same growth conditions as 
described before. DNA isolation was done with QIAprep spin Miniprep kit. The DNA was 
diluted in Tris EDTA (TE) buffer (Table 30). 
Table 30: Composition of Tris EDTA (TE) buffer 
Chemical Final concentration 
Tris HCl 10 mM 
EDTA 1 mM  
 Adjust to pH 8 
 
 3.2.6. DNA quantification 
NanoDrop 2000 was used to measure the DNA quantity. This was done by estimating the 
absorbance of 1 μl of DNA solution at 260 nm. The blank value was set with Tris EDTA 
(TE) buffer, since it was used to dilute the DNA. 
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3.2.7. DNA sequencing 
DNA plasmids were sent for sequencing to Eurofins MWG Operon, Ebersberg, Germany. 
15 μl of the test DNA (50-100 ng/μl) was sent along with a separate tube containing 15 μl 
of the primer (10 pM/μl). 5 μl of the primer per additional sequencing sample was sent. 
The automated sequencing results were validated with Chromas and Clone manager 
software.  
 3.2.8. Site-directed mutagenesis PCR 
Site directed mutagenesis PCR creates specific mutations at the target DNA sequences. 
Overlapping primers containing the required mutation were used to create a product with 
a substitution mutation in this study. The amplified product thus contained a combination 
of the newly synthesized mutated strand and the parental non-mutated strand. The parental 
strand was selectively digested using Dpn1 enzyme which can specifically digests 
methylated DNA. 
For single-site substitution mutation, the PCR reaction of 50 μl, containing 10 pM of the 
primer pair, 200 μM dNTPs and 2 U of Phusion DNA polymerase was performed. The 
PCR cycles were initiated at 98 °C for 30 seconds to denature the template DNA, followed 
by 18 amplification cycles. Each amplification cycle consisted of 98 °C for 10 seconds, 
annealing temperature of 50-60 °C for 20 seconds and 72 °C for 136 seconds. The PCR 
cycles were finished with an extension step at 72 °C for 10 minutes. 
1 μl of the PCR mix and 1 μl of the PCR template were electrophoresed on 1% agarose gel 
to confirm the amplification of DNA fragment. The entire PCR mix was treated with 10 U 
of DpnI enzyme for 1 h to digest the parental strand. The digested PCR mix was then 
transformed into competent Escherichia coli XL1-Blue bacteria and then plated on LB 
agar plates. The bacterial colonies were picked up after incubating the plates at 37 °C for 
16 h and the DNA was purified using the QIAprep spin miniprep kit. The miniprep DNA 
was sequenced by Eurofins MWG Operon, Ebersberg, Germany. The mutated DNA 
fragment was then re-cloned into a fresh vector backbone to eliminate the possibility of 
mutations in the vector backbone during the mutagenesis procedure. 
 3.2.9. Generation of Plasmids 
Series of phosphomimetic K5 and K8 mutants: The cloning was done by Dr. Nicole 
Schwarz using the primers and plasmids listed in table 31 and table 32. Site-directed 
mutagenesis of K5 YFP (plasmid no. 2091) or K8 CFP (plasmid no. 358), respectively, 
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was performed as described in 3.2.8. The sequence was checked with the primer 10-83 and 
the mutated keratin was cut and ligated into a fresh vector backbone (HindIII/BamHI 
fragment into EYFP-N1 for K5 mutants; EcoRI/BamHI fragment into ECFP-N1 for K8 
mutants). 
Table 31: Cloning strategy for K5 phosphomimetic mutants 
 Name Plasmid no. Primer Template 
1 T150D 2138 11-96 + 11-97 K5 YFP  
(Plasmid no. 2091) 
2 S35/T150D K5 2139 11-88 + 11-89 1 
3 S63/T150D K5 2140 11-90 + 11-91 1 
4 S76/T150D K5 2141 11-92 + 11-93 1 
5 S81/T150D K5 2142 11-94 + 11-95 1 
6 S35/63/T150D K5 2143 11-90 + 11-91 2 
7 S35/76/T150D K5 2144 11-92 + 11-93 2 
8 S35/81/T150D K5 2145 11-94 + 11-95 2 
9 S63/76/T150D K5 2146 11-92 + 11-93 3 
10 S63/81/T150D K5 2147 11-94 + 11-95 3 
11 S76/81/T150D K5 2148 11-94 + 11-95 4 
12 S35/63/76/T150D K5 2149 11-92 + 11-93 6 
13 S35/63/81/T150D K5 2150 11-94 + 11-95 6 
14 S35/76/81/T150D K5 2151 11-94 + 11-95 7 
15 S63/76/81/T150D K5 2152 11-94 + 11-95 9 
16 S35/63/76/81/T150D K5 2153 11-94 + 11-95 12 
 
Table 32: Cloning strategy for K8 phosphomimetic mutants 
 Name Plasmid no. Primer Template 
1 
S20/73D K8 2121 11-37 + 11-38 
K8 CFP 
(Plasmid no. 358) 
2 S21/73D K8 2122 11-39 + 11-40 K8 CFP 
3 S23/73D K8 2123 11-41 + 11-42 K8 CFP 
4 S26/73D K8 2124 11-43 + 11-44 K8 CFP 
5 S20/21/73D K8 2125 11-45 + 11-46 K8 CFP 
6 S21/23/73D K8 2126 11-39 + 11-40 3 
7 S20/23/73D K8 2127 11-37 + 11-38 3 
8 S21/26/73D K8 2128 11-43 + 11-44 2 
9 S20/26/73D K8 2129 11-43 + 11-44 1 
10 S23/26/73D K8 2183 11-43 + 11-44 3 
11 S20/21/23/73D K8 2130 11-41 + 11-42 5 
12 S21/23/26/73D K8 2131 11-43 + 11-44 6 
13 S20/21/26/73D K8 2132 11-43 + 11-44 5 
14 S20/23/26/73D K8 2135 11-43 + 11-44 7 
15 S20/21/23/26/73D K8 2184 11-43 + 11-44 11 
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T150A K5 YFP (Plasmid no. 2236): Site directed mutagenesis was performed on the WT 
K5 YFP plasmid (plasmid no. 2091) using the primers 14-110 and 14-111. The sequence 
was checked using the primer 10-83 and the mutated K5 was cut and ligated into a fresh 
WT K5 YFP vector using HindIII and BamHI enzymes. 
3.2.10. RNA purification from cells 
RNeasy mini kit by Qiagen was used to extract RNA from cells grown in a well of a 6-well 
culture plate. The cells were harvested by direct lysis using 10 μl β-mercaptoethanol (β-
ME) and the RNA purification was done with the protocol from RNeasy Mini Handbook. 
3.2.11. Reverse-transcriptase PCR 
Reverse transcriptase PCR (RT-PCR) is a technique for qualitative analysis of gene 
expression by reverse transcribing the RNA of interest into its complementary DNA which 
is further amplified by traditional PCR. 
The purified RNA was converted into cDNA with the Transcriptor First Strand cDNA 
synthesis kit from Roche. The cDNA was PCR amplified using the primers specific to the 
gene sequence to be detected. The PCR included 30 cycles and an annealing temperature 
of 55 °C for 30 seconds. 
3.2.12. Cell culture 
Keratinocyte-derived cell lines from human and murine origin were used in this work. The 
human epidermal keratinocyte derived HaCaT cells were cultivated at 37 °C and 5 % CO2 
in a humidified incubator. Collagen-coated plates were used only for live cell imaging. 
HaCaT cells were cultured in Dulbecco's modified eagle's medium (DMEM) supplemented 
with 10 % (v/v) FCS Gold without antibiotics. The cells were passaged once a week at a 
ratio of 1:10. For passaging, the cells were shortly washed with PBS and again incubated 
in PBS for 15 minutes at 37 °C. After ensuring sufficient gaps between the cell borders, 
PBS was aspirated and the cells were now incubated with trypsin for 5 minutes at 37 °C. 
The separated cells were then resuspended with DMEM medium and centrifuged at 1865 x 
g for 5 minutes. The resulting cell pellet was resuspended in fresh DMEM medium and the 
cells were then ready for seeding into new plates. 
The human epidermis-derived keratinocytes from Dowling Meara epidermolysis bullosa 
simplex (EBS-DM) patients, EBDM-4, and from healthy individuals, hKC, were cultivated 
at 37 °C and 5 % CO2 in a humidified incubator. Collagen-coated plates were used only for 
imaging. hKC and EBDM-4 cells were cultured in EpiLife medium with human 
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keratinocyte growth supplement and penicillin/streptomycin. The cells were passaged once 
a week at a ratio of 1:3. For passaging, the cells were shortly washed with PBS and again 
incubated in PBS for 15 minutes at 37 °C. After ensuring sufficient gaps between the cell 
borders, PBS was aspirated and the cells were now incubated with accutase for 5 minutes 
at 37 °C. The separated cells were then resuspended with a trypsin neutralizing solution 
and centrifuged at 1865 x g for 5 minutes.  
The murine epidermis-derived keratinocytes were of two different types- wild type (WT) 
and type II keratin knockout (KO) keratinocytes (Vijayaraj et al., 2009). Both, the WT and 
the KO cells were cultivated at 32 °C and 5 % CO2 in a humidified incubator. Collagen-
coated plates were used throughout the culturing of these cells. The murine keratinocytes 
were grown in DMEM/Ham’s F12 medium with low calcium (50 μM) and supplemented 
with the chemicals mentioned in table 33. 
Table 33: Chemical supplements for DMEM/Hams’s F12 medium 
Chemical Final concentration 
FCS Gold (Chelex-treated) 10% 
Glutamax 2 mM 
Pyruvate (100X) 1X 
Penicillin/Streptomycin 100 μg/ml 
Adenine 0.18 mM 
Epidermal growth factor (EGF) 10 ng/ml 
Insulin 2.5 μg/ml 
Hydroxycortisone 0.5 μg/ml 
Choleratoxin 10 M 
 
The cells were passaged once a week at a ratio of 1:3. For passaging, the cells were shortly 
washed with PBS and again incubated in PBS for 5 minutes at 37 °C, followed by 
trypsinization for 5 minutes at 37 °C. 
Collagen coating: 125 μl of 3.47 mg/ml collagen solution was diluted in 10 ml acetic acid. 
This collagen solution was then added to the plates at a sufficient volume for coating and 
incubated at 37 °C for 30 minutes. The collagen solution was removed and the plates were 
washed thrice with PBS. 
3.2.13. Cell counting 
Neubauer hemocytometer was used for cell counting. The trypsinized cell suspension was 
centrifuged at 1865 x g for 3 minutes and the resulting cell pellet was dissolved in the 
culture medium of volume depending on the pellet-size. A part of the cell suspension was 
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then diluted to half using trypan blue and mounted on the hemocytometer below the cover 
glass. Cells, which excluded the trypan blue stain, were counted in the 4 squares at the 
corners. The total no. of cells in the cell suspension = [No. of cells counted/ Total no. of 
squares] × Volume of cell suspension × Dilution factor × Neubauer’s factor (=104) 
3.2.14. Plasmid DNA transfection 
JetPEI and Xfect were the major transfection reagents that were used depending on the cell 
line. For both techniques, 50 % confluent cells were preferred and the required 
experiments were done 48h post-transfection. 
For the jetPEI protocol in 6-well plates, 3 μg of plasmid DNA was added to 100 μl of 150 
mM NaCl solution in tube A. In a separate tube B, 6 μl of jetPEI reagent was added to 100 
μl of NaCl solution. Both tubes were vortexed separately and tube B was added to tube A. 
This tube A + tube B transfection mix was incubated at room temperature (RT) for 30 
minutes. After vortexing, the transfection mix was then added to the cells grown in a well 
of the 6-well plate. 
For the Xfect protocol in 6-well plates, 5 μg of plasmid DNA was added to 100 μl of Xfect 
reaction buffer and vortexed. 1.5 μl of the Xfect polymer was then added to the DNA in the 
reaction buffer, vortexed and incubated for 10 minutes. This transfection mix was then 
added to the cells. 
3.2.15. Generation of stable cell lines 
Antibiotic resistance-mediated single cell clone selection method was used to generate 
stable cell lines. Cells were grown in 6-well plates and were transfected with the required 
plasmid. 24 h post-transfection, the appropriate antibiotic was added and henceforth 
maintained throughout the procedure. The medium was exchanged twice a week. After a 
period of approximately 3-4 weeks when the majority of cells were fluorescent, the cells 
were counted and seeded in all the wells of a 96-well plate 0.8 cells/well. After 24 h, the 
wells with a single cell seeded were demarcated and the expanded colony from each of 
these wells was then selected as a stable cell clone over a period of time and always 
cultured in the presence of antibiotic. 
3.2.16. Freeze-stock preparation and revival of cell lines 
The entire process of freeze-stock preparation was performed on ice. Confluent HaCaT 
cultures grown in 100 mm Petri dishes were trypsinized and resuspended in 5 ml of 
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freezing medium  [20 % DMSO, 20 % FCS, 60 % DMEM containing 10 % FCS, all (v/v)]. 
The cell suspension was aliquoted as 1 ml per cryo-tube and chilled in a Nalgene freezing 
box containing 250 ml isopropanol at 80 °C overnight. The tubes were then shifted in 
liquid nitrogen for long term storage. 
Confluent murine keratinocytes grown in 100 mm Petri dishes were trypsinized and 
resuspended in 3 ml of freezing medium (90 % Chelex-treated FCS Gold and 10 % 
DMSO). The cell suspension was aliquoted as 1 ml per cryo-tube and chilled by the same 
procedure as used for HaCaT cells. 
The revival of frozen cells was done by resuspending the cells in 10 ml of culture medium 
after thawing. The resulting cell pellet obtained after centrifugation of the cell suspension 
was then diluted in fresh medium and seeded in a flask with a surface area of 25 cm
2
. This 
procedure was the same for both human and murine keratinocytes. 
3.2.17. Cell viability assay 
The viability of the cells can be determined by assessing their metabolic activity using the 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay. 
Oxidoreductases reduce MTT to a purple colored formazan product which has an 
absorbance maximum near 590 nm.  
Cells were seeded at a density of 5000 cells/well in 96-well plates. The seeding was done 
consecutively for 3 days with an interval of 24 h and the MTT assay was performed on the 
4
th
 day by obtaining measurements for time points of 72 h, 48 h and 24 h. Each cell line 
was seeded in triplicate and different cell lines to be compared in an experiment were 
assayed in the same plate on the same day to reduce experimental variability. 
To perform the MTT assay on the 4
th
 day, medium from each well was carefully removed 
without disturbing the cell layer. 20 μl MTT reagent was added to each well and incubated 
for 3.5 h at 37 °C. MTT reagent was then removed and 150 μl MTT solvent [4 mM HCl, 
0.1% (v/v) Nonidet-40 (NP-40) in isopropanol] was added per well. The plate was covered 
with aluminium foil and shaken at RT for 15 minutes. Absorbance was measured at 590nm 
using a 96-well plate reader (TECAN Infinite 200). The experiment was repeated thrice 
and was performed in triplicate each time. 
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3.2.18. Cell lysate preparation 
Cell lysis was performed for the preparation of samples for immunoblot analysis and co-
immunoprecipitation. Cells grown to confluence were washed with chilled PBS, scraped 
off with a rubber scraper and lysed with lysis buffer (Table 35) with the appropriate 
volume as mentioned in table 34. The cells were then resuspended and centrifuged at 
20,000 x g at 4 °C for 20 minutes.  The supernatant was collected as the whole cell lysate. 
To prepare samples for loading on SDS-PAGE gels, the whole cell lysate was denatured in 
1X SDS buffer (Table 36) at 100 °C for 10 minutes. For long term storage, the samples 
were kept at -20 °C.   
Table 34: Volume of lysis buffer according to Petri dish diameter 
Petri dish diameter Volume of lysis buffer (μl) 
35 mm 100 
60 mm 500 
100 mm 1000 
 
Table 35: Composition of lysis buffer 
Chemical Concentration 
TRIS HCl, pH 8.5 100 mM 
EDTA 5 mM 
NaCl 20 mM 
SDS 0.2% 
Protease inhibitor Roche Complete was added. PhosSTOP was added when assaying for phosphorylated 
proteins. 
Table 36: 5X SDS denaturation buffer (Laemmli buffer) 
Chemical  Concentration 
0.6 M Tris-HCl pH 6.8 + 0.4% (w/v) SDS 15 ml 
Glycerol 12.5 ml 
Mercaptoethanol 2.5 ml 
SDS 2.5 g 
Bromophenol blue 0.4% (w/v) 
3.2.19. Keratin extraction from cells 
Segregation of cellular keratin into cytosolic and presumably filamentous fractions can be 
achieved by taking advantage of their different properties in detergent and high salt 
environments. The application of a triton X-100 detergent containing high salt buffer 
causes the solubilization of the cytosolic proteins whereas precipitation of the non-
cytosolic or filamentous keratin in the form of a pellet. The extraction of higher-order or 
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filamentous structures of keratins using a high salt buffer follows the principle of salting 
out of hydrophobic proteins. 
Cells were cultivated to complete confluence in 10 Petri dishes of 100 mm diameter. 
Chilled PBS was used to wash the cells. Cells were then scraped off using 750 μl low-salt 
buffer (LSB) (Table 37) per 100 mm dish. All the cells were collected in a 50 ml tube and 
were homogenized on ice, thrice for 3 seconds with intervals of 5 seconds. All the 
homogenization in this protocol was done using Ultra TURRAX T8. This homogenate was 
centrifuged at 5000 x g, 4 °C for 10 minutes. The resulting pellet was homogenized using 1 
ml high-salt buffer (HSB) (Table 38) and incubated on ice for 30 minutes. After vortexing 
twice, the homogenate was then centrifuged at 15000 x g, 4 °C for 10 minutes. The 
supernatant obtained was stored as triton X-100 soluble keratin fraction. The pellet was 
further subjected to homogenization using 1 ml HSB and incubated on ice for 30 minutes. 
The homogenate was then centrifuged at 15000 x g at 4 °C for 10 minutes. The resulting 
pellet was resuspended in 500 μl LSB and centrifuged at 15000 x g at 4 °C for 10 minutes. 
The pellet was resuspended in 500 μl purified distilled water and again centrifuged at 
15000 x g at 4 °C for 10 minutes. The final pellet obtained was then dissolved in 200 μl of 
2X sample buffer. 
Table 37:  Composition of low-salt buffer (LSB) 
Chemical Final concentration 
Tris pH 7.5 10 mM 
NaCl 140 mM 
EDTA 5 mM 
 
High-salt buffer was made by adding the following chemicals to the low-salt buffer. 
Table 38: Composition of high-salt buffer (HSB) 
Chemical Final concentration 
Triton X-100 1 % 
DTT 1 mM 
KCl 1.5 M 
2 mM PMSF and protease inhibitor Roche Complete was added to both the low-salt and high-salt buffers. 
3.2.20. Chemical crosslinking 
Stable crosslinking between two binding partner proteins can be generated with the help of 
disuccinimidyl suberate (DSS). The structure of DSS contains an eight-carbon spacer arm 
with two N-hydroxysuccinimide (NHS) ester groups on either side. The NHS ester groups 
react with primary amines creating stable amide bonds. DSS mediated chemical 
crosslinking of the type I and type II keratin pairs was done in this work as this method 
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ensures the linking of two non-randomly associated proteins existing in a binding 
relationship. 
Crosslinking of the proteins in the soluble fraction was done by treating with 1 mM DSS at 
20 °C for 15 minutes, with gentle shaking. The crosslinking reaction was quenched by 
treating with 40 mM glycine. The crosslinking process was confirmed by comparing the 
crosslinked and non-crosslinked fractions by immunoblotting. The crosslinked proteins 
were electrophoresed on SDS-PAGE gels of 6 % acrylamide and were subjected to a wet 
transfer to a PVDF membrane at 37 V for 16 h. 
3.2.21. Sucrose density gradient centrifugation 
Separation of particles based on their size and mass can be done by rate-zonal 
centrifugation technique. This procedure involves layering the sample on a preformed 
sucrose gradient and subjecting it to ultracentrifugation. When the sample particles are 
subjected to a high centrifugal force in a density gradient, they separate on the basis of 
their individual sedimentation rates, thus forming different zones within the centrifuge 
tube.  
For the sample preparation, cells grown to complete confluence in 20 petri dishes of 100 
mm were treated with 5 mM sodium butyrate to increase the expression of the recombinant 
protein. The detergent soluble fraction was then extracted as described in section 3.2.19. 
A continuous 5-30 % sucrose gradient was created using BioLogic LP from Biorad. The 
entire detergent-soluble fraction extracted from 10 Petri dishes with surface area of 100 
mm was loaded on sucrose gradient and subjected to ultracentrifugation using SW41 rotor 
at 100,000 x g, 4 °C for 20 h. Protein standards (1 mg/ml) - alcohol dehydrogenase (7.4 S), 
BSA (4.43 S) and carbonic anhydrase (3 S) were sedimented simultaneously, each in 
separate tubes. Following sedimentation, the gradients were eluted in 35 fractions of 315 μl 
each. The peaks for the protein standards were detected during the process of fractionation 
through the UV-spectrophotometer provided by BioLogic LP. The collected fractions of 
the test sample were concentrated by vacuum using Maxi-Dry Lyo vacuum concentrator. 
The location of the peak for keratin was determined by immunoblotting. 
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3.2.22. Co-immunoprecipitation (Co-IP) 
Co-immunoprecipitation is a technique used to identify the proteins interacting with the 
protein of interest in physiological conditions. The identification is accomplished by 
precipitating the protein-protein complexes with an antibody recognizing either of the 
proteins. 
Co-immunoprecipitation was done in following steps: 
Lysis: A confluent cell layer grown in a Petri dish of 100 mm diameter was washed with 
chilled PBS and lysed with 1 ml lysis buffer (Table 35). The cell lysate was centrifuged at 
20,000 x g and the supernatant was collected for co-immuoprecipitation. 10 % of the cell 
lysate was stored as the input fraction. 
A separate plate was used as the negative control and treated similarly. 
Washing the beads: 30 μl of Pierce protein A/G magnetic beads were used for Co-IP from 
a single 100 mm Petri dish. The beads were washed with 300 μl of wash buffer (Table 39) 
and gently vortexed. The wash was repeated with 1 ml of wash buffer and gently vortexing 
for 1 minute. 
Table 39: Composition of CO-IP wash buffer 
Chemical Concentration 
10X Tris buffer saline (TBS) 1X 
NaCl 0.05 M 
Tween-20 0.05 % 
D/W For dilution to the required volume 
 
Pre-clearing: The washed beads were added to the cell lysate and mixed for 30 minutes at 
room temperature (RT) to clear away the proteins non-specifically binding to the beads. 
Antibody-protein complexing: The pre-cleared supernatant was then mixed with the 
appropriate amount of the required antibody and mixed at RT for 1 h. The supernatant, 
which is used as the negative control, was not mixed with the antibody. 
Antibody-protein-beads complexing: 30 μl of freshly washed magnetic beads were mixed 
with the supernatant containing the antibody as well as the negative control for 1 h at RT. 
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Washing the Co-IP: The beads were washed with 500 μl of wash buffer followed by a 
wash with purified D/W. 
Elution: The Co-IP complexes were then eluted from the beads by heating the beads with 
2X SDS denaturing buffer at 100 °C 
3.2.23. Oxidative stress induction 
Oxidative stress is the persistence of surplus reactive oxygen species (ROS) beyond the 
antioxidant defense capacity of the cell. An oxidizing environment can be created within a 
cell by introducing hydrogen peroxide, which readily decomposes into ROS such as 
hydroxyl radicals.  
The cell lines to be tested were grown to confluence in a 6-well plate. Oxidative stress was 
induced in the cells by adding 30 % (v/v) H2O2 to the medium at a concentration of 10 mM 
for 1 h. A separate untreated control was maintained for each cell line tested. The cells 
were then harvested using 100 μl lysis buffer (Table 35). SDS denaturation buffer was 
added to the cell lysate at a concentration of 1X and heated at 100 °C.  
3.2.24. Enrichment of mitotic cells 
A predominant mitotic population can be achieved by arresting the cells in G2/M phase 
using the microtubule polymerization inhibitor nocodazole. Microtubule polymerization 
can be re-induced by culturing the cells after nocodazole removal for a minimum of 2 h.  
Cells were grown to a confluence of 60-80% and treated with nocodazole at a final 
concentration of 60 ng/ml for 16 h. The cells were washed thrice with PBS and kept in 
fresh medium for 2 h at the usual culturing temperature for the cell line to enable 
microtubule recovery. The cells were then used for imaging or immunoblotting 
3.2.25. SDS-PAGE 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is a 
discontinuous electrophoretic system to separate proteins on the basis of their molecular 
weight. It involves the migration of proteins through different buffer systems distinguished 
by pH. The protein sample is denatured into its primary structure using an anionic 
detergent, SDS, which also provides an overall negative charge to the protein molecule. 
The chloride ions and glycine from the electrophoresis buffer migrate along with the 
protein sample at different rates in different buffers. When the denatured protein sample is 
loaded on the stacking gel with a pH of 6.8, the migration speed towards the anode is 
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chloride ions (negative charge) > protein (negative charge) > glycine (neutral). However, 
in the resolving gel with pH of 8.8, the migration speed towards the anode changes to 
chloride ions (negative charge) > glycine (negative charge) > protein (negative charge). 
The reduced mobility of the protein and the decreased porosity in the resolving gel as 
compared to the stacking gel ensures the efficient separation of the protein solely on the 
basis of its molecular weight. 
Sample preparation was done by heating the protein sample at 100 °C in the presence of 
SDS denaturation buffer (Table 36). The protein samples were electrophoresed on 
acrylamide gels with the appropriate percentage depending on the molecular weight of the 
proteins to be analyzed. Table 40 and table 41 describe the composition for resolving and 
stacking gels, respectively. ProSieve QuadColor Protein Marker was used as the standard 
to mark the mobility of proteins of different molecular weight. 
Table 40: Resolving gel composition 
Chemical     6 % Acrylamide 
         (12 ml) 
       10 % Acrylamide  
            (for 12 ml) 
Water 7.2 ml 6 ml 
40 % Acrylamide 1.8 ml 3 ml 
Resolving gel buffer 3 ml 3 ml 
TEMED 12 μl 12 μl 
10 % APS 120 μl 120 μl 
Resolving gel buffer = 1.65 M Tris+ 6 N HCl pH 8.8 
Table 41: Stacking gel composition  
Chemical For 2.6 ml 
Water 1.6 ml 
40 % Acrylamide 313 μl 
Stacking gel buffer 625 μl 
Temed 2.5 μl 
10% APS 25 μl 
Stacking gel buffer = 1.65 M Tris+ 6 N HCl pH 6.8 
Table 42: Composition of 10X SDS running buffer 
Chemical Final concentration 
Tris 250 nM 
Glycine 1.921 M 
SDS 1 % (w/v) 
D/W For dilution to the required volume 
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3.2.26. Immunoblotting 
Immunoblotting is a technique used to detect the electrophoretically separated proteins on 
acrylamide gels using antibodies specific to the protein of interest. The amplification of the 
protein signal is achieved by linking the primary antibody with a horseradish peroxidase 
(HRP)-labelled secondary antibody. The signal is detected in the form of chemiluminescent 
product created by HRP from the provided substrate. 
The transfer of proteins resolved on SDS-PAGE gels to the PVDF membrane (pre-soaked 
in methanol for 5 minutes) was done in the presence of the transfer buffer of composition 
described in Table 43. The process of electroblotting was done at 100 V for 1 h in chilled 
transfer buffer and at 37 V for 16 h at 8 °C for high molecular weight proteins. 
The transfer of proteins from the gel to the PVDF membrane was checked by using 
Ponceau S stain. After 10 minutes of incubation with the stain, the membrane was washed 
with TBS-T to observe the bands clearly. The temporary stain was removed by washing 
the blot with TBS-T for 10 minutes on a shaker. 
The membrane was blocked at RT for 1 h using 10 % (v/v) Roti-Block solution to avoid 
non-specific binding of the antibody. The membrane was then incubated with the primary 
antibody solution for 16 h at 8 °C.  After the incubation, the membranes were given two 
washes of 10 minutes with TBS-T and further incubated with the appropriate HRP-coupled 
secondary antibody for 1 h at RT. The membranes were then washed twice with TBS-T for 
10 minutes each time and then treated with the Ace glow reagents, stabilized peroxide 
buffer and luminol/enhancer solution, mixed in equal proportion for 3 minutes. After 
draining away the solution, the chemiluminescence was detected using Fusion-
Solo.WL.4M CCD-camera and recorded with the Fusion Capt Advance software. 
For stripping the bound antibody, the blot membrane was incubated with the stripping 
buffer (0.1 M glycine, pH 2) for 30 minutes at RT. The membranes were shortly washed 
with TBS-T before proceeding with the next antibody incubation. 
Table 43: Composition of Immunoblot transfer buffer 
Chemical Amount for 1000 ml  
Glycine 3.03 g 
Tris base 14.4 g 
D/W 800 ml 
Methanol 200 ml 
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Table 44: Tris-buffered saline-Tween-20 (TBS-T) 
Chemical Amount for 1000ml 
NaCl 130 mM 
Tris base 50 mM 
Tween-20 0.1% (v/v) 
pH adjusted to 7.6  
10X stock solution without Tween-20 was prepared and Tween-20 was freshly added when diluting to 1X. 
3.2.27. Propidium iodide (PI) staining and flow cytometry 
Propidium iodide (PI) is used for the quantitative assessment of DNA content due to its 
DNA intercalating property and ease of detection on account of its fluorescence with an 
emission maximum at 617 nm. PI enables the staging of the cells in different parts of the 
cell cycle due to the marked differences in the DNA ploidy (Table 45) and thus 
fluorescence intensity.  
Table 45: DNA content in different cell cycle phases 
Cell-cycle phase DNA ploidy 
G1/G0 Diploid 
S Diploid + Tetraploid 
G2/M Tetraploid 
 
Flow cytometric analysis of PI-stained cells enables the qualitative as well as quantitative 
measurement of the DNA content. Flow cytometry involves the focusing of the cell 
suspension through a laser beam with the help of a sheath fluid. The fluorescence intensity 
of every cell that passes through a laser beam is reported in the form of a pulse of photon 
emission over time. This pulse is detected by a photomultiplier tube in the form of a voltage 
pulse and is called an ‘event’. The size of the voltage pulse area is directly proportional to 
the fluorescence intensity. Thus, a histogram of the fluorescence intensity v/s the number of 
events corresponds to the plotting of the DNA content v/s cell count in case of the PI 
staining. Additionally, a cell population of homogenous size and granularity can be 
selected for analysis based on the forward scattered and side scattered light, respectively. 
This process of selecting cell populations with common characteristics and ensuring the 
elimination of debris is called ‘gating’. 
10
6 
cells per clone were centrifuged at 1865xg  for  5  minutes and the cell pellet was 
washed with PBS. The cells were permeabilized by adding ice-cold 70 % ethanol dropwise 
with gently vortexing and incubating the cells in ethanol at 4 °C for 30 minutes. The 
ethanol was then removed and the cell pellet was washed with PBS twice. 50 μl of 0.1 
μg/μl RNase was preheated at 65 °C and added to the cell pellet for 20 minutes at RT. 
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Propidium iodide diluted in 0.1 % TritonX-100 was added to the cell pellet with RNase at 
a final concentration of 10 μg/ml and incubated for 30 minutes at RT. A negative control 
without PI was maintained. 
The stained cell samples were kept on ice and the PI staining was acquired using the Guava 
Easycyte mini flow cytometer. The Guava express Pro mode in Cytosoft software was used 
to perform the recordings and analysis. The capillary was rinsed with water and Guava 
instrument cleaning solution according to the cleaning program in the software. Before 
acquiring readings for the sample the red fluorescence from the PI was optimized by 
eliminating the bleed-through from the yellow fluorescence. The dot plot showing the side-
scatter (SSC) and forward scatter (FSC) was referred to adjust the optimal threshold for 
SSC and FSC. The cell population of the appropriate size and granularity was estimated 
from the SSC vs FSC plot and selected or gated. This gated population of cells was 
focused for further analysis in the histogram showing the cell count vs red fluorescence. A 
total of 10,000 events were acquired during every analysis. The settings were maintained 
constant throughout the experiment. The experiments were performed thrice in triplicate 
each time. 
The analysis of the cell count v/s fluorescence histogram was also done using Guava 
express Pro software. The histogram markers were selected were marked as G1 phase, S 
phase and G2 phase of the cell cycle in the ascending order of the red fluorescence 
intensity. The dimensions of the histogram markers demarcated for the control sample 
were maintained constant throughout the other test samples. The percentage of cell 
population present in each phase of the cell cycle was estimated based on the percentage of 
gated cell population corresponding to each of the histogram marker. 
3.2.28. Immunofluorescence 
Immunofluorescence is used for the visualization of specific proteins within the sample 
using antibodies recognizing the target proteins. Amplification of the antibody signal is 
accomplished by using fluorophore-conjugated secondary antibodies recognizing the 
primary antibody. The cell samples have to be pre-treated to immobilize the antigens and 
facilitate their accessibility to the antibodies without altering the cellular architecture. Use 
of methanol/acetone for fixation leads to precipitation of large protein molecules with a 
simultaneous permeabilization of the cell sample and thus is used for staining cytoskeletal 
or membranous proteins. Use of paraformaldehyde for fixation leads to the crosslinking of 
antigens due to the formation of intermolecular bridges through the free amino groups and 
Materials and Methods 
42 
 
thus is used to stain cytosolic proteins. An additional permeabilization step with methanol 
or tritonX-100 is essential in case of paraformaldehyde fixation. 
Cells were grown on glass coverslips before fixation. After a short wash with PBS, the 
cells were either fixed with paraformaldehyde (PFA) or methanol/acetone. 
Methanol/acetone fixation: The cells were fixed in methanol for 3 minutes followed by 
acetone for 30 seconds, both at -20 °C. The cells were then washed with water and 
mounted with Mowiol. 
Paraformaldehyde fixation: Cells were treated with paraformaldehyde for 15 minutes 
and washed with PBS followed by water before mounting with Mowiol. Fresh PFA 
aliquots stored at -20 °C were used each time after warming at 37 °C. 
In both types of fixation, the Mowiol was allowed dry overnight at 4 °C. 
For immunostaining with antibodies, the fixed cells were incubated with the primary 
antibody in an appropriate dilution for 1 h followed by three washes with 1X PBS, 10 min 
each. The cells were then incubated with the secondary antibody for 1 h and washed thrice 
similar to the previous step. For nuclear staining, 2 ng/μl DAPI was added to the secondary 
antibody solution. In case of paraformaldehyde fixation, permeabilization with 0.5 % 
TritonX-100 was done prior to primary antibody incubation followed by a wash with 1X 
PBS for 5 min. 
3.2.29. Microscopy 
3.2.29.1. Structured illumination microscopy (SIM) 
Structured illumination microscopy includes the super position of a grid pattern over the 
fluorescent sample. The projected grid falling on the specimen structures within the focal 
plane provides the best contrast whereas the out of focus structures are blurred out. This 
results in a precise optical section of the specimen with enhanced resolution and increased 
contrast. 
Zeiss ApoTome 2 microscope was used in this work to visualize fixed cell specimens using 
the principle of SIM. Optimal settings for automatic exposure were chosen during image 
acquisition. 
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3.2.29.2. Confocal laser scanning microscopy 
Confocal laser scanning microscopy involves the laser scanning of a specimen at a defined 
confocal plane. High-resolution optical imaging of thick specimen samples is enabled by 
the elimination of photons emitted from out-of-focus planes of the specimen due to the 
presence of a pinhole aperture in front of the detector. 
Confocal image recordings were done using Zeiss LSM 710 Duo microscope. All the 
images were recorded at 16 bit grey-scale resolution and bidirectional scanning was 
preferred for higher acquisition speed. When acquiring signals for more than one 
fluorophore, the excitation and emission spectra were well adjusted to prevent overlap. The 
LSM 710 unit also consisted of an Airyscan detector which provided higher quality images 
through its different modes such as Super Resolution (S-R), Resolution versus Sensitivity 
(R-S) and Confocal (CO). The images acquired by the S-R and R-S mode required a 
separate processing before they were fit for analysis. When imaging fixed cells, the R-S 
mode of the airyscan detector was used. 
Live cell imaging: Cells were grown in collagen-coated glass bottom dishes with the 
normal growth medium for live cell imaging. A temperature of 37 °C for HaCaT cells and 
32 °C for murine keratinocytes was maintained with a 5 % CO2 humidified atmosphere for 
both cell lines. The definite focus function was always used during live cell recordings. 
The S-R mode of the Airyscan detector was used for live cell imaging. 
Fluorescence recovery after photobleaching (FRAP): FRAP technique is often used to 
investigate the diffusion kinetics of proteins within the cell. It involves the permanent 
destruction of a fluorophore molecule by high intensity illumination thus creating a 
bleached area. The rate of reappearance of fluorescence as a result of the diffusion of the 
surrounding fluorescing molecules into the bleached area can be used to determine the 
turnover of the fluorescing protein.  
FRAP technique was performed by maintaining the standard environmental conditions for 
live cell imaging. 488 nm laser at 100 % intensity with 20 iterations was used for bleaching 
keratin filaments and 100 iterations for bleaching the non-filamentous keratin pool. The 
region of interest to be bleached and recovered was chosen and its area was kept constant 
throughout the experimental set. The definite focus function was used and recordings were 
done using the CO mode of the Airyscan detector. 
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3.2.29.3. Selective plane illumination microscopy-fluorescence correlation 
spectroscopy (SPIM-FCS) 
Various molecules in the cell are often involved in either free random Brownian motion, 
Brownian motion in a crowded environment or directed motion in association with 
structures such as the cytoskeleton. The mobilities of the cellular particles correspond to 
the diffusion characteristics. The diffusion kinetics of fluorescent molecules can be 
analyzed by fluorescence correlation spectroscopy (FCS), which measures the fluorescent 
fluctuations of a molecule with respect to time in a particular volume of interest. 
Simultaneous analysis of the diffusion properties of several molecules over a large area of 
interest in a live cell is possible when FCS is coupled with light sheet microscopy, together 
called selective/single plane illumination microscopy-fluorescence correlation 
spectroscopy (SPIM-FCS). SPIM technique involves the focusing of a light-sheet on only 
the focal plane of the detection objective lens thus allowing optical sectioning with limited 
photobleaching. 
SPIM-FCS in collaboration with Dr. Norbert Mücke (DKFZ, Heidelberg) was used to 
determine the diffusion characteristics of the free pool of keratin precursors which 
corresponded to the Brownian motion-induced keratin mobilities. After obtaining the value 
of the diffusion coefficient, the hydrodynamic radius of the molecule was calculated with 
the Einstein relation equation as follows: 
D = kB · T/ 6 π · ηvisc · Rh 
where, D is the diffusion coefficient of the particle, kB is Boltzman’s constant, T is the absolute 
temperature and ηvisc is the dynamic viscosity of the medium. 
The relative viscosity of the cytoplasm with respect to water was determined by measuring 
the diffusion coefficient of YFP monomers in the cells expressing the YFP constructs.  
SPIM-FCS analysis was done on adherent cells grown on glass cover slips of 5×10 mm
2 
size and a thickness of 0.28-0.32 mm. The glass cover slips were held with tweezers in a 
sample chamber containing the culture medium. The incubation conditions included a 
temperature of 32 °C in the absence of CO2 supply.  The cells from each cover slip were 
analyzed not more than 30 minutes. The image acquisition and analysis was done by Dr. 
Jan Krieger, DKFZ, Heidelberg. The calculation of hydrodynamic radii (RH) was done 
using the QuickFit 3 software. 
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3.2.30. Image editing and analysis 
The images acquired from the LSM 710 as well as ApoTome 2 were analyzed using the 
Fiji software. The recovery of bleached fluorescence during FRAP analysis was done using 
a sum of projection of the z-stack and maximum intensity projection of the z-stack was 
created for images used for representation. The Fiji software was also used for making 
movies, final editing, creation of composite images, addition of scale bars and time stamps. 
The images and movies were saved in the TIFF format. The movies were converted to 
Audio video interleaved (AVI) format for final presentation. 
3.2.31. Statistical analysis 
GraphPad Prism software was used for all the statistical analysis. The data which passed 
the D’Agostino & Pearson omnibus k2 test with significant P value was considered to have 
a Gaussian distribution. 
Comparison between two cell clones was performed with unpaired t test when data showed 
Gaussian distribution and Mann-Whitney test for the reverse case. When more than two 
cell clones were compared, one-way analysis of variance (ANOVA) was used for data with 
Gaussian distribution and Kruskal-Wallis test when otherwise. 
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4. Results 
4.1. Effect of phosphomimetic mutation on keratin filament network  
Most of the phosphorylation sites have been identified in the end domains of the keratin 
molecules (Steinert et al., 1982; Steinert, 1978; Steinert, 1988), thus making the head and 
tail regions important for studying the effect of phosphorylation on keratin assembly. The 
type II keratin head domain is suitable to address this hypothesis as it contains potential 
phosphorylation sites and has been shown to disrupt filament assembly upon deletion 
mutations (Hatzfeld and Burba, 1994; Steinert et al., 1985; Wilson et al., 1992). However, 
the contribution of specific phosphorylation sites in keratin head domain in affecting 
keratin filament formation is not yet known.  
The focus of this section was to determine the effect of phospho-site mutations in the type II 
keratin head domains on keratin filament formation.  
4.1.1. Increasing phosphomimetic mutations decreased keratin filament formation in 
normal keratinocytes 
Human epidermal keratinocyte-derived HaCaT cells were used to study the influence of 
phosphorylation on keratin filament organization in the presence of a normal keratin 
network pursuing the following aims: 
 Determination of whether phosphorylation affects keratin filament formation in an 
isotype-specific manner. 
 Analysis of whether phosphorylation has a cumulative effect on keratin filament 
formation 
The strategy used to address the above objectives was by studying the outcome of 
increasing phosphorylation on keratin filament formation simultaneously on two different 
type II keratins, namely, keratin 8 (K8), which is expressed in simple epithelia, and keratin 
5 (K5), which is expressed in stratified epithelia. Fig. 5 and Fig. 6 show the different sites 
in the K8 and K5 head domains, respectively, which were included in the analysis. The 
schemes also denote various kinases known to phosphorylate the selected residues or their 
binding partners upon phosphorylation. 
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Fig. 5: Scheme depicting the amino acid residues in the K8 head domain selected for phosphomimetic 
mutation. 
 
 
Fig. 6: Scheme depicting the amino acid residues in the K5 head domain selected for phosphomimetic 
mutation. 
 
 
 
 
The major phosphorylation site of K8, S73 (marked in red) in the H1 subdomain of the K8 head domain, was 
mutated alone and in combination with adjacent serine residues S20, S21, S23 and S26 (all marked in green). 
The kinases known to target the residues are denoted alongside with the respective reference. [Reference- a. 
PHOSIDA database; b. Akita et al. (2007); c. Ku et al. (2002); d. Menon et al. (2010); e. Woll et al. (2007); f. 
He et al. (2002); g. Ando et al. (1996); h. Ridge et al. (2005)] 
The major phosphorylation site of K5, T150 (marked in red) in the H1 subdomain of the K5 head domain 
was mutated alone and in combination with adjacent serine residues S35, S63, S76 and S81 (all marked in 
green). The kinases known to target the residues or the binding partner of the phosphorylated residue are 
denoted alongside with the respective reference. [Reference- a. PHOSIDA database; b. 
http://scansite.mit.edu/motifscan_seq.phtml; c. Toivola et al., (2002)] 
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 A series of phosphomimetic [substitution with a phosphate-mimicking amino acid residue 
such as aspartic acid (D)] YFP tagged-K5 and CFP tagged-K8 head mutants were created. 
In case of K8, phosphomimetic mutation was introduced in the major phosphorylation site, 
S73, alone and in combination with adjacent potential phosphorylation residues S20, S21, 
S23 and S26. Similarly, T150, the major phosphorylation site of K5 was mutated alone and 
in combination with other potential phosphorylation sites S35, S63, S76, and S81. Overall, 
1 single, 4 double, 6 triple, 4 quadruple and 1 quintuple phosphomimetic mutations as 
mentioned in Table 46, were created.  
Table 46: Series of phosphomimetic K8 and K5 mutants created. 
 
Degree of mutation 
 
Type of K8 CFP construct 
 
Type of K5 YFP construct 
 WT  WT  
Single S73D  T150D  
Double S20/73D S35/T150D  
S21/73D S63/T150D  
S23/73D S76/T150D  
S26/73D S81/T150D 
Triple S20/21/73D S35/63/T150D 
S21/23/73D S35/76/T150D 
S20/23/73D S35/81/T150D 
S21/26/73D S63/76/T150D 
S20/26/73D S63/81/T150D 
S23/26/73D S76/81/T150D 
Quadruple S20/21/23/73D S35/63/76/T150D 
S21/23/26/73D S35/63/81/T150D 
S20/21/26/73D S35/76/81/T150D 
S20/23/26/73D S63/76/81/T150D 
Quintuple S20/21/23/26/73D S35/63/76/81/T150D 
 
Each of the constructs mentioned in table 46 was transfected into HaCaT cells using the 
jetPEI transfection reagent as described in section 3.2.14. The transfected cells were then 
methanol-acetone fixed (section 3.2.28) 48 h post-transfection and mounted with mowiol 
mounting medium. 
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The fluorescence elicited by each of the constructs transfected into HaCaT cells was 
imaged with the Apotome microscope. Three major patterns were observed in each 
instance: filamentous, granular or mixed filaments/granular (Fig. 7). The phenotypes were 
visually scored and compared to those observed for WT keratin. The results showed that 
the filament forming ability decreases with an increase in the number of phosphomimetic 
mutations in K8 as well as K5 head domain (Fig. 8). However, when observed within a 
group of constructs with equal number of residues mutated, certain combinations of mutant 
residues showed less keratin filament forming defects, such as K8 S20/21/26/73D, K5 
double and triple mutants containing mutated S35 and S76 residues, and K5 
S35/76/81/T150D (Fig. 8). Taken together, phosphomimetic mutations affect keratin 
filament formation in a cumulative manner without showing an isotype preference. 
       
Fig. 7: Transient transfection of either K5 or K8 in HaCaT cells showed three different keratin 
phenotypes: filamentous, filamentous + granular and granular.  
 
HaCaT cells were transfected with phosphomimetic mutants of K8 and K5. 48 h post-transfection the cells 
were fixed by methanol/acetone. The fluorescence in transfected cells was imaged using ApoTome 
microscope. A-C are representative images for the three major fluorescent patterns observed by transfection 
of each of  K8 S73D CFP constructs and D-F  for those of T150D K5 YFP constructs in HaCaT cells. Scale 
bars = 10 μm 
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Fig. 8: Increasing keratin phosphorylation decreased keratin filament formation cumulatively. 
HaCaT cells were transiently transfected with phosphomimetic mutants of K8 (A) and K5 (B). 48h post-
transfection the cells were fixed by methanol/acetone. The transfected cells were imaged using ApoTome 
microscope. The percentage of cells expressing only filamentous keratin was quantified for each of the 
constructs. Each experiment was performed thrice and a minimum of 200 transfected cells were quantified 
each time. Statistical analysis was performed with Kruskal-Wallis one-way analysis of variance followed by 
Dunn’s post test. Note the decrease in the percentage of cells forming filaments upon increase in the number 
of phosphomimetic mutations in K8 and K5.  
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4.1.2. Phospho-site mutations altered keratin filament network formation in type II 
keratin knockout murine keratinocytes (KO) 
Type II keratin knockout murine keratinocytes (KO) were chosen as a model to study the 
role of phosphorylation in affecting keratin filament organization (Vijayaraj et al., 2009). 
The absence of type II keratins in these keratinocytes eliminated the possibility of 
endogenous compensation, thus, demonstrating inherent properties of mutant keratins. 
Phosphomimetic and phosphodeficient [substitution with an amino acid residue which 
cannot be phosphorylated such as alanine (A)] mutants of a major phosphorylation site 
T150 belonging to homology 1 (H1) head domain of K5 was used for further analysis. 
T150 K5 residue was chosen because besides being one of the major phosphorylation sites 
of K5, H1 domain of type II keratin was shown to be critical in alignment of neighboring 
molecules during keratin filament assembly (Parry, 1992; Steinert, 1991a; Steinert, 1991b). 
Transient transfections of WT K5 YFP, T150D K5 YFP and T150A K5 YFP were done in 
KO cells and the keratin expression patterns were compared to that in WT murine 
keratinocytes (WT). Live cell confocal imaging was done using the super-resolution (S-R) 
mode of the Airyscan detector.  KO cells showed an overall reduced ability for keratin 
filament induction as observed from the weaker keratin filament meshwork formed by WT 
K5 YFP in KO cells in comparison to WT cells (Fig. 9-A, D). However, T150D K5 YFP 
showed completely different phenotypes when expressed in WT and KO cells. T150D K5 
YFP mutant showed the presence of a major non-filamentous diffused pool containing a 
few granules and small filamentous fragments in the KO cells whereas the same mutant 
was capable to build a normal filamentous network in WT cells (Fig. 9-B, E). The 
phospho-deficient mutant T150A K5 YFP was able to form filaments in KO as well as the 
WT cells, but T150A K5 YFP filaments appeared thicker in KO cells in comparison to the 
finer network  formed by the same mutant in WT cells (Fig. 9-C, F).  
These results showed that alterations in keratin filament organization due to 
phosphomimetic and phosphodeficient mutations of T150 K5 residue could be clearly 
determined in KO cells. 
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Fig. 9: Transient transfection of T150D K5 YFP and T150A K5 YFP showed different keratin filament 
morphology in WT and type II keratin knockout (KO) murine keratinocytes.  
Generation of stable cell lines in type II keratin KO keratinocytes 
The transient transfections of the keratin mutants in KO cells (Fig. 9) showed that the 
properties of the keratin mutants can be clearly studied in KO cells. The next aim was to 
make stable cell clones of KO cells expressing WT K5 YFP, T150D K5 YFP and T150A 
K5 YFP by the method described in section 3.2.15. The stable cell lines created in KO 
cells were named as WT K5 YFP-KO, T150D K5 YFP-KO and T150A K5 YFP-KO, 
based on the keratin construct expressed. 
Detection of K5 YFP levels in stable cell lines: RNA was purified from each of the stable 
cell lines and cDNA was made by reverse transcription PCR (RT-PCR) The resulting 
cDNA was further PCR amplified by primers specific to K5 (primer nos. 01-31 + 13-002) 
and the house keeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (primer 
nos. 04-19 + 04-20).  
In Fig. 10A, the PCR product at 500 base pairs (bp) showed the detection of K5 and at 200 
bp that of GAPDH. KO cells were used as the negative control which showed the presence 
Live cell confocal images of transiently transfected WT K5 YFP, T150D K5 YFP and T150A K5 YFP in WT 
cells shown in A, B and C respectively, indicated keratin filament formation by WT as well as mutant 
keratins. T150D K5 YFP showed the loss of keratin filament forming ability in KO cells (E). T150A K5 YFP 
showed thicker filament patterns in KO cells (F) in comparison to WT K5 YFP filaments in KO cells (D). 
Scale bars = 10 μm 
A B C 
D E F 
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of GAPDH but not K5 whereas both GAPDH and K5 were detected in all the stable 
clones. 
Further, whole cell protein extracts were made by the protocol described in section 3.2.18 
and separated by SDS-PAGE to compare the level of keratin expression (Fig. 10B). The 
stable cell clones showed the signal for K5 antibody at approximately 88 kD which 
corresponded to the molecular weight of K5 YFP. KO cells were used as the negative 
control which showed absence of K5. 
Both, PCR and immunoblot analysis showed that the transcriptional and translational level 
of keratin expression in all the cell lines was similar when referred to the loading controls 
GAPDH and actin, respectively. 
                                   
Fig. 10: Cell lines derived from type II keratin knockout (KO) murine keratinocytes stably expressing 
WT and mutant keratin showed similar keratin expression at transcriptional and translational level.  
Analysis of the keratin phenotypes in stable cell lines: The keratin expression patterns and 
dynamics in KO cell lines stably expressing the different keratin constructs WT, T150D 
K5 and T150A K5 were studied and compared. All the experimental analyses described in 
this and further sections were done after seeding each of the clones for a period of ten days 
to ensure a well-developed keratin filament network in WT K5 YFP-KO cells. Live cell 
confocal imaging of the clones using the super-resolution mode of the Airyscan detector 
showed keratin phenotypes in accordance with the transient transfections shown in (Fig. 9). 
Both the mutant clones of T150D K5 mutant, namely T150D K5-KO C1 and  T150D K5-
KO C2, showed the presence of a pool of fine particles along with coarse granules and 
(A) Reverse transcriptase PCR (RT-PCR) amplification of cDNA from RNA extracted from the WT keratin- 
and mutant keratin- expressing KO cells using primers specific to K5 and housekeeping gene GAPDH 
showed similar level of keratin mRNA expression. (B) Immunoblot analysis of the whole cell extracts of WT 
keratin- and mutant keratin- expressing KO cells using antibodies specific to K5 and the loading control actin 
confirmed the similarity in keratin expression at the protein level. This is a representative image of three 
experiments. 
A 
 B 
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some filamentous particles in KO cells suggesting the loss of filament forming ability of 
these K5 mutants (Fig. 11-B,C,F,G) (Movie no. 2).  
 
Fig. 11: Keratin expression patterns of WT and mutant keratin stably expressed in type II keratin 
knockout (KO) murine keratinocytes. 
Although T150A K5-KO clone was still able to form filaments in the absence of 
phosphorylation at T150 K5 residue, T150A K5 filaments appeared much thicker and the 
overall network was less dense (Fig. 11-D, H) (Movie no. 3) than that in WT K5 YFP-KO 
clone (Fig. 14-A,E) (Movie no. 1). Additionally, time lapse recordings showed that the 
sparsely complexed keratin network consisting of thicker filaments formed by T150A K5 
YFP mutant was less dynamic in comparison to the denser WT K5 YFP network composed 
of finer filaments (Movie no. 1 and 3). The non-filamentous free pool of fine particles and 
granules in the T150D K5 YFP mutant showed extremely high mobility throughout the 
cytosol (Movie no. 2). A detailed analysis of the dynamics of the various keratin patterns 
will be described in section 4.3. 
Further, WT K5 network pattern in KO cells improved with time after seeding. Similarly, 
the T150A K5 mutant filament network also enhanced with time after seeding. In case of 
A-D show live cell confocal images (zoom =0.9x) of WT K5 YFP-KO, T150D K5 YFP-KO C1, T150D K5 
YFP-KO C2 and T150A K5 YFP-KO stable cell lines grown in a monolayer. E-H show live cell confocal 
images (zoom=1.8x) for single cells of each of the stable clones. Note the absence of keratin filaments in 
both KO clones expressing T150D K5 YFP (B, C, F, G) and the difference in the keratin filament network 
formed by the KO clone expressing T150A K5 YFP (D, H) in comparison to that of the KO clone expressing 
WT K5 YFP (A, E). Scale bars = 10 μm 
A B C D 
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the T150D K5 mutant, when observed on the fifth day after seeding, KO cells stably 
expressing the mutant showed a small percentage of cells containing short fragments of 
keratin filaments at the cell periphery along with diffuse and granular keratin (Fig. 12C). 
The proportion of cells expressing diffuse + granular + short fragments of filaments of the 
T150D K5 mutant increased slightly with time after seeding. Thus, keratin patterns of all 
the three, WT K5, T150D K5 and T150A K5, constructs stably expressed in KO cells 
showed that the keratin filament forming ability of KO cells steadily increased with time, 
suggesting the gradual slowdown of the keratin cycle of assembly and disassembly after 
seeding.  
 
Fig. 12: Assembly incompetent T150D K5 mutant showed three characteristic keratin patterns in type 
II keratin knockout (KO) cells. 
 
 
 
 
 
 
Majority of the T150D K5-KO mutant cells showed the presence of a predominantly diffuse pool of keratins 
(A). A small fraction of cells showed the presence of more coarse granules along with the typical diffuse 
keratin (B) and cells with diffused + granular + filamentous fragments containing cells (C). Traces of 
filamentous particles are marked by red arrows in (B) and (C). Amount of cells expressing keratin patterns 
shown in (B) and (C) gradually increased with time after seeding indicating the failed attempt of filament 
formation by the T150D K5 mutant. Scale bars = 10μm 
A B C 
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4.2. Effect of phosphorylation on keratin structure  
Phosphorylation-mediated conformational modifications in the keratin molecule (Yeagle et 
al., 1990) indicated the potential of phosphorylation in altering keratin assembly. 
Phosphorylation-mediated keratin filament reorganization and enhancement of the 
detergent solubility of keratin have been studied before (Chou et al., 1993; Strnad et al., 
2002; Woll et al., 2007; Zhou et al., 1999). However, these reports were based on drug-
induced keratin phosphorylation analyses or the use of keratin phospho-site mutants in the 
presence of WT keratins. Thus, the full extent of a keratin site-specific phosphorylation on 
keratin structure was not exactly revealed. 
The altered keratin morphology of KO cells stably expressing T150D K5 YFP and T150A 
K5 YFP mutants provided a suitable system for a detailed analysis of the effect of 
modifying a single keratin phosphorylation site on the keratin structure.  
The aim of this section was to examine the structure of the phosphodeficient keratin, 
T150A K5 YFP, and the phosphomimetic keratin, T150D K5 YFP. 
4.2.1. Phosphodeficient keratin mutant showed modified filament topology 
Confocal imaging showed that the filaments of the T150A K5 YFP (Fig. 9F; Fig. 11H) 
mutant were thicker than WT K5 YFP filaments in KO cells (Fig. 9 D; Fig. 11E). T150A 
K5 YFP filament network showed less webbing in comparison to WT K5 YFP filament 
network.  
The aim of this experiment was to compare the network properties of WT and 
phosphodeficient keratin filaments to delineate the difference in their network morphology. 
The difference in the appearance of the filaments formed by WT K5 YFP and T150A K5 
YFP in the KO cells was further confirmed by performing branching analysis of the keratin 
filament network by Prof. Obara (Durham University). The analysis was done based on an 
algorithm designed by Dr. Gerlind Herberich (RWTH Aachen University) which detected 
the branching points within the keratin filament network. The mean keratin filament length 
between the branches was measured for 20 z-stack images of each WT K5 YFP-KO and 
T150A K5 YFP-KO cells, acquired using laser scanning confocal microscopy by 
superresolution (S-R) mode of the airyscan detector.  
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Fig. 13: Lack of phosphorylation at T150 K5 decreased branching in the keratin filament network.  
The measurements showed that filament length of the phosphodeficient keratin T150A K5 
in KO cells was significantly higher than that of WT K5 (Fig. 13; Fig. 14). This suggested 
that the number of branching points between the phosphodeficient keratin filament 
meshwork were significantly lower than that of WT keratin. Fig. 13-A, B shows live cell 
confocal images of WT K5 YFP and T150A K5 YFP networks stably expressed in KO 
cells. The skeletonized images and their magnified view made the increased complexity of 
WT K5 YFP network (Fig.13-C, E) over T150A K5 YFP network (Fig.13-D, F) clearly 
evident. 
20 live cell confocal images of WT K5 YFP-KO (A) and T150A K5 YFP-KO (B) were subjected to 
measurement of the length of keratin filaments between two branching points in the keratin network by Prof. 
Obara (Durham University), based on an algorithm designed by Dr. Gerlind Herberich (RWTH Aachen 
University). The higher amount of branching points in WT K5 YFP filament network can be clearly observed 
in the skeletonized images (created by Fiji software) (C,E) in comparison to the sparse filament network 
formed by the T150A K5 YFP in the KO cells (D,F). (E,F are magnified views of regions marked with 
squares in C,D respectively) Scale bars = 10 μm 
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Fig. 14: Lack of phosphorylation at T150 K5 led to a significant increase in the inter-branch filament 
length of the keratin filament network. 
4.2.2. Phosphomimetic keratin mutant showed enhanced solubility  
The presence of a large amount of non-filamentous, diffusible keratin pool in the 
phosphomimetic keratin-expressing cell line T150D K5 YFP-KO, led to assessment of the 
detergent solubility of the T150 K5 mutant. 
The aim of this experiment was to investigate the effect of phosphomimetic and phospho-
deficient mutations of T150 K5 residue on keratin solubility. 
Soluble and filamentous keratin was extracted as described in section 3.2.19 from each of 
the stable cell clones, WT K5 YFP-KO, T150D K5 YFP-KO C1 and T150A K5 YFP-KO. 
Immunoblot analysis showed that phosphomimetic keratin T150D K5 contained both, a 
significant amount of triton X-100 soluble fraction as well as an insoluble fraction (Fig. 
15). However, WT K5 and phosphodeficient keratin, T150A K5, only showed the presence 
of triton X-100 insoluble fraction. The soluble fraction of T150D K5 mutant clone also 
showed the presence of K14 which is the type-I keratin binding partner of K5.  
 
Graphical representation of keratin filament length measurements between the network branching points in 
WT K5 YFP-KO (N=20) and T150A K5 YFP-KO (N=20) cells, performed by Prof. Obara (Durham 
University). The increase in the intra-branch filament length of T150A K5 mutant indicated the reduction of 
the overall branching points in the phosphodeficient keratin cytoskeleton. Statistical analysis was done by 
two tailed Mann-Whitney test. 
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Fig. 15: Phosphomimetic mutation at T150 K5 enhanced K5/K14 detergent solubility.  
Further, to view the structure of keratin in the soluble and insoluble fraction of T150D K5, 
live cells of the T150D K5 YFP-KO C1 were subjected to 0.05% triton X-100 treatment 
for 10 minutes and confocal images were acquired before and after triton X-100 treatment. 
Fig. 16 shows that the keratin fluorescence composed of a diffuse cytosolic signal 
containing granules dispersed throughout the cytoplasm was reduced to a granular pattern 
devoid of diffuse fluorescence after triton X-100 treatment. The triton X -100 treatment 
also revealed the presence of thin keratin threads connecting the keratin granules. 
These results showed that a phosphomimetic mutation at T150 K5 residue led to the 
formation of a large amount of detergent soluble fraction consisting of dispersed cytosolic 
keratin and a detergent insoluble fraction of keratin granules and filamentous fragments. 
The enhanced detergent solubility of T150D K5 mutant was accompanied with a 
simultaneous increase in K14 solubility. However, phosphodeficient mutation at T150 K5 
did not detectably alter keratin solubility as observed in the T150D K5 mutant (Fig. 15).          
 
Immunoblot analysis of the triton X-100 soluble (S) and insoluble (I) extracts of the WT K5 YFP-KO, 
T150D K5 YFP-KO C1 and T150A K5 YFP-KO cells was performed. K5 and K14 were observed in the 
detergent insoluble fraction of all the cells. However, only the T150D K5 YFP-KO C1 soluble fraction 
showed the presence of K5 as well as K14. This increase of K5/K14 detergent solubility was not observed in 
the WT K5 YFP-KO and T150A K5 YFP-KO cells. The actin signal confirmed the presence of protein in all 
the lysates. This result was confirmed thrice. 
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Fig. 16: The detergent soluble fraction of T150D K5 YFP was composed of freely diffusible fine 
particles and the insoluble fraction mainly contained in coarse granules. 
4.3. Effect of phosphorylation on keratin assembly 
The presence of a predominant diffusible, soluble keratin pool instead of a keratin filament 
network in T150D K5 YFP-KO cells raised the question if the phosphomimetic keratin is 
composed of distinct keratin assembly intermediates. 
The aim of this section was to investigate the molecular nature of T150D K5 YFP soluble 
pool. 
4.3.1. Phosphomimetic keratin showed hydrodynamic properties of a tetrameric 
molecule 
Single plane illumination microscopy fluorescence correlation spectroscopy [(SPIM FCS) 
in cooperation with Dr. Mücke, DKFZ, Heidelberg] was performed for the determination 
of the oligomeric state of non-filamentous keratins on the basis of the diffusion coefficient. 
The diffusion coefficients were measured at 32 °C as described in section 3.2.29.3. 
The diffusion coefficient measured in this experiment represented the movement of free 
particles. Fig. 17 shows a graphical representation of the diffusion coefficient values before 
(green) and after (red) pixel binning. The YFP-expressing cells showed a diffusion 
coefficient value 26 μm2/s which was higher than the 6 μm2/s value in the keratin-
expressing cells. This can be explained by the smaller size of YFP monomers compared to 
Live cell confocal imaging of a T150D K5 YFP-KO C1 cell before and after treatment with 0.05% triton X-
100 for 10 minutes was done. Note that the diffuse fluorescent signal (A) was lost after 10 minutes of 
detergent treatment leaving behind granules (B). This confirmed that a major pool of cytosolic fluorescence 
in T150D K5 YFP mutant was soluble in triton X-100 whereas granular keratin was the detergent insoluble 
fraction of the phosphomimetic keratin. Scale bars = 10μm           
A B 
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keratin oligomers. A similarity in the values of the diffusion coefficients for WT K5 YFP 
and T150D K5 YFP expressing cells was observed. 
The diffusion coefficient values were further used to derive the molecular properties of the 
fluorescent particles. The diffusion coefficient and the hydrodynamic radius (RH) at 20 °C 
in a medium with a relative viscosity of water (D 20,W)  were calculated using the QuickFit 
3.0 software. The WT K5 YFP, T150D K5 YFP C1 and T150D K5 YFP C2 clones 
contained a pool with a D 20,W  of 19.8 μm
2
/s, whereas the YFP expressing cell clones 
showed a D 20,W  of 85.8 μm
2
/s. The hydrodynamic radii values thus obtained were 10.85 
for WT K5 and T150D K5 and 2.5 for YFP. Assuming a cylindrical shape and taking 
length/diameter values for dimer, tetramer and ULF forms of intermediate filaments into 
account (Herrmann et al., 1999; Quinlan et al., 1986), hydrodynamic radii of various 
keratin oligomers were calculated (Table 47) 
The analysis showed that the diffusible keratin pool in both WT K5 YFP and T150D K5 
YFP correlated with an oligomeric state which was greater than a dimer and less than a 
unit length filament (ULF), thus likely corresponding to the tetrameric form of keratin 
(Table 47 and 48).  
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Fig. 17: The diffusion coefficient of the free pool was the same for WT and T150D keratin.   
Table 47: Calculation of hydrodynamic radii for a keratin cylinder at different oligomeric states 
 
Oligomeric state 
 
Length  
 
Diameter  
 
Hydrodynamic radius 
(RH)  
 
Dimer
a
 
 
50 nm 
 
2.4 nm 
 
7.34825 nm 
 
Tetramer
a
 
 
72 nm 
 
2.8 nm 
 
9.9686 nm 
 
ULF
b
 
 
60 nm 
 
16 nm 
 
16.8001 nm 
a(Quinlan et al., 1986)
   
b(Herrmann et al., 1999)
 
Table 48: Hydrodynamic analysis of WT K5 and T150D K5 
 
 
  Cell sample 
 
 
Observed 
diffusion 
coefficient  
(D) 
Diffusion 
coefficient at 
relative 
viscosity of 
water at 20 °C 
(D 20,W) 
 
Hydrodynamic 
radius (RH) 
 
Possible oligomeric 
state 
  WT K5 YFP   
      6 μm2/s 
 
         19.8 μm2/s 
 
         10.85 nm 
  
       Tetrameric T150D K5 YFP C1 
T150D K5 YFP C2 
 
         YFP  
 
    26 μm2/s 
 
         85.8 μm2/s 
 
         2.50 nm 
 
      Monomeric 
Graphical representation of the diffusion coefficient values of WT K5 YFP-KO, T150D K5 YFP-KO C1, 
T150D K5 YFP-KO C2 before and after 2x2 pixel binning. N = 20 for all the cells. The diffusion coefficient 
represented the diffusion of freely moving fluorescent molecules in the cytosol.  Both, WT and T150D 
keratins showed similar values for the diffusion coefficient. The YFP fluorescence comprising monomeric 
particles showed the highest diffusion coefficient. 
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4.3.2. Phosphomimetic keratin was a tetramer composed of typeI/typeII keratin  
The determination of the molecular weight of soluble T150D K5 fraction was done by 
electrophoresing chemically crosslinked keratin complexes on a denaturing gel. 
Crosslinking of the keratins was done using disuccinimidyl suberate (DSS) as described in 
section 3.2.20. Fig. 18 shows that DSS crosslinking of the T150D K5 YFP soluble fraction 
led to a loss of monomeric K5 as compared to the non-crosslinked fraction. Additionally, 
the crosslinked fraction showed an immunologically detected-signal in the range of 250-
315 kD molecular weight suggesting the crosslinking of K5 into a higher oligomeric 
structure. The higher molecular weight species was also detected by K14 antibody. These 
observations hinted towards the presence of a K5 YFP/K14 tetramer (approximately 
280kD).  
                
Fig. 18: Chemical crosslinking of the T150D K5 YFP-KO C1 soluble pool showed a shift of the 
monomeric forms of K5 and K14 to distinct higher oligomeric state. 
Sucrose density gradient sedimentation was used to determine the molecular size of the 
T150D K5 YFP fraction. T150D K5 YFP C1 cells were treated with the histone 
deacetylase inhibitor, sodium butyrate, as described in section 3.2.21 to increase the yield 
of the mutant keratin. Fig. 19 shows that sodium butyrate treatment increased the 
expression of the mutant keratin substantially as detected by microscopy. The increased K5 
The disuccinimidyl suberate (DSS)-mediated crosslinked T150D K5 YFP mutant soluble pool was 
electrophoresed on a denaturing gel and compared against the non-crosslinked fraction. Immunoblot analysis 
with antibodies specific to K5 (A) and K14 (B) showed that the signal intensity was shifted from the 
monomeric forms (M) of both K5 (88kD) and K14 (52kD) to a higher molecular weight (250-315 kD) in the 
crosslinked fraction. The higher oligomeric state roughly corresponded to the tetrameric form (T) of K5 
YFP/K14 (88/52kD) which was expected to be 280kD. 
A B 
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YFP signal in the sodium butyrate-treated lysate was confirmed by densitometry analysis 
of the immunoblot with reference to the loading control, actin.  
The sodium butyrate-mediated enhanced detergent soluble fraction extracted from T150D 
K5-C1 cells was loaded on a continuous 5-30 % sucrose gradient, ultracentrifuged and 
fractionated as described in section 3.2.21. Immunoblot analysis of the collected fractions 
showed a peak for both K5 and K14 corresponding to a sedimentation coefficient value of 
6.6 S at 20 °C in water (S20,w) (Fig. 20A), estimated based on the sedimentation of standard 
proteins with known S20,w values- alcohol dehydrogenase (7.4 S), BSA (4.43 S) and 
carbonic anhydrase (3 S) (Fig. 20B). Based on the S20,w value of 4.7 S which was obtained 
for K8/K18 tetramer (54/48 kD) (Chou et al., 1993), 6.6 S value would correspond to K5 
YFP/K14 (88/54 kD) tetramer. Further, each of the fractions was subjected to chemical 
crosslinking using DSS. Immunoblot analysis of the crosslinked fractions with the anti-K5 
antibody also showed a peak at 6.6 S with a molecular weight of K5-YFP/K14 tetramer 
(approximately 280 kD) (Fig. 20A). This provided confirmatory evidence to the presence 
of K5/K14 tetrameric species in the T150DK5 YFP soluble fraction. 
Thus, the triton-x soluble fraction of T150DK5 mutant predominantly consists of K5 YFP/ 
K14 tetramers as summarized in table 49. 
Table 49: T150D K5 is tetrameric 
                         Parameter                      Value 
Diffusion co-efficient (D 20,W ) 19.8 μm
2
/s 
Hydrodynamic radius (RH) 10.85 nm 
Svedberg’s co-efficient 6.6 S 
Molecular weight (Mr) ~ 280 kD 
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Fig. 19: Sodium butyrate increased the expression of keratin in the T150D K5 YFP-KO C1 cells. 
(A) Live cell confocal imaging showed that treating the T150D K5 YFP-KO C1 cells with 5 mM sodium 
butyrate for 24 h increased the keratin fluorescence. (B) Immunoblot analysis of the whole cell lysate of 
sodium butyrate-treated T150D K5 YFP-KO C1 cells and that of the untreated cells confirmed the 
upregulation of K5 YFP protein by an antibody specific to K5. (C) This was further validated by 
densitometry measurement of K5 band intensity with reference to actin intensity from two experiments. 
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Fig. 20: Detergent-soluble fraction extracted from T150D K5 YFP-KO C1 cells showed that K5 and 
K14 co-sediment and correspond to the size of K5 YFP/K14 tetramer.  
 
 
 
 
 
(A) Immunoblot analysis of the T150D K5 YFP-soluble pool separated by sedimentation velocity 
ultracentrifugation through a continuous sucrose gradient of 30-5 % density showed the presence of both K5 
YFP and K14 signal in the fraction with a sedimentation coefficient corresponding to 6.6 S. DSS mediated 
crosslinking of each of the gradient fractions confirmed the presence of K5 YFP/K14 at a molecular weight 
≥250kD and a sedimentation coefficient (S20,w) of 6.6 S. These results indicated that T150D K5 YFP soluble 
pool consists of mainly K5 YFP/K14 tetramers. (B) Linear regression analysis for set of protein standards 
with known sedimentation coefficient (S20,w) values [namely, alcohol dehydrogenase (AD)- 7.4 S, bovine 
serum albumin (BSA)- 4.4 S and carbonic anhydrase (CA)- 2.9 S] used to calibrate the sucrose gradient 
showed a coefficient of variation (R
2
) of 0.9956. 
A 
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4.4. Effect of phosphorylation on keratin mobility 
Phosphorylation increased the speed of the keratin filament cycle of assembly and 
disassembly (Moch et al., 2013; Windoffer et al., 2004; Woll et al., 2007). The loss of 
filaments by phosphomimetic keratin, T150D K5, when expressed in KO cells (section 
4.1) served as a hint towards the possibility of the keratin cycle skewed towards the 
process of keratin filament disassembly. Contrariwise, the increased filament length and 
thickness of the T150A K5 YFP keratin in KO cells (section 4.2.1) suggested the 
possibility of the keratin cycle biased towards keratin filament assembly. This hypothesis 
can be validated by the comparison of the keratin turnover in the WT, phosphomimetic and 
phosphodeficient keratin. 
The aim of this section was to investigate the influence of phosphorylation on keratin 
turnover by measuring the fluorescence recovery after bleaching (FRAP) of WT K5 YFP, 
T150D K5 YFP and T150A K5 YFP expressed in two different cell lines, namely, HaCaT 
and keratin type II-deficient murine keratinocyte cell line (KO).  
This also provided an idea of keratin dynamics in two systems distinguished by the 
presence/absence of endogenous keratins. 
4.4.1. Phosphomimetic keratin mutant showed higher filament mobility in the 
presence of WT keratins 
WT K5 YFP, T150D K5 YFP and T150A K5 YFP constructs were transiently transfected 
into HaCaT cells using Xfect transfection reagent as described in 3.2.28. FRAP was carried 
out 48 h post-transfection to compare the keratin turnover in the filaments formed by each 
of the above mentioned K5 constructs in HaCaT cells.  
For FRAP analysis, fluorescence was bleached in an area of 100 x 100 μm2 using 20 
iterations of 488 nm laser of 0.2 % intensity. Fluorescence recovery was recorded every 4 
minutes after bleaching for a total time of 12 minutes. Imaging was done using a pixel 
dwell time of 1.27 μs with a resolution of 1024 x 1024 pixels in the confocal mode (CO) of 
the airyscan detector. Image analysis of the recordings was done using the Fiji software. 
The fluorescence recovery in the region of interest was calculated by defining the 
fluorescence intensity before bleaching as 100 % and 0 % at the time point of bleaching 
(Fig. 21). 
The results showed that the recovery of fluorescence for WT K5 YFP and T150A K5 YFP 
filaments were similar at all time points during the 12 minutes of the post-bleach 
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recordings (Fig. 21). However, the T150D K5 YFP mutant showed a significant increase in 
the fluorescence recovery rate when compared to WT K5 YFP (Fig. 21).  
Thus, in the presence of the endogenous keratins, the phosphodeficient mutant, T150A K5 
YFP, showed an unaltered turnover. Contrariwise, within the same milieu, the filaments of 
the phosphomimetic mutant, T150D K5, had higher turnover. 
4.4.2. Phosphodeficient keratin mutant showed reduced filament mobility in KO cells 
The turnover analysis of the mutant keratin filaments in HaCaT as described in section 
4.3.1 measured the mutant keratin filament dynamics under the influence of the normal 
keratin filaments. However, the lack of difference in the turnover of WT K5 YFP and 
T150A K5 YFP filaments indicated the requirement of a system devoid of endogenous 
keratin to determine minor changes in turnover of the phospho-site keratin mutant. Thus, 
keratin type II-deficient murine keratinocyte cell lines (KO) expressing the WT K5 YFP 
and T150A K5 YFP were used for FRAP analysis.  
Both, WT K5 YFP-KO and T150A K5 YFP-KO cells were seeded for 10 days to ensure a 
well-formed filamentous network. For FRAP analysis, fluorescence was bleached in half 
of the cell using 20 iterations of 488 nm laser of 0.2 % intensity. Fluorescence recovery 
was recorded every minute after bleaching for a total time of 7 minutes. A pixel dwell time 
of 1.27 μs with a resolution of 1024 x 1024 pixels in the confocal mode (CO) of the 
airyscan detector was used for imaging. Fiji software was used to measure the fluorescence 
recovery after bleaching in the boxed region of interest as shown in (Fig. 22), which 
consisted of filament-dense areas. The fluorescence recovery in the region of interest was 
calculated by defining the fluorescence intensity before bleaching as 100 % and 0 % at the 
time point of bleaching. 
The results showed that in the absence of endogenous compensation from normal keratin 
filaments, T150A K5 YFP filaments had a slower turnover as observed from the 
fluorescence recovery rate after photobleaching as compared to that of the WT K5 YFP 
filaments (Fig. 22). This suggested that the filaments of the phosphodeficient keratin 
mutant, T150A K5 YFP, were less dynamic than that of WT K5 YFP. 
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Fig. 21: T150D K5 YFP filaments showed faster recovery after photobleaching than WT K5 YFP and 
T150A K5 YFP filaments. 
(A) Maximum intensity projections of the confocal images of live HaCaT cells transiently transfected with 
each of WT K5 YFP, T150D K5 YFP and T150A K5 YFP constructs. The turnover of the WT and mutant 
keratin filaments was measured by calculating the fluorescence recovery after photobleaching (FRAP). The 
bleached regions (100 x 100 μm2) are denoted by squares. Pre-bleach and 0 min images represent the 
fluorescence patterns 1 min before and immediately after photobleaching, respectively. The recordings for 12 
min post-bleaching at time intervals of 4 min showed that T150D K5 YFP filaments had the highest 
fluorescence recovery (%). Scale bars = 10 μm (B) Statistical analysis was done with Kruskal-Wallis one-
way analysis of variance followed by Dunn’s multiple comparison post test. The whiskers are 5-95 % 
percentiles. 
A 
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Fig. 22: T150A K5 YFP filaments showed slower recovery after photobleaching than WT K5 YFP 
filaments in KO cells. 
(A) Maximum intensity projections of the confocal images of live WT K5 YFP-KO and T150A K5 YFP-KO 
cells. The turnovers of the WT and mutant keratin filaments were measured by calculating the fluorescence 
recovery after photobleaching (FRAP). The bleached part of the cell is distinguished from the unbleached 
part by a horizontal line. Pre-bleach and 0 min images represent the fluorescent patterns 1 min before and 
after photobleaching, respectively. Average recovery of fluorescence after photobleaching was measured in 
the regions denoted by squares. The recordings for 7 min post-bleaching at time intervals of 1 min, showed 
that T150A K5 YFP filaments had a lower fluorescence recovery (%) than WT K5 YFP filaments. Scale bars 
= 10 μm (B) Statistical analysis was done with Mann-Whitney test. The whiskers are 5-95 % percentiles. 
A 
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4.4.3. Soluble pool of phosphomimetic keratin mutant was highly mobile 
As mentioned in section 4.1.2, the phosphomimetic keratin mutant T150D K5 YFP stably 
expressed in keratin type II-deficient murine keratinocyte cell lines (KO) contained a major 
pool of diffusible, non-filamentous keratin. This served as an appropriate system to 
determine the flux characteristics of the soluble keratin fraction. The turnover of keratin in 
the phosphomimetic clones T150D K5 YFP clone 1 (C1) and T150D K5 YFP clone 2 (C2) 
was measured and compared to each of the cell clones stably expressing WT K5 YFP and 
T150A K5 YFP using FRAP.  
Each of the cell clones was cultivated for 10 days to 60 % confluence. For FRAP analysis, 
fluorescence was bleached in an area of 50 x 50 μm2 using 100 iterations of 488 nm laser 
of 1 % intensity. Fluorescence recovery was recorded every 15 seconds after bleaching for 
a total time of 60 seconds. Imaging was done using a pixel dwell time of 3.15 μs with a 
resolution of 512 x 512 pixels. Image analysis of the recordings was done using the Fiji 
software. The fluorescence recovery in the region of interest was calculated by defining the 
fluorescence intensity before bleaching as 100 % and 0 % at the time point of bleaching. 
The results showed that the fluorescence recovery rate after photobleaching was the 
highest for T150D K5 YFP and lowest for WT K5 YFP and T150A K5 YFP (Fig. 23). The 
FRAP analysis showed that within a short time span of 60 seconds the soluble T150D K5 
mutant pool had an average recovery rate of 60 % in comparison to the predominant 
filamentous WT K5 and T150A K5 mutant which recovered to 20 % on average (Fig. 23). 
Thus, T150D K5 mutant, which was composed of a large amount of diffuse, non-
filamentous keratin fraction was highly dynamic. 
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Fig. 23: The non-filamentous T150D K5 YFP mutant pool was highly dynamic. 
(A) Maximum intensity projections of the confocal images of live WT K5 YFP-KO, T150D K5 YFP-KO C1, 
T150D K5 YFP-KO C2 and T150A K5 YFP-KO cells. The turnovers of WT and mutant keratin fluorescence 
were measured by calculating the fluorescence recovery after photobleaching (FRAP). The bleached region 
(50 x 50 μm2) is denoted by a square. Pre-bleach and 0 min images represent the fluorescent patterns 1 min 
before and immediately after photobleaching, respectively. The recordings for 60 seconds post-bleaching 
with time intervals of 15 seconds, showed that T150D K5 YFP fluorescence, which mainly comprised the 
diffusible pool, had a faster fluorescence recovery (%) than WT K5 YFP and T150A K5 YFP. Scale bars = 
10 μm (B) Statistical analysis was done with one-way analysis of variance (ANOVA) followed by a 
Bonferroni’s post test when the data showed Gaussian distribution. Kruskal-Wallis one-way analysis of 
variance followed by Dunn’s multiple comparison post test was used when the data did not show Gaussian 
distribution. The whiskers are 5-95 % percentiles. 
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4.5. Effect of keratin phosphorylation on cell physiology 
It was known that keratin phosphorylation played a role in regulating cell physiology 
(Chamcheu et al., 2011; Duan et al., 2009; Ku et al., 1998a; Liao et al., 1997; Toivola et 
al., 2002; Zhou et al., 2006). However, the precise effect of keratin phosphorylation in 
affecting each of the physiological events was masked in the milieu of the endogenous 
keratin. Thus, KO cell lines stably expressing keratin phospho-site mutants would provide 
a clearer understanding of the function of keratin phosphorylation. The previous sections 
have described T150 K5 phosphorylation-mediated alterations in filament formation and 
dynamics of K5.  
The aim of this section was to determine if the T150 K5 phosphorylation mediated keratin 
structure modifications are accompanied by changes in aspects such as cell viability, cell-
cycle and response to oxidative stress.  
KO cell lines stably expressing K5 phospho-site mutants were subjected to various assays 
as discussed in detail in this section to determine the physiological status in comparison to 
the WT keratin-expressing cells. 
4.5.1. Keratin phospho-site mutations reduced cell viability 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was done to 
understand if the keratin phospho-site mutant expressing KO clones, T150D K5 YFP-KO 
C1, T150D K5 YFP-KO C2 and T150A K5 YFP-KO, showed abnormalities in viability 
which is a reflection of either cell proliferation, metabolic activity or both. 
MTT assay was performed on WT and KO murine keratinocytes and the stable clones, 
T150D K5 YFP-KO C1, T150D K5 YFP-KO C2, and T150A K5 YFP-KO by the method 
described in section 3.2.17. The purple colored product formed by MTT reduction was 
estimated at 590 nm using a plate reader. The absorbance for each of the cell lines was 
estimated at 24 h, 48 h and 72 h after seeding and this experiment was done thrice in 
triplicate. Both WT and KO murine keratinocytes did not show a major difference in 
viability. The WT K5 YFP-KO clone showed a slightly reduced absorbance value at 590 
nm, 72 h after seeding in comparison to the WT and KO cells (Fig. 25). The phospho-
deficient keratin cells T150A K5 YFP showed a considerable reduction in cell viability as 
compared to not only the WT and KO murine keratinocytes but also the WT K5 YFP-KO 
clone, 72 h post-seeding (Fig. 25). However, the most significant decrease in viability was 
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observed in both the phosphomimetic keratin clones T150D K5 YFP-KO C1 and T150D 
K5 YFP-KO C2 (Fig. 25).  
Thus, phosphomimetic as well as phosphodeficient mutation of T150 K5 caused a 
reduction in cell viability and the effect was more prominent in the latter. 
                              
 
Fig. 24: Phospho-site mutation at T150 K5 reduced cell viability.  
 
WT, KO, WT K5 YFP-KO, T150D K5 YFP-KO C1, T150D K5 YFP-KO C2 and T150A K5 YFP-KO cells 
were seeded at a density of 5000 cells per well of a 96 well plate. The cells were grown for different 
durations such as 24h, 48h and 72h. The cell viability was estimated by the MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay by measuring the absorbance of the reduced MTT at 590 nm. The 
results showed that the viability of the WT, KO and WT K5 YFP-KO cells steadily increased every 24 h. 
However, the viability of T150A K5 YFP-KO and the clones of T150D K5 YFP-KO did not show a 
substantial increase resulting in a considerably reduced viability in comparison to the KO- and the WT 
keratin-expressing cells at the 48 h and 72 h time points. The experiment was replicated thrice and each cell 
line was measured in triplicate. Statistical analysis was performed using the Kruskal-Wallis one way analysis 
of variance followed by the Dunn’s multiple comparison post test.  
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4.5.2. Heat shock proteins were associated with phosphomimetic keratin 
KO cells stably expressing the phosphomimetic keratin T150D K5 YFP contained a major 
amount of soluble keratin tetramers as described in Section 4.2. Thus, it served as an 
appropriate system to determine the proteins normally present in complex with this non-
filamentous form of keratin.  
The aim of this section was to detect the set of proteins bound to T150D K5 mutant to 
understand their role in regulating keratin structure and function. 
Keratin-associated proteins were extracted by co-immunoprecipitation (CO-IP) of T150D 
K5 YFP-KO C1 cell lysates with an antibody specific to K5 as described in section 3.2.22. 
The enrichment of K5 by CO-IP was confirmed by the increased signal in the immunoblot 
for ‘Bound’ lane representing the proteins attached to the anti-K5+beads complex (Fig. 24) 
in comparison to the input lane which consisted of 10 % of the lysate used for CO-IP. The 
absence of bound keratin in the negative control immunoblot confirmed that the K5 protein 
was pulled down specifically by the antibody and not by non-specific affinity of K5 to the 
beads. 
               
Fig. 25: Co-immunoprecipitation of T150D K5 YFP.  
The proteins pulled down by CO-IP were separated by SDS-PAGE and the gel was cut 
with reference to the electrophoresed protein ladder to extract proteins ranging between 
different molecular weights, i.e. 10-42 kD, 42-55 kD, 55-72 kD, 72-95 kD and 95-140 kD. 
The proteins were trypsinized and the resulting peptides were analyzed by matrix-assisted 
laser desorption/ionization mass spectrometry (MALDI MS) by the facility headed by Prof. 
Joachim Jankowski (Uniklinik RWTH Aachen). The masses of the peptides/peptide 
fragments derived from the MS fingerprint analysis were searched against the Mascot 
Immunoblot analysis with anti-YFP antibody confirmed the enrichment of K5 YFP from T150D K5 YFP-
KO cells, which was done by co-immunoprecipitation using K5 specific antibody + protein A/G sepharose 
magnetic beads. The absence of YFP signal in the ‘Bound’ lane of the negative control, which represents the 
proteins pulled down by beads in the absence of the anti-K5 antibody, validated the specificity of the co-
immunoprecipitation. The input lane showed the amount of K5 YFP present in 10 % of the total cell lysate 
used for co-immunoprecipitation. 
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database software. The proteins showing a significant sequence match between the 
experimental data and the database were chosen based on a Mascot score greater than 55. 
Table 50 is the protein identification report created from peptide mass fingerprinting of 
T150D K5 YFP-KO C1 protein lysate, co-immunoprecipitated by an antibody specific to 
K5. Mass spectrometry results were confirmed twice along with the negative control. 
Table 50: Proteins detected in mass spectrometry fingerprint analysis 
Mass (Da)                            Name Mascot 
score 
70036 Heat shock 70 kD protein 1A (HSP70-1A) 60 
70133 Heat shock 70 kD protein 1B (HSP70-1B) 59 
83382 Heat shock protein (HSP90-B1) 74 
96346 Heat shock protein 105 kD (HSP105) 56 
 
The results showed that the keratin expressed in T150D K5-KO C1 cells was associated 
with multiple heat shock proteins (HSPs) namely HSP70-1A and HSP70-1B (together 
called HSP70-1), HSP90 and HSP105. 
4.5.3. Keratin phospho-site mutations caused elevated JNK signaling as well as 
keratin-HSP70 association upon oxidative stress 
Mass spectrometric detection of heat shock proteins (HSPs) in association with the T150D 
K5 mutant led to the question if keratin phosphorylation was linked to stress-response 
function. The HSPs along with MAPK signaling pathway were known to play a major role 
in stress-response mechanism. Oxidative stress is one such form of stress, which triggered 
mitogen-activated protein kinase (MAPK) signaling (Son et al., 2011). 
The aim of this experiment was to determine if the presence of phospho-site mutant keratin 
changes the level of MAPK activation and HSP expression in response to oxidative stress. 
Comparison of the level of HSPs in response to stress: Oxidative stress was induced in 
the WT, KO, WT K5 YFP-KO, T150D K5 YFP-KO C1, T150D K5 YFP-KO C2 and 
T150A K5 YFP-KO cell lines by treatment with 10 mM H2O2 for 1 h. Immunoblotting of 
whole cell lysates for each of the cell lines with and without stress treatment was done. The 
results showed that the level of HSP70, HSP90 and HSP105 were similar in all cell lines 
irrespective of stress induction (Fig. 26). Thus, K5 T150 phospho-site mutants did not alter 
the total HSP content with or without oxidative stress. 
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Fig. 26: T150 K5 site mutation did not affect the level of the heat shock proteins (HSP) irrespective of 
oxidative stress induction.  
Comparison of the level of mitogen-activated protein kinase (MAPK) activation in 
response to stress:  The MAPK cascade is mediated by stress-activated protein kinase/Jun 
–amino-terminal kinase (JNK), extracellular signal regulated kinase (ERK) and p38 
MAPK. Whole cell lysates from oxidative stress assay were analyzed for the level of 
activation for each of these enzymes. Immunoblot analysis showed higher amount of 
phospho-JNK-1 (T183/Y185 residues), which is the activated form of JNK-1 in T150D K5 
and T150A K5 phospho-site mutants as compared to KO and WT keratin containing cells 
(Fig. 27-A,C). The blot showed that total SAPK/JNK levels were similar for all the cell 
lines.  
JNK signaling had a critical role in the induction of apoptosis (Dhanasekaran and Reddy, 
2008). The next objective was to check if oxidative stress-mediated JNK activation led to 
apoptosis. Cleaved caspase-3 was used as the marker to determine the occurrence of 
apoptosis. A positive control for apoptosis was made by treating WT K5-KO cells with 
330 μM of an apoptosis-inducing drug anisomycin for 7 h. The immunoblot showed 
absence of cleaved caspase-3 signal in all the cell lines in the stress assay except for the 
positive control (Fig. 27B). This result confirmed that oxidative stress-mediated JNK 
activation was not accompanied with apoptosis. 
Immunoblot analysis to determine the amount of ERK activation showed equal levels of 
phospho-ERK-1 (T202/Y204 residues) in all the cells in response to oxidative stress (Fig. 
28A). Similar amounts of total ERK1/2 in all the cell lines with reference to actin loading 
control confirmed that the level of ERK activation due to oxidative stress induction was 
similar in KO cells, WT keratin and mutant keratin expressing cells (Fig. 28A). 
Immunoblot analysis showed that levels of HSP70, HSP90 and HSP105 proteins were similar in WT, KO, 
WT K5 YFP-KO T150D K5 YFP-KO C1, T150D K5 YFP-KO C2 and T150A K5 YFP-KO cells with or 
without oxidative stress induction by 10 mM H2O2 for 1 h. This is a representative blot of three experiments. 
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Further, absence of signal for phospho-p38 MAPK (T180/Y182 residues) for all the cells 
that were subjected to the stress assay showed that p38 MAPK activation did not occur in 
response to oxidative stress (Fig. 28B). The presence of activated p38 MAPK signal in the 
positive control (WT K5 YFP-KO cells treated with 330 μM anisomycin which is a MAPK 
stimulator) confirmed that the antibody was functional (Fig. 28B). The expression of total 
p38MAPK was observed in all the cell lines (Fig. 28B). 
These results showed that both, phosphomimetic T150D K5- as well as phosphodeficient 
T150A K5- expressing cells triggered elevated JNK signaling in response to oxidative 
stress, when compared to WT keratin expressing and KO cells. This observation was 
accompanied with absence of apoptosis and p38 MAPK activation and unaltered levels of 
HSPs and activated ERK. 
                   
                                                   
Fig. 27: T150 K5 phospho-site mutant cells showed elevated Jun –amino-terminal kinase (JNK) 
activation in response to oxidative stress, without apoptosis.  
(A) Immunoblot analysis showed that with reference to the total JNK signal, level of phospho-JNK-1 
(T183/Y185) was upregulated in T150D K5 YFP-KO and T150A K5 YFP-KO cells in comparison to WT, 
KO and WT K5 YFP-KO cells in response to oxidative stress by 10 mM H2O2 for 1 h (B) The absence of 
apoptotic marker, cleaved caspase-3, in all the cells confirmed that oxidative stress-mediated JNK activation 
did not lead to apoptosis. WT K5-KO cells treated with 330 μM anisomycin for 7 h was used as the positive 
control for apoptosis. (C) Densitometric analysis of the fold change of phospho-JNK:total JNK ratio 
compared to WT from three experiments. Statistical analysis was done using Kruskal-Wallis one way 
analysis of variance followed by the Dunn’s multiple comparison post test. 
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Fig. 28: T150 K5 phospho-site mutant cells did not show alteration in extracellular signal related 
kinase (ERK) activation in response to oxidative stress and oxidative stress did not activate p38 MAPK 
in murine keratinocytes.  
Comparison of the level of keratin-bound HSPs during oxidative stress: As described in 
section 4.5.2, heat shock proteins (HSPs) were associated with the T150D K5 mutant as 
detected by mass spectrometry. HSPs were reported to inhibit MAPK signaling (Gabai et 
al., 1997; Meriin et al., 1999). Although neither oxidative stress nor T150 K5 residue 
mutation showed any alteration in total expression levels of heat shock proteins, the 
proportion of keratin-bound HSPs was still a crucial factor to be examined. 
Oxidative stress was induced in WT K5 YFP-KO, T150D K5 YFP-KO C1 and T150A K5 
YFP-KO cell lines by treatment with 10 mM H2O2 for 1 h. K5 was immunoprecipitated 
using an antibody specific to K5 as described in section 3.2.22 and was confirmed by 
immunoblot analysis (Fig. 29A). The amount of HSP pulled down along with K5 was 
quantitated by normalizing densitometric measurements of each of the HSP signals with 
K5 signal in immunoblot (Fig. 29-B, C). Further, to derive a comparison between amount 
of HSPs bound to WT K5 and mutant K5, WT K5 YFP-bound HSP in absence of stress 
induction (resting state) was used as the control. T150D K5 YFP-KO C1 cell line subjected 
to oxidative stress was used as the negative control. 10% of input fraction was analyzed to 
determine the total amount of protein present in the lysate used for co-
immunoprecipitation.
(A) Immunoblot analysis showed that with reference to the total ERK signal, level of phospho-ERK-1 
(T202/Y204) was similar in WT, KO, WT K5 YFP-KO, T150D K5 YFP-KO and T150A K5 YFP-KO cells 
in response to oxidative stress by 10 mM H2O2 for 1 h. (B) The absence of phospho-p38 MAPK 
(T180/Y182) signal in any of the cells in spite of the presence of total p38 MAPK confirmed that p38 MAPK 
was not activated in response to oxidative stress. WT K5-KO cells treated with 330 μM anisomycin for 7 h 
was used as the positive control for p38 MAPK activation. This is a representative blot of three experiments. 
A 
B 
Results 
80 
 
 
 
Fig. 29: Phosphomimetic (T150D K5) as well as phosphodeficient (T150A K5) mutant keratin showed 
increased association with HSP70, which further elevated upon oxidative stress. 
The result showed that at resting state, the proportion of HSPs bound to T150D K5 and 
T150A K5 was higher in comparison to WT K5 (Fig. 29-A,B,C). Keratin-bound HSP 
fractions increased further upon oxidative stress induction such that both T150D K5 and 
T150A K5 were associated with highest level of HSPs (Fig. 29-A, B, C). These differences 
were more prominent in case of HSP70 (Fig. 29 C) whereas negligible when examined for 
HSP90 (Fig. 29 B). HSP105 did not give sufficient IP yield for quantification, hence was 
excluded from analysis. The specificity of immunoprecipitation was confirmed by the 
negative control. 
(A) Immunoblot analysis of the WT K5 YFP-KO, T150D K5 YFP-KO C1 and T50A K5 YFP-KO C2 cell 
lysates co-immunoprecipitated using anti-K5 antibody showed that both T150D K5 as well as T150A K5 
mutants showed increased levels of bound HSP70 in comparison to WT K5. The keratin-bound HSP70 levels 
elevated in WT K5 during oxidative stress induced by 10 mM H2O2 for 1 h. Mutant keratins showed an 
additional increase in the amount of associated HSP70 upon oxidative stress. Differences in level of HSP90 
bound to WT and mutant keratin were less than that of HSP70. 10% of cell lysate was immunoblotted to 
determine levels of total protein. Graphical representation of keratin-bound HSP90 (B) and keratin-bound 
HSP70 (C). Statistical analysis done using Kruskal-Wallis one way analysis of variance followed by Dunn’s 
multiple comparison post test showed that differences in HSPs bound to WT and mutant keratins were not 
statistically significant. The experiment was performed in triplicate. 
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This result showed that both T150D K5 as well as T150A K5 mutants were associated with 
relatively higher levels of HSP70 which further increased during oxidative stress when 
compared to WT K5. Thus, structural alterations in phospho-site mutant keratin filament 
network as described in section 4.1, 4.2 and 4.3, were accompanied with elevated 
sequestration of the HSPs. 
4.5.4. Phosphodeficient keratin mutation altered cell cycle progression without 
affecting keratin filament reorganization during mitosis 
Hyperphosphorylation of T150 K5 residue was observed during mitosis in primary human 
foreskin keratinocytes and in biopsies of psoriasis and squamous cell carcinoma (Toivola 
et al., 2002).  
The aim of this section was to examine the influence of T150 K5 phospho-site mutations on 
cell-cycle progression. 
4.5.4.1. Phosphodeficient keratin expressing cells showed a lower G1:G2 phase ratio 
Analysis of the percentage distribution of cells in G1 phase, S phase and G2 phase was 
done by measuring the DNA content using propidium iodide staining. 10
6 
cells were 
harvested from each cell clone and propidium iodide staining was performed as described 
in section 3.2.27. 
Flow cytometric analysis of propidium idodide-stained cells was done using CytoSoft 
software. The different cell-cycle stages were demarcated as G1, S and G2/M based on 
ascending order of propidium iodide fluorescence intensity. Histograms plotting red 
fluorescence emitted by propidium iodide v/s cell count were provided by the CytoSoft 
software. The histograms obtained for WT murine keratinocytes were used as the control. 
The borders of various cell cycle stages marked in WT histograms were fixed and further 
applied to other samples analyzed namely, KO, WT K5 YFP-KO, T150D K5 YFP-KO C1, 
T150D K5 YFP-KO C2 and T150A K5 YFP cells. This experiment was done thrice in 
triplicate. 
The representative histograms in Fig. 30 show propidium iodide fluorescence v/s cell count 
for each of the cell lines. The histograms clearly showed prominent peaks for cell 
population in G1 phase in case of WT, KO, WT K5 YFP-KO, T150D K5 YFP-KO C1 and 
T150D K5 YFP-KO C2 cell lines (Fig. 30). However, G1 peak observed for T150A K5 
YFP-KO cell line was relatively reduced (Fig. 30D).  
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Graphical representation and statistical analysis of the propidium iodide staining for all cell 
lines from three experiments, each in triplicate is shown in Fig. 31. The control cell 
population, WT keratinocytes, showed on average 60 % of the cells in G1 phase, 7 % in S 
phase and 33 % in G2 phase (Fig. 30A; Fig. 31) The distribution of cell population in the 
different cell cycle phases was determined for other cell lines with reference to WT cells as 
described below (Fig. 30A; Fig. 31). The statistical analysis was done using Kruskal-
Wallis test followed by Dunn’s post test  
KO cells: KO keratinocytes showed an average of 46 % cells in G1 phase which was lower 
than in WT cells (Fig. 30B; Fig.31A). Further, KO cell population in S phase was 11 % 
and 43 % in G2/M phase which was higher than in WT cells (Fig. 30B, Fig.31-B, C). 
WT K5 YFP-KO cells: WT K5 YFP-KO consisted of 46 % cells in G1 phase, 11 % in S 
phase and 43 % in G2 phase on average (Fig. 30C; Fig.31). This distribution was similar to 
that of WT cells suggesting that expression of keratins was able to rescue the cell cycle 
defect in KO cells.  
T150D K5 YFP-KO cells: Both clones of T150D K5 YFP-KO cells, C1 and C2, showed 
on average 59 % of cells in G1 phase, 10 % in S phase and 31 % in G2/M phase (Fig. 30-
E,F; Fig. 31). Thus, cell cycle progression of phosphomimetic keratin-expressing cell 
clones did not differ from WT cells. 
T150A K5 YFP-KO cells: T150A K5 YFP-KO mutant cells contained 40 % of cells in G1 
phase which was a significantly lower proportion in comparison to WT cells (Fig. 30D; 
Fig.31A). The decreased G1 phase cell population of T150A K5 YFP-KO cells was also 
accompanied by an average of 50 % cells population in G2/M phase which was a 
significant elevation as compared to WT cells (Fig. 30 D; Fig. 31-A, C). The average S 
phase cell population of T150A K5 YFP-KO mutant was 10 % which was slightly more 
than WT but without statistical significance (Fig. 31B). 
These results showed that WT keratin- and phosphomimetic keratin T150D K5- expressing 
cells had similar cell cycle profile but KO- and phosphodeficient keratin T150A K5- 
expressing cells showed cell cycle defects in the form of decreased G1 phase population 
and elevated G2/M phase population. This suggested that T150 K5 phosphorylation 
regulated cell cycle progression.           
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Fig. 30: Cell cycle distribution was altered in the absence of T150 K5 phosphorylation.  
 
 
 
 
 
DNA content analysis of WT (A), KO (B), WT K5 YFP-KO (C), T150A YFP-KO (D), T150D K5 YFP-KO 
C1 (E)  and T150D K5 YFP-KO C2 (F) cells was done by measuring propidium iodide fluorescence intensity 
using flow cytometry.  Representative histograms depict distribution of cells in each of the interphase stages, 
G1, S and G2. Percentage of cells in each phase was calculated with CytoSoft software using WT cell line as 
the control. Note the sharp reduction in G1 peak in T150A K5 YFP-KO cells (D). This result was confirmed 
thrice. 
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Fig. 31: Cell cycle distribution was affected in the absence of T150 K5 phosphorylation. 
4.5.4.2. Keratin phospho-site mutations did not alter the mitotic rate 
Alterations in the interphase stages of the cell cycle in KO and T150A K5 YFP-KO cells 
led to the question if there is a difference in mitotic rates of the mutant keratin-expressing 
cells as compared to WT keratin-expressing cells. Mitotic cells were enriched by the 
technique described in 3.2.24. The proportion of cells undergoing mitosis in all the cell 
lines was determined by using a mitotic marker phospho-Histone H3 (Serine 10 residue), 
which is specific to condensed chromosomes. 
Immunoblot analysis of whole cell lysates of WT, KO, WT K5 YFP-KO, T150D K5 YFP-
KO C1, T150D K5 YFP-KO C2 and T150D K5 YFP-KO showed that the level of 
phospho-Histone H3 was similar for all the cell lines with reference to the actin loading 
control. This suggested that the amount of cells undergoing mitosis were similar in KO 
cells, WT keratin-expressing and phospho-site mutant keratin-expressing cells. 
Graphical representation of the percentage of cells in each stage of the interphase was done by estimating 
propidium iodide staining using flow cytometry (A) KO and T150A K5 YFP-KO cells showed reduced 
G1/G0 cell population. (B) KO cells had the highest percentage of cells in S phase. (C) KO and T150A K5 
YFP-KO cells had a significantly higher cell population at G2/M phase as compared to WT cells. Statistical 
analysis of triplicate measurements was done using Kruskal-Wallis one analysis of variance followed by 
Dunn’s multiple comparison post test. 
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Fig. 32: The proportion of mitotic cells was unaltered upon T150D K5 site mutation.  
4.5.4.4. Keratin phospho-site mutations did not alter keratin filament reorganization 
during mitosis  
Keratin filament network reorganization was observed during mitosis (Aubin et al., 1980; 
Baribault et al., 1989; Fey et al., 1983; Lane et al., 1982). Phosphorylation of keratin was 
detected during mitosis as observed for S73 K8 and T150 K5 residues (Toivola et al., 
2002; Woll et al., 2007).  
Since T150 K5 site underwent phosphorylation during mitosis, the aim of this experiment 
was to investigate if phosphorylation at T150 was essential for mitotic reorganization of 
K5. 
Keratin filament network reorganization during mitosis: Although keratin filament 
network modifications during mitosis have been reported, its characteristics were not 
clearly defined. The aim of this experiment was to determine the temporal and structural 
behavior of keratin filament reorganization during mitosis. Human epidermis-derived cell 
line HaCaT B10, stably expressing K5 YFP, were enriched for the mitotic population using 
nocodazole as described in section 3.2.24. The cells were fixed using methanol/acetone as 
described in section 3.2.28 and images of cells in different stages of mitosis were acquired 
using Apotome microscope. Fig. 33 shows that formation of keratin granules began at 
prophase and was retained until the cells exit the last mitotic stage of telophase. Keratin 
granules formed during mitosis were dispersed throughout the cytoplasm in initial mitotic 
stages of prophase and telophase but were preferably localized at the cleavage furrow 
during the late mitotic stages of anaphase and telophase. 
Immunoblot analysis using a mitotic marker, phospho-Histone H3 (Serine 10), which specifically recognized 
condensed chromosomes showed that number of cells undergoing mitosis was similar in WT, KO, WT K5 
YFP-KO, T150D K5 YFP-KO C1, T150D K5 YFP-KO C2 and T150A K5 YFP-KO cells with reference to 
the loading control, actin. This is a representative blot of three experiments. 
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Fig. 33: Keratin filament network disassembled and reassembled during mitosis.  
Role of phosphorylation in keratin filament reorganization during mitosis: 
Phosphorylated T150 K5 was detected in mitotic keratinocytes and in hyperproliferative 
conditions such as human biopsies of psoriatic skin and squamous cell carcinoma (Toivola 
et al., 2002). However, association of T150 K5 phospho-epitopes with keratin filament 
network changes during mitosis was not known. The aim of this experiment was to 
determine if K5 granule formation during mitosis was linked to phosphorylation of T150 
K5 residue. HaCaT B10 cells were enriched for the mitotic population using nocodazole as 
described in section 3.2.24. The cells were fixed using methanol/acetone as described in 
Fluorescence images of methanol/acetone fixed human epidermis-derived keratinocytes stably expressing K5 
YFP acquired in different stages of mitosis after treatment with 60 ng/ml nocodazole for 16 h. Different 
stages of mitosis were determined by Hoechst nuclear staining (A-F) and keratin filament network 
reorganization was observed in the form of granules starting from prophase till telophase (A´-F´). Note the 
accumulation of keratin granules in the cleavage furrow (arrows in D´ and E´). Scale bars = 10 μm. This 
result was confirmed thrice. This figure was published in (Sawant and Leube, 2016) 
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section 3.2.28 and stained for T150 K5 phospho-epitopes using a phospho-site specific 
antibody, LJ4. The confocal images in fig. 34 showed that K5 granules formed during 
mitosis were positive for phosphorylated T150 K5 (pT150 K5) residue. This result showed 
that keratin filament network reorganization during mitosis involved phosphorylation of 
T150 K5 residue.  
               
Fig. 34: T150 K5 residue phosphorylation was linked to keratin filament reorganization during 
mitosis. 
 
Effect of T150 K5 phospho-site mutations on keratin reorganization during mitosis: 
Colocalization of mitotic K5 granules with phosphorylated T150 K5 (pT150 K5) residue, 
raised the question if mutation of T150 K5 residue affected keratin filament reorganization 
during mitosis. Hence the aim of this experiment was to determine differences in keratin 
filament modifications during mitosis on account of mutations in T150 K5 phospho-site. 
Transient transfections of WT K5, T150D K5 and T150A K5 were done in HaCaT (human 
keratinocytes) and WT cells (murine keratinocytes) using Xfect. Mitotic cells were 
enriched by adding nocodazole as described in section 3.2.24. Additionally, mitotic 
(A) shows methanol/acetone fixed, fluorescence image of human keratin 5-yellow fluorescent protein (K5 
YFP) expressing stable cell clones in human epidermal keratinocyte derived HaCaT cells. (B) shows staining 
of phosphorylated T150 K5 residue using a phospho-site specific keratin antibody (LJ4), (C) provides  
corresponding Hoechst stained nuclear images confirming presence of condensed nucleus in the mitotic cells 
marked with *. Note the appearance of K5 phospho-epitopes in K5 granules formed in the mitotic cells as 
shown in the merged image (D). Scale bars = 10 μm. This is a representative image of three experiments. 
A B 
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enrichment of stable cell lines WT K5 YFP-KO, T150D K5 YFP-KO C1 and T150A K5 
YFP-KO was also done. The cells were fixed using paraformaldehyde and imaged using 
laser scanning microscopy with Resolution vs sensitivity (R-S) mode of the airyscan 
detector.
 
Fig. 35: Keratin reorganization during mitosis was not affected in the absence of T150 K5 site 
phosphorylation.  
These results suggested that keratin reorganization occurred in WT, phosphomimetic 
(T150D K5) as well as in phosphodeficient (T150A K5) keratin during mitosis. Thus, 
phosphorylation at T150 K5 is redundant for keratin reorganization during mitosis. 
 
 
 
 
 
Confocal images of paraformaldehyde fixed HaCaT, WT, KO cells expressing WT K5 YP, T150D K5 YFP 
and T150A K5 YFP constructs. HaCaT and WT cells were transiently transfected whereas KO cells were 
stably expressing the keratin constructs. Mitotic cell population was enriched by treating with 60 ng/ml 
nocodazole for 16 h. Both, WT and mutant keratin showed mitotic reorganization in all the cell lines. Scale 
bars = 10 μm. This result was confirmed thrice. 
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4.6. Keratin phospho-epitopes were associated with mutant keratin aggregates in 
epidermolysis bullosa simplex (EBS) disease 
The skin blistering disease, epidermolysis bullosa simplex, occurs from mutations in either 
of the basal layer keratins, K5 or K14 (Albers and Fuchs, 1992). Extreme skin fragility and 
keratin aggregation are characteristics of EBS disease (Chan et al., 1993; Coulombe et al., 
1991a). It was suggested that increased colocalization of phosphorylated T150 K5 with 
HSP70 facilitated the clearance of heat-induced keratin aggregates in a severe form of EBS 
disease, EBS-DM (Dowling Meara) with E475G K5 mutation (Chamcheu et al., 2011). 
The results described in sections 4.1, 4.2 and 4.3 showed that phosphorylation of T150 K5 
regulated keratin structure and dynamics. Moreover, higher amount of HSP70 was 
associated with T150 K5 phospho-site mutants as described in section 4.5.3.  
The aim of this section was to examine the contribution of T150 K5 phosphorylation in 
keratin filament alteration in EBS disease. 
Immortalized cells derived from EBS-DM (R125C K14 mutation) patients, EBDM-4, and 
a healthy control, hKC, were immuno-stained for K14 and phosphorylated T150 K5 
epitopes (pT150 K5) using methanol/acetone fixation as described in section 3.2.28. 
Confocal images of immunofluorescent detection of K14 in EBDM-4 cells showed that the 
keratin filament network contained an additional granular pattern preferably at cell 
periphery whereas the keratin filament morphology of hKC cells was devoid of such 
alterations (Fig. 36). Further, while pT150 K5 epitopes showed a punctate, cytoplasmic 
staining in hKC cells ((Fig. 36 A-A´´), they colocalised with K14 granules in EBDM-4 
cells (Fig. 36 B-B´´). Additionally, human epidermis-derived HaCaT cells that were 
transiently transfected with YFP tagged R125C K14 DNA showed the presence of K14 
granules at cell periphery which were positive for pT150 K5 residues (Fig. 36 C-C´´). 
This result showed that phosphorylation of T150 K5 was involved in keratin filament 
network modifications observed in EBS disease. 
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Fig. 36: Phosphorylated T150 K5 (pT150 K5) epitopes colocalized with Dowling-Meara EBS (EBS-
DM) keratin granules. 
Fluorescence micrographs of methanol/acetone fixed immortalized cells derived from (A-A´´) healthy human 
control (hKC), (B-B´´) EBS-DM patient (EBDM-4) harboring R125C K14 mutation and (C-C´´) human 
epidermis-derived HaCaT cells. Antibody recognizing K14 showed (A) a normal keratin filament network in 
hKC cells whereas (B) an additional granular pattern at cell periphery in EBDM-4 cells. (C) YFP tagged K14 
R125C transiently transfected in HaCaT cells also showed presence of keratin granules at cell periphery. 
Corresponding staining with a site-specific antibody (LJ4) recognizing phosphorylated T150 K5 (pT150 K5) 
residue showed (A´) a punctate staining in hKC cells whereas (B´) EBDM-4 and (C´) HaCaT cells showed 
an added granular staining. (A´, B´ and C´) provide the merge images confirming colocalization of pT150 
K5 epitopes in R125C K14 mutant granules along with the corresponding nuclear staining with DAPI. Scale 
bars= 10 μm. This observation was confirmed thrice. 
C C´ C´´ 
B 
A A´ A´´ 
B´ B´´ 
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Fig. 37: Cells derived from EBS-DM patients showed increased phosphorylation of T150 K5 (pT150 
K5) and decreased keratin expression 
Further, immunoblot analysis of whole cell lysates of hKC and EBDM-4 cells followed by 
densitometry analysis showed increased K5 phosphorylation and decreased keratin 
expression (Fig. 37).  
Thus, in comparison to the cells from healthy individuals, Dowling-Meara EBS patient 
cells showed altered expression of T150 K5 phospho-epitopes. 
(A) Immunoblot analysis shows that whole cell lysates from EBS-gen sev patient-derived EBDM-4 cells 
have (1.5 fold) increased T150 K5 phosphorylation and decreased levels of K5 (0.6 fold) and K14 (0.7 fold) 
when compared to keratinocytes derived from healthy individuals (hKC). (B-D) Graphical representation of 
densitometric analysis of immunoblots from four separate samples. Error bars: mean±SD. 
A B 
C D 
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5. Discussion 
5.1. The additive effect of phosphorylation on keratin filament formation 
The keratin head domain played an important role during keratin filament assembly 
(Hatzfeld and Burba, 1994; Wilson et al., 1992). It was shown that extent of alteration in 
keratin filament assembly was proportional to the size of deletion in K8 head domain 
(Hatzfeld and Burba, 1994). Additionally, pairing with phosphomimetic keratin mutant 
such as S73E K8:WT K18, S431E K8:WT K18 and WT K8:S52E K18 showed reduced 
connectivity of keratin filament network with increasing mutant keratin:WT keratin ratio 
(Deek et al., 2016). Phosphorylation, which introduces a negative charge, has been linked 
with conformational modifications of the keratin molecule (Sanhai et al., 1999; Yeagle et 
al., 1990). In this context, the question was to determine if the degree of phosphorylation 
correlated with keratin filament network disorganization in keratinocytes.  
In order to analyze if the influence of phosphorylation on keratin filament network 
formation was a common property of keratins, two different keratins, K5 (stratified 
epithelia) and K8 (simple epithelia) were studied. The residues selected for 
phosphomimetic substitutions in K5 and K8 head regions always included the major 
phosphorylation site within the highly conserved LLS/TPL motif of homology 1 (H1) 
subdomain (which were S73 K8 and T150 K5) in combination with other sites known or 
predicted to be phosphorylated (Fig. 5 and Fig. 6). The transfection of various K5 and K8 
mutants into human epidermis-derived HaCaT cells showed decrease in the proportion of 
cells producing normal keratin filament meshwork with increase in the number of 
phosphomimetic mutations in K5 or K8 (Fig. 8). This supported the hypothesis of a 
cumulative effect of phosphorylation-mediated hindrance on keratin filament organization, 
irrespective of the keratin isotype. 
However, some deviations within the group were observed. For example, there was a lower 
impact on keratin filament formation by K5 constructs (double, triple, quadruple) bearing 
mutations at S35 and S76 and for K8 quadruple mutant with S20/21/26/73 mutations (Fig. 
8). This suggested that the amino acid position within keratin head domain may also play a 
role. A possible reason for the residue-specific effect of phosphorylation on keratin 
filament organization may be due to a difference in the secondary structure of the mutated 
keratin molecules. It has been shown that in addition to the protein sequence, the keratin 
molecules also contained  highly conserved secondary conformations (Chipev et al., 1992).  
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Further, transfected cells with a granular pattern either alone or in combination with 
filamentous keratin were scored as defective in keratin filament formation (Fig. 7). This 
granular pattern of keratins that was often observed during keratin reorganization during 
mitosis, apoptosis and stress  (Liao et al., 1997; Schwarz et al., 2015; Toivola et al., 2002) 
(Fig. 33) and was shown to colocalize with keratin phospho-epitopes  (Fig. 34). Increasing 
proportion of granular keratin with increasing degree of phosphomimetic mutations 
indicated the obstructing influence of negatively charged aspartate residue on keratin 
filament network formation. However, a small percentage of cells transfected with WT 
keratin also contained granular pattern which would be the result of over-expression of a 
single keratin type in absence of its complementary binding partner. 
In spite of the clearly observed trend of decreased keratin filament formation with an 
increase in the level of phosphomimetic mutations, there was still a considerable 
percentage of cells forming a normal filament network. Additionally, reduction in number 
of cells forming normal keratin filaments was statistically significant only in case of 
quadruple and quintuple mutants in comparison to WT keratin. Also, the extent of loss in 
filament formation in the quintuple mutant was less as compared to some of the quadruple 
mutants. These discrepancies are likely due to a compensatory effect executed by 
endogenous keratin in HaCaT cells. This necessitated the use of a system devoid of WT 
keratins to study the true properties of keratin mutants, which led to the use of murine 
keratinocytes lacking type II keratins as described in further experiments. 
5.2. Modifications in keratin filament formation and keratin cycling due to a single 
phospho-site mutation in H1 head domain of K5  
Consequence of phosphorylation on filament formation was investigated in detail for K5. 
K5 along with its type I partner, K14, forms the predominant keratin pair in basal layer of 
the epidermis (Bragulla and Homberger, 2009). K5 gene mutations were associated with 
skin blistering disorder, epidermolysis bullosa simplex (EBS), which involved formation of 
keratin aggregates (Chan et al., 1993; Coulombe et al., 1991b). Moreover, it was shown 
that Dowling Meara-epidermolysis bullosa simplex (EBS-DM) keratin contained 
hyperphosphorylated T150 K5 epitopes bound to HSP70 (Chamcheu et al., 2011). 
Similarly, L to P mutation at 160 K1 position, which was homologous to T150 K5, was 
implicated in epidermolytic hyperkeratosis (Chipev et al., 1992). Both, L160 K1 and T150 
K5 belong to H1 domain known for its high sequence conservation among the type II 
keratins (Chipev et al., 1992). The H1 subdomain is essential to propagate normal keratin 
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filament assembly (Parry, 1992; Steinert, 1991a; Steinert, 1991b). Thus, T150 K5 residue 
was an appropriate candidate to examine the effect of phosphorylation on filament 
formation of basal layer keratin. 
Phosphodeficient and phosphomimetic mutants, T150A K5 and T150D K5, respectively, 
were expressed in murine epidermis-derived type II keratin knockout (KO) keratinocytes 
to evade the masking of mutant phenotypes by endogenous keratin. The validity of this 
approach became evident by the pronounced modifications in keratin phenotypes in KO 
keratinocytes. KO cells showed an overall reduced capacity to form a well-developed 
keratin filament meshwork. Less efficient filament forming ability also reflected higher 
sensitivity of KO cells towards slight modifications in the keratin molecule thus making it 
a suitable system to distinguish between WT and mutant keratins. Loss of a normal keratin 
filament network by T150D K5 in KO cells as opposed to WT cells showed that 
constitutive phosphorylation at a single site in the K5 H1 domain was sufficient to interfere 
with keratin filament formation only in the absence of WT keratins (Fig. 9; Fig. 11). 
T150D K5 mutation manifested in the form of a predominant non-filamentous, free pool of 
keratins throughout the cytoplasm in transiently transfected as well as stably expressing 
KO cells (Fig. 9; Fig. 11; Movie no. 2). Some of the T150D K5 cells also presented keratin 
granules throughout the cytoplasm along with the diffuse pattern (Fig. 12). In case of 
T150A K5 mutant, keratin filaments looked thicker when expressed in KO cells as 
compared to WT K5 and appeared less mobile in comparison to WT K5 filaments (Fig. 9; 
Fig. 11; Movie no. 3).  Thus, although lack of phosphorylation at T150 K5 allowed keratin 
filament formation, these filaments looked more bundled and showed weaker networking 
(Fig. 13; Fig. 14). 
Modified keratin patterns by T150 K5 phospho-site mutants led to the analysis of keratin 
cycling in these mutants. The keratin cycle involves multiple steps as follows- 1) 
Nucleation: Keratin molecules at cell periphery nucleate to form keratin filament 
precursors (KFPs). 2) Elongation: KFPs further elongate. 3) Integration: The elongated 
KFPs integrate into the existing keratin filament network. 4) Bundling: Keratin filaments 
get thicker as individual filaments associate laterally. 5) Maturation: Keratin filaments, 
especially at the perinuclear space are stabilized for a long period of time. 6) Disassembly: 
Keratin filaments disassemble into KFPs, which diffuse rapidly and re-initiate the keratin 
cycle at the periphery (Kolsch et al., 2010; Windoffer and Leube, 2001) (Fig. 38A). The 
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deviant phenotypes of K5 mutants from WT K5 filament network hint towards an 
alteration of the keratin cycle on account of changes in phosphorylation (Fig. 38).  
                           
Fig. 38: Filament forming defect in the T150D K5 mutant indicated a modification of the keratin cycle 
of assembly and disassembly 
The rapidly diffusible keratin particles observed in T150D K5 expressing KO cells may 
indicate faltering of the keratin cycle at the second step, which involves elongation of 
KFPs into keratin filaments. Further, fragments of filaments observed at periphery of 
T150D K5-expressing KO cells may indicate a futile attempt of filament formation due to 
an inefficient elongation. Also, a slight time-dependent increase in the percentage of cells 
showing trace of filament particles may be a consequence of a steady slow-down of the 
keratin cycle (Fig. 12). Thus, T150D K5 expressing KO cells contained a large proportion 
of keratin molecules arrested between the nucleation and elongation step of the keratin 
cycle (Fig. 38-B, C). On the other hand, altered filament topology in the form of increased 
(A) shows a scheme (Windoffer et al., 2011) depicting different stages of the keratin cycle beginning at cell 
periphery and further progressing centripetally towards the nucleus. The first step involves (1) nucleation of 
keratin filament precursors that further show (2) elongation. The elongated keratin undergoes (3) integration 
into the existing keratin network and forms thicker filaments by (4) bundling. The keratin filament network 
can then either go through (5) maturation which involves stabilization for a longer period of time or 
disassembly back into keratin filament precursors to continue the keratin cycle. The keratin cycle is 
superimposed on WT K5 YFP-KO clone (B) and T150D K5 YFP-KO clone (C). Note the arrest of the 
T150D K5 cycling at the second step of elongation hinted at by presence of a few filamentous particles near 
the periphery. Scale bars = 10 μm 
A 
B C 
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filament thickness and decreased intra-filament branching in the T150A K5 filament 
network hinted towards an upregulation in the bundling step (Fig. 13; Fig. 14)  
5.3. Inhibitory effect of phosphorylation on keratin filament assembly 
Phosphorylation led to conformational modifications in the keratin molecule as observed 
by nuclear magnetic resonance (NMR) studies (Sanhai et al., 1999; Yeagle et al., 1990). 
Thus, phosphorylation was suspected to be a potent interfering factor in keratin filament 
assembly. Further, keratin reorganization and its enhanced detergent solubility as a result 
of drug-induced phosphorylation has been a common observation (Strnad et al., 2002; 
Woll et al., 2007). Moreover, drug-mediated solubilized keratin contained a major fraction 
of tetrameric keratin species (Chou et al., 1993). However, in addition to off-target effects, 
drug-induced keratin phosphorylation presented uncertainties by creating two possibilities 
explaining the influence of phosphorylation on keratin filament assembly:  
(i) Prevention of keratin tetramers in forming unit length filament (ULF) (Fig.2). or 
(ii) Disintegration of keratin filaments back into their subunits (Fig. 2). 
Phosphomimetic keratin-expressing cell line with non-filamentous keratin was a suitable 
tool to clearly determine the mode of action of phosphorylation in keratin assembly. The 
freely diffusible pool of non-filamentous keratin observed in the T150D K5 mutant showed 
enhanced detergent solubility, thus providing a preliminary indication of a system skewed 
towards disassembled or unassembled keratin filaments (Fig. 15). Simultaneous occurrence 
of the type I partner, K14, in soluble fraction of the T150D K5 cells indicated heterotypic 
nature of the soluble phosphomimetic keratin (Fig. 15). These observations were 
confirmed using different approaches to confirm the molecular nature of the T150D K5 
mutant as discussed below. 
Single plane illumination microscopy-fluorescence correlation spectroscopy (SPIM FCS) 
was used to determine diffusion characteristics of the highly abundant non-filamentous 
pool of T150D K5 mutant. Analysis of diffusion coefficient and hydrodynamic radius of 
the mutant keratin showed values that coincided with tetrameric form of keratin (Table 47 
and 48). Moreover, similar value was observed in case of WT keratin, which further 
confirmed that keratin tetramers formed a major fraction of non-filamentous free pool of 
keratins in both WT as well as the phosphomimetic keratin (Table 48) (Section 4.3). 
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Further, sucrose density gradient centrifugation coupled with chemical crosslinking of the 
T150D K5 mutant soluble pool confirmed presence of a K5/K14 tetramer according to the 
molecular weight and sedimentation characteristics (Fig. 18 and Fig. 20).  
It was known that tetramer was a basic unit of polymerization of keratin filaments which 
consisted of two antiparallel heterodimers arranged in a staggered fashion. Eight tetrameric 
keratin molecules further unite to form ULF structures (Quinlan et al., 1984; Steinert, 
1991a) (Fig. 2). However, the absence of a keratin filament network indicated 
incompetence of T150D K5/K14 tetramers to laterally associate into unit length filament 
(ULF) structures. Electrostatic repulsion between negatively charged head domains of the 
T150D K5 mutant may hinder the construction of ULF (Fig. 2). Another possibility could 
be generation of a defectively staggered T150D K5/K14 tetramer consequently hindering 
the process of filament formation (Aebi et al., 1983; Strelkov et al., 2002).  
Further, since a dimeric fraction of keratin was not detected by SPIM-FCS, chemical 
crosslinking or sucrose density gradient sedimentation, it showed that T150D K5 mutant 
was capable of forming stable tetramers unlike the loss of tetramer forming efficiency of 
K8 mutant lacking a large portion of the H1 head domain as examined by (Hatzfeld and 
Burba, 1994).  
Additional evidences have shown that although formation of a tetramer was an early 
process, it was the formation of an octamer (two tetramers aligned in a staggered fashion), 
which was the rate limiting step of keratin filament assembly (Steinert, 1991a; Steinert, 
1990). A critical concentration of an appropriately formed octamer provided a template for 
rapid addition of molecules leading to the assembly of ULF (composed of four octamers) 
(Steinert, 1991a). Moreover, charge modifications in H1 subdomain of type II keratin head 
region impaired the formation of an octamer (Steinert and Parry, 1993). Thus, presence of 
a phosphomimetic mutation at T150 residue of K5 H1 domain may possibly cause a defect 
at the octameric stage of assembly resulting into hindrance of keratin filament formation. 
T150D K5 keratin fraction, which was composed of a predominant pool of tetramers may 
contain oligomers below the critical concentration leading to inadequate nucleation 
material for filament assembly (Steinert, 1991a).  
Hence, analysis of the T150D K5 molecule presented a clearer understanding revealing 
that presence of a phosphate acted upon the alignment of keratin tetramers preventing them 
from forming higher order structures resulting in the loss of keratin filament network. 
Discussion 
98 
 
5.4. Phosphorylation- a momentum to keratin dynamics 
The keratin cycle of assembly and disassembly provides a dynamic nature to keratins thus 
contributing to cellular pliability (Windoffer et al., 2011). Phosphorylation was identified 
as a regulator of the keratin cycle. Drug-mediated activation of epidermal growth factor 
(EGF) increased the speed of the keratin cycle (Moch et al., 2013; Woll et al., 2007). As 
discussed in section 5.2, the upregulated pool of highly diffusible, non-filamentous keratins 
in the T150D K5 mutant as opposed to the longer and thicker filaments of T150A K5 
mutant were indications of altered keratin cycling. Effect of phosphorylation on the 
progression of keratin cycle was further confirmed by measuring the dynamics of the 
keratin mutants (Section 4.4). 
T150D K5 mutant expressed in KO cells showed an average recovery of 60 % after 
photobleaching within 60 seconds as opposed to an average recovery of 20 % in case of 
WT K5 and T150A K5 mutant (Section 4.4.3). The obvious factor that distinguished the 
T150 K5 mutant from WT K5 and T150A K5 was abundance of a highly mobile, non-
filamentous keratin pool in comparison to presence of a keratin filament meshwork in 
latter cases. Similarity in the percentage recovery of bleached fluorescence in WT K5 and 
T150A mutant can be explained by the fact that a short duration of 60 seconds would only 
measure non-filamentous keratin fraction which would be extremely sparse in WT and the 
phosphodeficient keratin mutant as compared to the phosphomimetic keratin. Thus, a large 
fraction of soluble, highly diffusible keratin tetramers present in the T50D K5 mutant 
provided it with enhanced keratin dynamics. 
However, in order to compare the effect of phosphorylation on keratin turnover between 
the T150D K5 and T150A K5 mutant required a more comparable system of measurement. 
Thus, analysis of filaments formed by each of the mutants was done (Section 4.4.1). Since 
T150D K5 was unable to form filaments in KO cells, it was transiently expressed in 
HaCaT cells, in which the mutant showed a considerable amount of filament formation, 
owing to the compensation from endogenous keratins. A statistically significant increase in 
the turnover of the T150D K5 mutant filaments in comparison to WT K5 confirmed the 
increased mobility of phosphomimetic keratin filaments (Fig. 21).  
However, HaCaT cells caused a limitation in defining the turnover of T150A K5 due to 
masking of its mutant properties by endogenous keratins. Hence, the T150A K5 mutant 
filament dynamics was finally determined in KO cells (Section 4.4.2). Since the T150A K5 
filament network had lower connectivity, it contained larger inter-filament spaces in 
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comparison to WT K5 (Section 4.2.1).  Hence, fluorescence was bleached in a larger part 
of the cell and filament rich regions were chosen to analyze fluorescence recovery post-
bleaching. This method ensured measurement of filament dynamics instead of including 
the non-filamentous regions. Turnover analysis showed that filaments of the 
phosphodeficient mutant were less dynamic in comparison to WT K5 (Fig. 22). This 
observation supported altered the T150A K5 filament topology, which showed increased 
thickness and less network branching. 
As discussed in section 5.3, the T150D K5 mutant was arrested at tetrameric stage of 
filament assembly most possibly due to inefficiency of the mutant tetramer in creating a 
sufficient oligomer concentration to promote further steps of filament assembly. This 
indicated that presence of a negative charge (mimicking phosphorylation) created dynamic 
equilibrium causing rapid exchange between tetrameric and octameric keratin subunits, 
thus preventing stability of higher order filament structures. This explained the increased 
mobility of T150D K5 and vice versa in case of T150A K5. 
These findings showed that phosphorylation was an impetus to the keratin cycle and hence, 
keratin dynamics. 
5.5. Requirement of T150 K5 residue phosphorylation for cell cycle progression  
Keratin 5 is the primary type II keratin of proliferating layer of the epidermis (Bragulla and 
Homberger, 2009). T150 K5 site phosphorylation was observed during mitosis and was 
detected in hyperproliferative situations such as psoriasis and squamous cell carcinoma 
(Toivola et al., 2002). Thus, cell cycle analysis of the KO cells expressing phospho-site 
mutants of T150 K5 was done (Section 4.5.4). 
Type II keratin KO cells showed a decreased G1:G2 ratio as compared to WT cells. The 
discrepancy in cell cycle distribution of KO cells was rescued by expression of WT K5 as 
well as T150D K5. However, T150A K5 expressing KO cells also showed a decreased 
G1:G2 ratio, suggesting the requirement of T150 K5 phosphorylation for normal cell cycle 
progression in epidermis-derived keratinocytes (Fig. 30; Fig. 31). Further, proportion of 
cells undergoing mitosis was unaltered in KO as well as T150A K5 expressing KO cells 
(Fig. 32). This observation hinted towards the possible defects in KO and T150A K5-KO 
cells at various points during the cell cycle such as: (i) G2/M block leading to inefficient 
entry into mitosis or (ii) Cytokinetic failure resulting in a low G1 population or (iii) 
Override of the G1/S checkpoint causing fast G1 to S transition.  
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Each of the above possibilities was linked to keratin or intermediate filaments previously. 
Phosphorylation of S33 K18 was required for normal G2/M progression (Ku et al., 1998a; 
Ku et al., 2002). Lack of vimentin S72 phosphorylation led to cytokinetic defects (Yasui et 
al., 1998). Finally, K8/K18-free hepatocytes from K8 null mice showed more efficient G1 
to S progression with a compromise in cell size (Galarneau et al., 2007). Elucidation of 
each of the above possibilities would be an important aspect to study the contribution of 
T150 K5 phosphorylation in cell cycle progression. 
Further, T150 K5 phosphorylation was associated with keratin granule formation during 
mitosis (Toivola et al., 2002). A detailed analysis of keratin filament modifications during 
mitosis performed in this work showed that keratin granules displayed a peculiar 
arrangement depending on the stage of mitosis. It was observed that cells in prophase and 
metaphase consisted of keratin granules dispersed in the cytoplasm. However, cells in 
anaphase and telophase showed keratin granules concentrated at the cleavage furrow (Fig. 
33). Since the cleavage furrow was enriched with intermediate filament-phosphorylating 
kinases such as Rho-kinase and Aurora B (Horwitz et al., 1981; Kawajiri et al., 2003; 
Kosako et al., 1999; Yasui et al., 1998), the presence of keratin granules within this niche 
indicated contribution of phosphorylation in keratin filament restructuring during mitosis. 
This hypothesis was proven by detection of T150 K5 phospho-epitopes in keratin granules 
formed during mitosis in HaCaT cells (Fig. 34). 
Further, considering the presence of phosphorylated T150 K5 residue with mitotic keratin 
granules, alteration in mitotic rearrangement of the phosphodeficient T150A K5 keratin 
was an obvious question to address. However, confocal imaging showed the presence of 
keratin granules even by the T150A K5 mutant during mitosis (Fig. 35). This suggested 
that phosphorylation at T150 K5 residue was not required for mitotic restructuring of K5. 
However, this did not overrule the possibility of a defect in segregation of daughter cells 
during cytokinesis, which was shown to be regulated by phosphorylation of the 
intermediate filament, vimentin (Izawa and Inagaki, 2006; Yasui et al., 2001). Also, 
phosphorylated keratin residues acted as binding motifs to important cell cycle regulating 
proteins such as 14-3-3 (Kim et al., 2006; Ku et al., 2002). Hence, phosphorylation at T150 
K5 residue may act as a switch to modulate certain pathways affecting the process of cell 
cycle. 
Thus, T150 K5 site phosphorylation mediated regulation on cell cycle progression of 
epidermal keratinocytes served as an interesting finding for further investigation of the role 
of K5 phosphorylation in basal layer of stratified epithelia. 
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5.6. Role of T150 K5 phosphorylation in oxidative stress 
One of the major highlights of EBS disease is occurrence of keratin aggregates that may 
contribute to basal cell cytolysis (Chan et al., 1993). T150 K5 phosphorylation was 
observed in Dowling Meara- epidermolysis bullosa simplex (EBS-DM) cells that increased 
with heat-induced aggravation of keratin aggregates (Chamcheu et al., 2011). Further, the 
phosphorylated T150 K5 residue was associated with HSP70 chaperone and this 
association was reduced upon treatment with chemical chaperones and kinase inhibition 
(Chamcheu et al., 2011). Besides, phosphorylation was known to cause conformational 
modifications of the keratin molecule (Sanhai et al., 1999; Yeagle et al., 1990). Thus, 
phosphorylation mediated keratin-misfolding posed as a potential cause of basal layer 
damage as observed in EBS disease. 
Further, it has been shown that protein misfolding led to an unfolded protein response 
(UPR), which was marked by accumulation of unusually folded proteins in the 
endoplasmic reticulum. UPR was often coupled with altered mitochondrial functioning 
(Malhotra and Kaufman, 2011). One such phenomenon, which involved UPR and 
mitochondrial cross talk, was presence of reactive oxygen species (ROS) causing oxidative 
stress (Senft and Ronai, 2015). Hence, T150 K5 mutant-expressing KO cells were induced 
with H2O2-mediated oxidative stress and the consequent effect was analyzed by measuring 
the level of stress-activated protein kinase/Jun –amino-terminal kinase (SAPK/JNK) 
activation that is a marker of both oxidative stress as well as protein misfolding (Section 
4.5.3) (Darling and Cook, 2014; Son et al., 2013; Wagner et al., 2013). Both, T150D K5 
and T150A K5 mutants showed elevated JNK signaling as compared to WT cells in 
response to oxidative stress (Fig. 27). The absence of upregulated JNK activation in KO 
cells in response to H2O2 indicated that lack of keratins was not responsible for this 
observation. Additionally, similar response to oxidative stress in both the phosphomimetic 
as well phosphodeficient mutants of T150 K5 residue showed that phosphorylation at this 
residue may not be directly involved in the increased kinase activation. However, an 
enhanced JNK signaling in both, T150D K5 and T150A K5 mutants in response to H2O2 
may be a result of increased keratin misfolding occurring due to phospho-site mutations.  
Additionally, MTT assay, which measures mitochondrial enzyme activity, also showed 
decreased viability in both, T150D K5 and T150A K5 mutant-expressing KO cells in 
comparison to WT cells (Section 4.5.1). This suggested overall reduced mitochondrial 
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vitality in phosphomimetic as well as phosphodeficient mutants of T150 K5 residue that 
may further contribute to increased JNK activation upon oxidative stress induction 
Further, unaltered level of heat shock protein (HSP) chaperones in mutants with/without 
stress when compared to WT cells was observed (Fig. 26). Similar levels of HSPs observed 
in mutants as compared to WT suggested that there was no distinct upregulation of these 
chaperones in the T150 K5 phospho-site mutants. However, increased HSP-keratin 
association, particularly upon stress in keratin phospho-site mutants was observed by co-
immunoprecipitation assays (Fig. 29). Elevated binding of heat shock chaperone with 
mutant keratin was more prevalent in case of HSP70 as compared to that of HSP90. This 
showed that altered keratin filament network properties in both T150D K5 and T150A K5 
mutants were accompanied with enhanced sequestration of HSP70 chaperone. Improved 
binding of HSP70 to mutant keratins additionally indicated occurrence of keratin filament 
protein modifications in T150 K5 phospho-site mutants.  HSPs were not only associated 
with misfolded proteins but were also involved in inhibition of MAPK pathway (Gabai et 
al., 1997; Meriin et al., 1999). Thus, increased association of HSP70 with mutant keratin 
may act as a possible cause of elevated JNK activation in T150 K5 phospho-site mutants. 
5.7. Association of T150 K5 phosphorylation with mutant keratin granules in EBS 
disease 
Keratin filament network modifications manifested in form of keratin granules was 
observed as a common characteristic of EBS patients besides extreme skin fragility (Albers 
and Fuchs, 1992; Chan et al., 1993; Coulombe et al., 1991a). Several indirect evidences 
created a hint towards implication of keratin phosphorylation in EBS disease (Chamcheu et 
al., 2011; Chipev et al., 1992; Werner et al., 2004). However, the exact role of keratin 
phosphorylation in the prevalence of typical EBS disease keratin aggregates was still 
unclear. 
Colocalization of phosphorylated T150 K5 (pT150 K5)  epitopes with mutant keratin 
granules observed in immortalized cells derived from EBS-DM (R125C K14 mutation) 
patients confirmed the link between phosphorylation and keratin filament alterations 
observed in EBS disease (Fig. 36; Section 4.6). Increased keratin phosphorylation 
accompanied with decreased keratin expression in the EBS patient cells may indicate 
reduced keratin stability on account of phosphorylation (Fig. 37).  
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Co-existence of EBS disease keratin aggregates with T150 K5 phospho-epitopes was 
reminiscent of Mallory-Denk bodies (MDBs), which were primarily misfolded K8/K18 
proteins sequestering S73 K8, S431 K8 and S33 K18 phospho-epitopes, detected in livers 
of chronic liver disease patients (Denk et al., 1979; Fausther et al., 2004; Fickert et al., 
2003; Stumptner et al., 2000; Zatloukal et al., 2007). Formation of MDBs required keratin 
phosphorylation and was advantageous to develop tolerance to liver toxicity (Ku et al., 
1998b; Zatloukal et al., 2000). This suggested that association of EBS keratin aggregates 
with T150 K5 phospho-epitopes may be an indication of a cellular defense mechanism to 
combat the disease condition. Moreover, similar to assumptions in case of MDBs, EBS 
keratin aggregates may play a role of segregating aberrantly folded keratins to be 
processed by chaperones. Improved binding of HSP70 to T150 K5 phospho-site mutants as 
shown by co-immunoprecipitation assays discussed in section 5.6, further strengthened the 
hypothesis that T150 K5 phosphorylation may be involved in the process of chaperone 
mediated control of EBS keratin aggregates. 
5.8. Significance of optimal phosphate balance on keratin structure and function 
Analysis of the T150D K5 and T150A K5 mutants showed that phosphomimetic and 
phosphodeficient keratin mutants result in opposing effects on the structure and dynamics 
of keratin filament network (Fig. 39). Further, although cell cycle progression of the 
T150A K5-KO mutant cells showed an alteration in G1:G2 ratio, the T150D K5-KO 
mutant cells did not show this effect (Fig. 39). 
However, since both T150D K5 and T150A K5 mutants represented anomalous 
phosphorylation of keratin, they also manifested some common effects on cell physiology 
such as lower cell viability, elevated stress mediated JNK signaling and increased 
association with HSP70 chaperones (Fig. 39). 
The results discussed in this thesis have shown that maintenance of an appropriate 
phosphate load is a crucial regulatory factor for keratin filament network architecture and 
function. Also, increasing hindrance on keratin filament network arrangement with 
increase in the number of phosphomimetic mutations indicated the requirement of a spatio-
temporal control ensuring a suitable combination of phosphorylated residues, thus, creating 
a ‘phosphate code’ for each keratin. 
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Fig. 39: Venn diagram depicting opposing and common effects of phosphomimetic (T150D K5) and 
phosphodeficient (T150A K5) mutants expressed in type II keratin knockout cells. 
 
Venn diagram illustrates that expression of the T150D K5 mutant (in red) showed defects in keratin filament 
network formation, increased keratin dynamics and unaltered cell cycle progression. However, the T150A K5 
mutant (in green) showed thicker keratin filaments with reduced branching, lower keratin dynamics and cell 
cycle defects. Moreover, both mutants showed common effects such as reduced cell viability, elevated stress-
mediated JNK signaling and enhanced association with HSP70 chaperones. 
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6. Summary 
Intermediate filaments, microtubules and microfilaments are major components of the 
mammalian cytoskeleton. Keratin intermediate filaments, which are strictly composed of a 
type I and a type II partner, play an important role in maintaining the mechanical integrity 
of epithelial tissues. Keratin molecules are composed of head (amino-terminal), rod (coiled 
–coil region) and tail (carboxyl-terminal) regions. It was shown that the head region of 
type II keratin is crucial for keratin filament assembly. Phosphorylation, which is one of 
the major post-translational modifications of keratins, occurs mainly in the head and tail 
regions of keratins. This was often accompanied by altered keratin filament rearrangement. 
Keratin phosphorylation was also linked to fundamental physiological mechanisms such as 
stress, mitosis and apoptosis. Moreover, several epithelial diseases such as epidermolysis 
bullosa simplex were associated with abnormal keratin phosphorylation. The aim of this 
work was to decipher the mechanism of action of phosphorylation on keratin filament 
network formation and function. 
To study the effect of phosphorylation on keratin filament network organization, the 
filament-forming efficiency of a series of phosphomimetic mutants of the type II keratins 5 
(K5) and 8 (K8) head regions were examined. Various mutants differing in the number of 
mutant residues were expressed in human epidermis-derived HaCaT cells. The percentage 
of cells with keratin filament forming defects correlated with the number of mutated 
residues. This observation can be taken as an indication of the additive effect of 
phosphorylation on keratin filament formation irrespective of the keratin isotype.  
Further, a model system to determine the consequence of phosphorylation on keratin 
filament organization and function in the absence of endogenous wild type keratins was 
established. This was achieved by preparing type II keratin knockout murine keratinocyte 
clones stably re-expressing phosphorylation mutants of the K5 head domain residue T150. 
T150 K5, which is one of the major phosphorylation sites of K5, was either mutated into a 
phosphomimetic (T150D K5) or a phosphodeficient (T150A K5) residue. T150D K5-KO 
keratinocytes showed a diffuse keratin pattern with few granules and small filamentous 
particles. Further, the T150D K5 mutant was highly soluble, extremely dynamic and 
mainly composed of tetrameric intermediates most likely arrested during keratin filament 
assembly. Contrariwise, the T150A K5 mutant was competent in filament formation but 
exhibited decreased turnover and altered filament topology in the form of increased 
Summary 
 
106 
 
filament thickness and reduced network branching. Thus, phosphorylation of the T150 K5 
residue regulated keratin filament network assembly, dynamics and morphology. 
Both T150D K5 and T150A K5 mutant clones showed reduced cell viability, upregulated 
response to oxidative stress and increased association with HSP70 chaperones. T150A K5-
KO mutants additionally showed a cell cycle defect marked by a decrease in the G1:G2 
phase ratio. Thus, phosphorylation of the T150 K5 residue was linked to cell physiology. 
Further, immortalized keratinocytes derived from patients with epidermolysis bullosa 
simplex disease showed colocalization of T150 K5 phospho-epitopes with R125C K14 
mutant keratin aggregates, confirming the link between T150 K5 phosphorylation and 
keratin filament network alteration. 
In summary, this work showed that mutation at a single phosphorylation site in the keratin 
molecule could alter keratin filament network formation, keratin dynamics and 
physiological processes in the cell. Also, a negative correlation between the quantity of 
phosphorylated residues and keratin filament formation was observed. Thus, 
phosphorylation was identified as a potent switch in the regulation of keratin structure and 
function.
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7. Zusammenfassung 
Intermediärfilamente, Mikrotubuli und Aktin-Mikrofilamente sind Hauptbestandteile des 
Zytoskeletts von Säugetieren. Keratin-Intermediärfilamente bestehen aus äquimolaren 
Mengen von Keratin-Typ I und Keratin-Typ II Polypeptiden. Sie spielen eine wichtige 
Rolle bei der Aufrechterhaltung der mechanischen Integrität von Epithelien. Keratin-
Polypeptide bestehen aus einer aminoterminalen Kopfregion, einer zentralen stabförmigen 
coiled-coil Domäne und einer carboxyterminalen Schwanzregion. Es konnte gezeigt 
werden, dass die Kopfregion der Keratin-Typ II Polypeptide essentiell für die 
Keratinfilament-Bildung ist. Phosphorylierung ist eine wichtige post-translationale 
Modifikation der Keratine, die hauptsächlich die Kopf- und Schwanzregionen betrifft. Sie 
führt häufig zu einem Umbau und einer Umstrukturierung der Keratinfilamente. Es wurde 
außerdem gezeigt, dass Keratin-Phosphorylierung im Zusammenhang mit grundlegenden 
physiologischen Prozessen steht, insbesondere mit Stressreaktionen, Zellteilung und 
Apoptose. Darüber hinaus sind mehrere epitheliale Erkrankungen, insbesondere 
Epidermolysis bullosa simplex, mit anormaler Keratin-Phosphorylierung assoziiert. Das 
Ziel der vorliegenden Arbeit war die mechanistische Aufklärung der Auswirkung von 
Phosphorylierung auf die Bildung und Funktion von Keratinfilament-Netzwerken. 
Um den Effekt der Phosphorylierung auf das Keratinfilament-Netzwerk zu untersuchen, 
wurde die Effizienz der Filamentbildung einer Serie von phosphomimetischen Mutanten 
der Kopfregion der Typ II Keratine K5 und K8 analysiert. Mutanten mit unterschiedlich 
vielen mutierten Aminosäuren wurden in immortalisierten humanen Keratinozyten der 
Zelllinie HaCaT exprimiert. Der Prozentsatz an Zellen mit Störungen der Filamentbildung 
korrelierte mit der Anzahl an mutierten Aminosäuren. Diese Beobachtung deutet darauf 
hin, dass sich Phosphorylierung additiv auf die Störung der Keratinfilamentbildung 
auswirkt und dass diese Eigenschaft unabhängig vom Keratin-Isotyp ist. 
Im Folgenden wurde ein Modellsystem etabliert, um die Auswirkung der Phosphorylierung 
auf die Keratinfilament-Bildung und -Funktion in Abwesenheit von wildtypischen Typ II 
Keratinen zu untersuchen. Dazu wurden stabile Zell-Linien von murinen Keratin Typ II-
Knockout (KO)-Keratinozyten hergestellt, in die K5 Mutanten eingeschleust wurden, die 
eine veränderte Phosphorylierung von T150 in der Kopfdomäne aufwiesen. T150, das eine 
der Hauptphosphorylierungsstellen in K5 ist, wurde entweder zu einer 
phosphomimetischen Aminosäure in T150D K5 oder eine nicht-phosphorylierbare 
Aminosäure in T150A K5 mutiert. T150D K5-KO Keratinozyten wiesen eine diffuse 
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Keratinverteilung auf mit einigen Granula und kleinen filamentösen Partikeln. Die T150D 
K5-mutanten Polypeptide waren überwiegend löslich, zeigten eine hohe Beweglichkeit im 
Zytoplasma und bestanden hauptsächlich aus Tetrameren - vermutlich auf Grund einer 
gestörten Keratinfilamentbildung. Im Gegensatz dazu bildeten T150A K5-Mutanten 
Filament-Netzwerke aus. Diese wiesen aber einen deutlich reduzierten Turnover und eine 
veränderte Netzwerk-Morphologie mit erhöhter Filamentbündeldicke und reduzierter 
Verzweigung auf im Vergleich zu Zellen, in denen wildtypisches K5 eingeschleust wurde. 
Diese Beobachtungen zeigen, dass die Phosphorylierung von T150 in K5 eine zentrale 
Bedeutung für die Regulation des Keratinfilament-Netzwerk-Aufbaus, den 
Keratinfilament-Turnover und die Netzwerk-Morphologie hat. 
Sowohl T150D K5-KO als auch T150A K5-KO Zellklone zeigten eine reduzierte 
Lebensfähigkeit, eine verstärkte Reaktion auf oxidativen Stress und eine erhöhte 
Assoziation mit HSP70 Chaperonen. Zusätzlich war in den T150A K5-KO Zellklonen ein 
Zellzyklusdefekt nachweisbar, der auf einer Reduktion des Verhältnisses der G1:G2 
Phasen beruht. Außerdem konnte ich in immortalisierten Keratinozyten, die von 
Epidermolysis bullosa simplex Patienten gewonnen wurden, zeigen, dass T150 K5 
Phosphoepitope mit R125C K14-haltigen Keratin-Aggregaten ko-lokalisieren. Dies ist ein 
weiterer Hinweis auf den Zusammenhang zwischen T150 K5 Phosphorylierung und 
gestörter Keratinfilament-Netzwerk-Bildung. 
Zusammenfassend zeigt die Arbeit erstmals, dass die Mutation einer einzigen 
Phosphorylierungsstelle in einem einzelnen Keratin-Polypeptid ausreicht, um die Keratin-
Filament-Netzwerk-Bildung zu unterbinden und dass dies Auswirkungen auf die 
Keratindynamik und mehrere zelluläre Prozesse hat. Darüber hinaus stellte sich heraus, 
dass multiple phosphomimetische Mutationen einen potenzierenden Effekt auf die Störung 
der Netzwerkbildung in Gegenwart von wildtypischen Keratinen hat. Insgesamt kann 
geschlossen werden, dass Keratinphosphorylierung ein wichtiger Schalter in der 
Regulation der Keratin-Strukturbildung und -Funktion ist. 
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8. Outlook 
The analysis of single phospho-site mutants of T150 residue of keratin 5 (K5), within a 
cellular environment devoid of endogenous keratins, provided a clear proof that 
phosphorylation alone, is a highly effective tool to modify the structural properties of 
keratin filament organization as well as its functions.  
Detection of T150 K5 phosphorylation in mutant keratin aggregates of skin blistering 
disease, epidermolysis bullosa simplex (EBS), provided an additional validation of the 
effect of T150 K5 phospho-site mutations on structure and dynamics of keratin filament 
network that was discovered in this work. Investigating specific kinases such as from the 
MAPK pathway associated with the hyper-phosphorylated keratin aggregates would reveal 
additional mechanisms by which keratin phosphorylation may contribute to EBS disease. 
Modifications in various aspects of cell physiology as a result of keratin phospho-site 
mutations presented a crucial hint correlating keratin phosphorylation to the weak 
epidermal integrity reflected in the form of skin fragility in EBS disease patients. Thus, 
keratin phosphorylation would serve as an appropriate target to design a cure-strategy for 
EBS disease. Additionally, the requirement of T150 K5 phosphorylation for a normal cell 
cycle progression hinted towards the implication of keratin phosphorylation in diseases 
linked to hyperproliferation such as psoriasis and cancer as well as hepatic diseases 
involving liver regeneration. 
Future experiments such as examining the level of markers for endoplasmic reticulum 
stress, unfolded protein response and measuring the level of reactive oxygen species in the 
keratin phospho-site mutants can provide additional understanding of the role of keratin 
phosphorylation in maintaining homeostasis. Moreover, a detailed analysis of cell cycle 
progression in phosphodeficient keratin mutant can be done by synchronizing the cells to 
each of the cell cycle phases and examining the activity of crucial cell cycle kinases such 
as Aurora, Polo-like kinase or cyclin dependent kinases. Transition between the phases can 
also be analyzed by screening the related markers such as the Akt pathway for G1 to S 
phase transition, the level of keratin associated 14-3-3 proteins for G2 to M progression 
and the anaphase promoting complex to ensure the efficient conclusion of mitosis. 
Also, EBS patient cells should be scrutinized with respect to aspects such as oxidative 
homeostasis and cell cycle progression. Experiments using kinase inhibitors or 
phosphatases as a possible rescue strategy for keratin aggregation and disease phenotype in 
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EBS disease should be utilized. Additionally, the EBS aggregates can be examined for the 
presence of proteins such as p38MAPK, JNK, heat shock proteins and ER stress markers. 
A proteomic screen of EBS disease keratin isolated using antibodies specific to keratin 
phosphoepitopes can provide a systematic analysis of the mechanisms associated in the 
generation of hyperphophorylated keratin aggregates in EBS disease. 
Dose-dependent hindrance of phosphorylation on keratin filament formation in both, K8 as 
well as K5, revealed the potential of phosphorylation as a global, calibrating switch for 
keratin filament organization. This work suggested that keratin phosphorylation was not 
only a player in the remodeling of the keratin cytoskeleton but also had an active role in 
regulating cellular processes, which influence tissue morphogenesis. Hence, assessing and 
attuning the level of keratin phosphorylation would be a promising factor in the 
development of diagnostic and therapeutic tools for the diseases of epithelia. 
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RT Room temperature   
RT-PCR Reverse-transcriptase PCR   
S Sedimentation coefficient   
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SIM Structured illumination microscopy   
SPIM-
FCS 
Selective plane illumination 
microscopy-fluorescence correlation 
spectroscopy 
  
S-R Super resolution   
TBS Tris buffer saline   
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UPR Unfolded protein response   
UV Ultraviolet   
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YFP Yellow fluorescent protein   
 
Table 51: Amino acids. 
A   alanine (Ala) G   glycine (Gly) M   methionine (Met) S    serine (Ser) 
C   cysteine (Cys) H   histidine (His) N   asparagine (Asn) T    threonine (Thr) 
D   aspartic acid (Asp) I    isoleucine (Ile) P   proline (Pro) V    valine (Val) 
E   glutamic acid (Glu) K   lysine (Lys) Q   glutamine (Gln) W   tryptophan (Trp) 
F   phenylalanine (Phe) L   leucine (Leu) R   arginine (Arg) Y    tyrosine (Tyr) 
List of Figures 
121 
 
11. List of Figures 
Fig. 1: Scheme depicting the structure and phosphorylation sites identified in type II keratin K8. .. 3 
Fig. 2: Scheme depicting the different stages of intermediate filament assembly. ............................ 4 
Fig. 3: Representation of the different layers of the mammalian skin and keratin expression in it. 10 
Fig. 4: Scheme representing the activation of the mitogen activated protein kinase (MAPK) 
pathway. ........................................................................................................................................... 11 
Fig. 5: Scheme depicting the amino acid residues in the K8 head domain selected for 
phosphomimetic mutation. ............................................................................................................... 47 
Fig. 6: Scheme depicting the amino acid residues in the K5 head domain selected for 
phosphomimetic mutation. ............................................................................................................... 47 
Fig. 7: Transient transfection of either K5 or K8 in HaCaT cells showed three different keratin 
phenotypes: filamentous, filamentous + granular and granular. ...................................................... 49 
Fig. 8: Increasing keratin phosphorylation decreased keratin filament formation cumulatively. .... 50 
Fig. 9: Transient transfection of T150D K5 YFP and T150A K5 YFP showed different keratin 
filament morphology in WT and type II keratin knockout (KO) murine keratinocytes. .................. 52 
Fig. 10: Cell lines derived from type II keratin knockout (KO) murine keratinocytes stably 
expressing WT and mutant keratin showed similar keratin expression at transcriptional and 
translational level. ............................................................................................................................ 53 
Fig. 11: Keratin expression patterns of WT and mutant keratin stably expressed in type II keratin 
knockout (KO) murine keratinocytes. .............................................................................................. 54 
Fig. 12: Assembly incompetent T150D K5 mutant showed three characteristic keratin patterns in 
type II keratin knockout (KO) cells. ................................................................................................. 55 
Fig. 13: Lack of phosphorylation at T150 K5 decreased branching in the keratin filament network.
 .......................................................................................................................................................... 57 
Fig. 14: Lack of phosphorylation at T150 K5 led to a significant increase in the inter-branch 
filament length of the keratin filament network. .............................................................................. 58 
Fig. 15: Phosphomimetic mutation at T150 K5 enhanced K5/K14 detergent solubility. ................ 59 
Fig. 16: The detergent soluble fraction of T150D K5 YFP was composed of freely diffusible fine 
particles and the insoluble fraction mainly contained in coarse granules. ....................................... 60 
Fig. 17: The diffusion coefficient of the free pool was the same for WT and T150D keratin. ........ 62 
Fig. 18: Chemical crosslinking of the T150D K5 YFP-KO C1 soluble pool showed a shift of the 
monomeric forms of K5 and K14 to distinct higher oligomeric state. ............................................. 63 
Fig. 19: Sodium butyrate increased the expression of keratin in the T150D K5 YFP-KO C1 cells. 65 
Fig. 20: Detergent-soluble fraction extracted from T150D K5 YFP-KO C1 cells showed that K5 
and K14 co-sediment and correspond to the size of K5 YFP/K14 tetramer. ................................... 66 
List of Figures 
122 
 
Fig. 21: T150D K5 YFP filaments showed faster recovery after photobleaching than WT K5 YFP 
and T150A K5 YFP filaments. ......................................................................................................... 69 
Fig. 22: T150A K5 YFP filaments showed slower recovery after photobleaching than WT K5 YFP 
filaments in KO cells. ....................................................................................................................... 70 
Fig. 23: The non-filamentous T150D K5 YFP mutant pool was highly dynamic. .......................... 72 
Fig. 24: Phospho-site mutation at T150 K5 reduced cell viability. .................................................. 74 
Fig. 25: Co-immunoprecipitation of T150D K5 YFP. ..................................................................... 75 
Fig. 26: T150 K5 site mutation did not affect the level of the heat shock proteins (HSP) irrespective 
of oxidative stress induction. ............................................................................................................ 77 
Fig. 27: T150 K5 phospho-site mutant cells showed elevated Jun –amino-terminal kinase (JNK) 
activation in response to oxidative stress, without apoptosis. .......................................................... 78 
Fig. 28: T150 K5 phospho-site mutant cells did not show alteration in extracellular signal related 
kinase (ERK) activation in response to oxidative stress and oxidative stress did not activate p38 
MAPK in murine keratinocytes........................................................................................................ 79 
Fig. 29: Phosphomimetic (T150D K5) as well as phosphodeficient (T150A K5) mutant keratin 
showed increased association with HSP70, which further elevated upon oxidative stress. ............. 80 
Fig. 30: Cell cycle distribution was altered in the absence of T150 K5 phosphorylation. ............... 83 
Fig. 31: Cell cycle distribution was affected in the absence of T150 K5 phosphorylation. ............. 84 
Fig. 32: The proportion of mitotic cells was unaltered upon T150D K5 site mutation.................... 85 
Fig. 33: Keratin filament network disassembled and reassembled during mitosis. ......................... 86 
Fig. 34: T150 K5 residue phosphorylation was linked to keratin filament reorganization during 
mitosis. ............................................................................................................................................. 87 
Fig. 35: Keratin reorganization during mitosis was not affected in the absence of T150 K5 site 
phosphorylation. ............................................................................................................................... 88 
Fig. 36: Phosphorylated T150 K5 (pT150 K5) epitopes colocalized with Dowling-Meara EBS 
(EBS-DM) keratin granules. ............................................................................................................ 90 
Fig. 37: Cells derived from EBS-DM patients showed increased phosphorylation of T150 K5 
(pT150 K5) and decreased keratin expression ................................................................................. 91 
Fig. 38: Filament forming defect in the T150D K5 mutant indicated a modification of the keratin 
cycle of assembly and disassembly .................................................................................................. 95 
Fig. 39: Venn diagram depicting opposing and common effects of phosphomimetic (T150D K5) 
and phosphodeficient (T150A K5) mutants expressed in type II keratin knockout cells. .............. 104 
List of Tables 
123 
 
12. List of Tables 
Table 1: Nomenclature of intermediate filaments based on (Snider and Omary, 2014) .................... 1 
Table 2: List of chemicals ................................................................................................................ 15 
Table 3: List of molecular ladders .................................................................................................... 16 
Table 4: List of kits .......................................................................................................................... 16 
Table 5: List of enzymes .................................................................................................................. 16 
Table 6: List of activators and inhibitors ......................................................................................... 17 
Table 7: List of cell culture media, media supplements, matrix proteins and antibiotics ................ 17 
Table 8: List of primary antibodies .................................................................................................. 17 
Table 9: List of secondary antibodies .............................................................................................. 18 
Table 10: List of labware ................................................................................................................. 18 
Table 11: List of cell culture equipment .......................................................................................... 19 
Table 12: List of centrifuges and related equipment ........................................................................ 20 
Table 13: List of electrophoresis equipment .................................................................................... 20 
Table 14: List of power supplies ...................................................................................................... 20 
Table 15: List of shakers and mixers ............................................................................................... 20 
Table 16: Spectrometers ................................................................................................................... 21 
Table 17: List of immunoblot and gel imaging equipment .............................................................. 21 
Table 18: List of miscellaneous equipment ...................................................................................... 21 
Table 19: List of the components Zeiss LSM 710 Duo ................................................................... 21 
Table 20: List of the components Zeiss ApoTome 2 ....................................................................... 22 
Table 21: List of Bacterial strains .................................................................................................... 22 
Table 22: List of primers .................................................................................................................. 22 
Table 23: List of plasmids ................................................................................................................ 23 
Table 24: List of cell lines ................................................................................................................ 23 
Table 25: List of softwares ............................................................................................................... 23 
Table 26: Composition of Tris/Borate/EDTA (TBE) buffer (5X) ................................................... 24 
Table 27: Composition of transformation buffer I (TFB I) .............................................................. 25 
Table 28: Composition of transformation buffer II (TFB II) ........................................................... 25 
Table 29: Composition of LB (Luria-Bertani) medium ................................................................... 26 
Table 30: Composition of Tris EDTA (TE) buffer .......................................................................... 26 
Table 31: Cloning strategy for K5 phosphomimetic mutants .......................................................... 28 
Table 32: Cloning strategy for K8 phosphomimetic mutants .......................................................... 28 
Table 33: Chemical supplements for DMEM/Hams’s F12 medium ................................................ 30 
Table 34: Volume of lysis buffer according to Petri dish diameter ................................................. 33 
Table 35: Composition of lysis buffer .............................................................................................. 33 
List of Tables 
124 
 
Table 36: 5X SDS denaturation buffer (Laemmli buffer) ................................................................ 33 
Table 37:  Composition of low-salt buffer (LSB) ............................................................................ 34 
Table 38: Composition of high-salt buffer (HSB) ............................................................................ 34 
Table 39: Composition of CO-IP wash buffer ................................................................................. 36 
Table 40: Resolving gel composition ............................................................................................... 38 
Table 41: Stacking gel composition ................................................................................................. 38 
Table 42: Composition of 10X SDS running buffer ........................................................................ 38 
Table 43: Composition of Immunoblot transfer buffer .................................................................... 39 
Table 44: Tris-buffered saline-Tween-20 (TBS-T) .......................................................................... 40 
Table 45: DNA content in different cell cycle phases ...................................................................... 40 
Table 46: Series of phosphomimetic K8 and K5 mutants created. .................................................. 48 
Table 47: Calculation of hydrodynamic radii for a keratin cylinder at different oligomeric states . 62 
Table 48: Hydrodynamic analysis of WT K5 and T150D K5.......................................................... 62 
Table 49: T150D K5 is tetrameric .................................................................................................... 64 
Table 50: Proteins detected in mass spectrometry fingerprint analysis ........................................... 76 
Table 51: Amino acids. .................................................................................................................. 120 
List of Movies 
125 
 
13. List of Movies 
Movie no. 1: WT K5 YFP in motion in a single murine epidermis-derived type II 
keratin knockout (KO) cell. WT K5 YFP stably expressed in a KO cell shows the 
presence of a keratin filament network. Note the centripetal movement of the keratin 
filaments corresponding to the keratin cycle as described in section 5.2. 
Movie no. 2: T150D K5 YFP in motion in a single murine epidermis-derived type II 
keratin knockout (KO) cell. T150D K5 YFP stably expressed in a KO cell does not show 
keratin filament network formation. The mutant keratin is expressed in a predominant 
diffuse pattern along with a few granular structures. Note the rapid movement of the fine 
keratin particles dispersed throughout the cytoplasm.  
Movie no. 3: T150A K5 YFP in motion in a single murine epidermis-derived type II 
keratin knockout (KO) cell. T150A K5 YFP stably expressed in a KO cell shows the 
presence of a keratin filament network. Note the increased filament thickness and 
decreased network branching in this mutant in comparison to WT K5 YFP network as seen 
in movie no. 1. Additionally, the keratin filament network appears less dynamic than WT 
K5. 
Publications and Presentations 
126 
 
14. Publications  
Mugdha S. Sawant, Reinhard Windoffer, Nicole Schwarz , Thomas Magin, Jan Krieger, 
Norbert Mücke, Boguslaw Obara, Rudolf E. Leube. Mutation of a single phosphorylation 
site in the keratin H1 head domain prevents network assembly affecting cell cycle 
progression and oxidative stress response. (Manuscript in preparation) 
Mugdha Sawant and Rudolf E. Leube. Consequences of keratin phosphorylation for 
cytoskeletal organization and epithelial functions. International review of cell and 
molecular biology. December 2016, Volume 330. (Book chapter) 
Dennis Eschweiler, Jakob Unger, Kraisorn Chaisaowong, Mugdha Sawant, Reinhard 
Windoffer, Rudolf E. Leube and Dorit Merhof, Detection and quantification of cytoskeletal 
granules. Bildverarbeitung für die Medizin. 2016, pp 260-265 (Conference paper) 
 
15. Presentations 
Poster entitled ‘Role of phosphorylation in keratin reorganization’. Mugdha Sawant, 
Nicole Schwarz, Rudolf E. Leube. 9
th
 European Intermediate filament meeting. Stockholm, 
24-27 June 2015. 
Poster entitled ‘Effect of phosphomimetic mutations on keratin reorganization’. 
Mugdha Sawant, Nicole Schwarz, Rudolf E. Leube. 8
th
 European conference on 
intermediate filaments in health and disease, Amsterdam, 18-21 September 2013. 
Oral presentation entitled ‘Analyzing the effect of phosphorylation on keratin filament 
network arrangement’. Intermediate filament meeting, Amsterdam, 15 February 2013. 
(Received a travel grant from NANONET – a network sponsored by the European Union) 
Acknowledgements 
127 
 
16. Acknowledgements 
I would like to extend sincere gratitude towards my doctoral thesis supervisor, Prof. Dr. 
Rudolf Leube for his expert guidance and helpful discussions throughout the course of this 
work. The motivation and freedom provided by him in putting forward my ideas and 
experiments was a good learning experience. 
I would also like to thank Prof. Dr. Reinhard Windoffer for his fruitful ideas during this 
work and especially for his expertise in microscopy and related experiments. 
I thank Prof. Dr. Gabriele Pradel for her helpful opinions and review of this work. 
I thank Dr. Nicole Schwarz for her scientific and non-scientific support throughout my 
tenure as a doctoral student. I especially thank her for the cloning experiments and for 
proof-reading this thesis. 
I would like to thank Dr. Marcin Moch for his teaching and timely help during the 
performance of microscopy experiments. I thank Dr. Sebastian Kant for his patient 
guidance especially for the sucrose density gradient experiments. 
Ursula Wilhelm, Christiane Jaeschke, Sabina Hennes-Mades, Bärbel Bonn, Markus Paul, 
Justus Schwarzott,  Mykhaylo Anokhin and Felix Meuer, I thank you all for the technical 
support.  
I thank Dr. Norbert Mücke and Dr. Jan Krieger for the provision of the SPIM FCS facility 
and the stimulating discussions regarding it. I thank Prof. Dr. Joachim Jankowski and Dr. 
Vera Jankowski for providing the mass spectrometry facility. I thank Prof. Obara for the 
analysis of the miscrocopy data.  
I thank Prof. Dr. Stefan Uhlig and Prof. Dr. Andreas Ludwig for access to the 
ultracentrifuge. I thank Prof. Dr. Markus Kipp for access to the microplate reader.  
I would also like to thank Dr. Volker Buck, Dr. Florian Geisler, Richard Coch, Anne Pora, 
and Nadieh Kuijpers for the stimulating scientific discussions as well as the enjoyable time 
outside work. I thank Oliver Jahnel, Mariam Al Bayati, Dennis Lawin, Florian Streuter, 
Florian Bruns, Benjamin Freytag, Thomas Kienzle, Mustafa Gercek, Muhammed Gercek, 
Sonja Lehmann, Kateryna Venger and Cendra Zajber for contributing to a favorable work 
environment. I thank Elke Broekmeulen for her administrative expertise. I thank Adam 
Breitscheidel for his graphic designing skills. 
I would like to thank my friends, Hanan Jamadar and Lalit Sehgal, my sister, Anvi Sawant 
and my parents, Suresh and Sharayu Sawant for their consistent understanding, support and 
encouragement, which was highly beneficial during this work. 
